var title_f17_50_18208="Collagenous colitis US";
var content_f17_50_18208=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F79824&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F79824&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Collagenous colitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 327px; height: 316px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAE8AUcDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5xUkcD8q0tH0y71GdktYpJnRGlZUGSFUZY49AASauW8GkA4lvUDjqPLc/0r0H4V2miya/OPt1vIz2FyoRopcqShG4fKAcZ6ZB9K7I0rvdfeialXlTaT+5mt8KvA2h6j4R1fxF4kuLz7HZXC24hslBkU/L854bK/vBxgY2kk46dToPhbwDrmvWujQtrMdxciQxZIXdtUseTFgYAPWuR8PR3Wh+Z/Z2rQKsuGZGhm257kAqMHHfvge1btzf63ceRI2qWTCFi6A28hwSCD/D6GumNNKNnv8AL/M4JynKV7/19x4546sodN8U6rZWZYR2l7PbxMzAttSRlBJHGcAVytw0juWkZmYnkk5zXo+t6LDJdzTz3cHmyu0jhbeUDJJJx8nHOeKyX0eyDlBeRbi2ADFJzx/u1hKi+rX3o76c7LY44HoCDihkwenHau8j8NQOQRdQ5/65Sf8AxNMk8P26sf8AS4gw7eRL/wDEVHsCvbLscE4OAQpwKZtPevUNX0PSJja/2W8MCC1jE6lZ2zOFHmMNy5wTkgds4rOPhq32nN3Bn/rnJ/8AE0vYen4Aq67HCSPJ5IjySmc4pn7xUKjO0+ldtJo1mgXN5D7jyn/+JqL+y7Mjm7iHA/5ZP3/4DQ6PmvvLVTyOKIOcDNO+Z1A7gYrrf7P093AW+hD9CDE4/mtWbTRbOYIPtsSluf8Aj3lP8kpKhfRNfegdW3T8DldP0u5vhL9lheUxRtNJtGdqLyzH0A7mq7QlWwMmvZfB+jWukSaxLdXVs0d7o11YIxt5SYpJVXa+NnOMHjrzXIy6LZRyBDqURYDBxbTf/EVbw9l0+9ERr3bVn9zOLeAiHfjAzj6moRE3Yda9GbQ7dkC/b4gF7eS5B/Sqsuh2SnH9pRZ7/wCjS/8AxNR9X8196L9uuz+5nAONuOOab8xGMGvQV8NWrnnUYQew+zyN/JasR+DoGTP9poP+3Kc/+yU1hpPa33r/ADJeIiu/3P8AyPNtjs3AJpDGwIO0kV6JP4csbcnfq8anv/oM4/8AZKt32jaHeRWA069gt5EtlS6PkTnzpgTmT5h8uQVG0YHyk96bwz8vvX+YvrCfR/c/8jzAIc5K4p07PK4aQszYC5POABgD8AAPwr02HwZaSDnWYee/2OQ/0pkvg+zTltYhJ5zizl4/Tmj6rL+mv8w+sR8/uf8AkeZopG7GQRTfKdiPlIB4Bx3r0GTwxYIc/wBtRY7EWcv8sZqzH4VspvLVdeQSKWOBp057DuFx6/pil9Wk+33r/MHiIre/3P8AyOA0vSb7V9RSysITNduruE3BflRS7EkkAAKrEknoKfZ6Vd3UF28ELPHaoJZjjlF3Bc/mwH413l14Z0i3SRLjXIjk/fOnTjp7ba2/DWmaVaWWs28HiFJU1C2FuJG0q5BT50fdjv8AcxjnrTWFd7P81/mS8SrXSf3P/I8beNmkAwxPSkkiZWIweK9XbwLpkQ3f8JQh/wC4RcD+lVX8K6OXIPiVAD0A0q4P9P8APtSeFl/TX+YLFU3tf7n/AJHmAjbP3TT0jORkH8q9IPhPSVBx4kBOO+k3A/pUS+HtJTCHxDGScgj+z5eD+VJ4aXl96/zKWJg9r/8AgMv8jz8xnjANKFcucqTnqcV6WnhLTHXjxEPl9NLlPH51BJ4e0iJ8HxGD05/suVf60fV2tf1X+YvrMOl/ul/kefeSx7HH0pGhbjKHHavV/wCwNGvNJ063g1GKC5hMhmu1s5Wa53NlcqXwu0DHAGc881bsvAOnSyR+Z4kBjLDIGmOCV7/x8fr+NX9Vk9vzX+YvrcFv+T/yPGzE/ZTn6Uqwvn7pr3hPhZYuA48VRoD2/shzj/yJVe4+GdhCpJ8Vqx9tHYY/8i0vqsu35f5i+uU77/g/8jxARunO0jPTioyCN3BzXrlz4L0pflPicsR/1CiMfh5lee+IbNNP1Ca3il85FJCy7Nu8euMnH0yaidFwV3+hrTrxqOy/J/qjJgYDrRSIhY/LRUJ2NSyhO4cc16b8FI2l8WBOMm0n6/7hrzRRzxXrX7PMIl8fwqy5BtJwee2w1tS0kmc2KdqbZ6jYaZCwzOgNbUVtpcCAlcEdjW3BpKjJ8vIqnLosV3LsGUNeuklseLzX6mDenR2Y5t4y3qRXLXtrpks+7yFGD2FdxdeC3Q71cuPSoIfByzkAqykVDXNqWppdTEsV0tEBMAOKztbvtNQlY7ZB74rvj4IKxYGcVg6j4JiyTMTS3VkClG+rOEivbIn/AFI59qS6m0/yiTDzW9J4TgiYlX4qePRNPijHnMG9s1PLLqa8y6HmVzLatKcREihri0OAYAMV6HNoFjdg/Z4VU9jWc3ghfmaSVcVk6UuhqqsepxLpp5mBaEfUVuWOoadbxjbGvFLe+F9pKxSKQPeqUfhG8uHC2+HH1qUpJ7FNwluzQl163LFRgimWKWN1KWnXnORTP+ERurYfv4ufatrT/CszIrIpFWlJvVEtxS0ZDPaWCYKHAqe00/TZyPNINM1XwxqCr8qMQPSsu10+9ilKbXyKrZ6onfqdtZadpNsuRGGPqamnuNOSHaqKMdK5gmeGHEiuMdaS10+41BwYiwX0JqubokRy9Ww1aKyudxOB6YrlnsvLuCYU3KOxr1PTPB6sgM5BJ960LjwbFjMISh0nLUaqqOh5ppKlh5co2+/pXQwafYjBkYtWz/wiLxOXd1C+lOfQvMcLHIoxTUGhOaezM5tF0aRQ3lnf7VFLBbWqboEAKng4rqLPwvMMZkU8VLL4PlmBEk6KvU89abi+xHOu55Tq9sLuY/KFFaGkaRKir5bp+NeiL4Qs4zhpFY+tEvh2OLmB14HrSVJ7l+1VrI5+20nMX+kMje1QXNpY2yZ8lCR3q7exXMD7FUkeoqBdGvdQXCgLnuxp26JCXmYE17ZhypgQj6VLb2WnXI3/AGNd574rSl8CXanzJJUwOSAa0NN062txtkk2ketTyvqVzRt7pzN1aSR4EMC7PpUlrb2Ey/6Vaqze4rq7hLAAh7hfzrIuIrLzP3Um78aHGwc1y1p1joyBQIAPatoWWn7AYI9p9aydL00yyAq4A9zXWQ6OhhG6ZRj3rSK02M5O3UzQkYAXGahuoomUgx1rNpyRtkTrimyQW+BvmAqrE3PMPEunxqWdEbPtXi/itCuovuB/Gvp3VrS1ZWxICPevnv4kpHHr0iREFcDkfSuHFQtG534Sd5WONhXJ+UUVbtEBbAUdPWiuJI9BysRp97Ir2X9nSaAeN7JDDidYrp5J95+eMxoETb0G0rIc9W8zB+4teNKMck49znH6V6X8E5mt/GCyfdYWk3/oNaU1eSOfFK9No+sjqNvFFztqi+uafG24lA3rmvKdU8QXHlEITXD32v3ckxXcwOa73yRPHhQcj6MPiayPAdfzpkfiWzjOdy185Q6tdDJZyPxpz61dAcMxFLmhbYv6sfSE/jSzSM/MufrXJa94wt5wwQivEZdfkJ2vIQfrUaX8jv8AfyKUZwj8KKWGtudxqWrNIGKzbRXI3fiGSGfb5m7HvVXUJ5Ps3yHLVgRmMSbrnlqidR3OinTVtTs4/Fs6xfLwBUTeK7llbLHH1rn4bq3c7AOKe6w7SVPHWjnl3HyR7BL4nm+0nLnrzXZeGPEa4GK8rvokFwTu4610Gg3FtDGPn5qYTknqXUpxa0R7N/btvJDhwpOKzF8WC0kKAjb2rhF1SFiV839aiZoZmyZq3dVvY5/ZJbnq8XjBJIuQpqjP4ot0YsY0z61xdk1qigGTj60atDbSW5aKT5vrVOpKxKpxvY6W68U21xGVKR81WtdTEXzQ8ewrzd1lickPkD0rrNAurPyl+0PzWcajk9TSVJRWh1J8VTxkDNWIfGUnALfrWJPLpEinD4P1rCvUtlJaGfmrc5LqZqEX0O6n8U+aCC361Xi1sCQEN39a8/tbtFkKzNlfWt6y1bTIwA+CaSqX6lOnboeg2/iGRUXDZ/Gq2peJpgp+Yj8a5hNZ0xzhXx+NMuL3S5Ad0hPtmrdR23M+RX2IbzxbdR3BZSdn1rR03xdLKPn/AJ1yl4bSWQ+VnZVNzCh+SQjisueSe5tyRa2PRH8TDqdpHpSL4xSPpgCvOUYsp2y5NUboSk8sVFDrSQKinuenz+NlZDhs/jXK6l4t3yEZA+lcPM7xuQJeTUdtC890pnPy1Eq0pGsaMUdJc6u0kRZCSx71Ri1e8ibJJA966zRbLT2hGUUn3qW+0CynGV4+lPkk9bkqcU7WM/TfFFwoUbzmuntPEdxJEMs2a5R9DEDbo26GrMV+lqpV16d6qMpLdkSUZbI7CPVZ5F5f8zVe5lncbvPx+NcnNr1qucOc+1JHr1q2AWJp+0TJ9m+xr3V9KPkeTg9ea8f8cT51mTacjFei3NzbzgkN1ry/xhsGqOEPGK58Q/dOrDK0jOs7wRyAyRiRMY2kkfyoqqPLEYCsQ/eiuNTsehYuxucj0FegfCZ2XX5W9LOY/pXARsNwFem/CKK3Go3V3LcWxVbK4jMBciX7o+YDGCOfWt6KbmjlxOkGad7qr7yPwrJu5y+TtwT3rR1BrUnKDBPSsuZXbgHI7Vu2zjgkY0uoSJKysxwKVL+eYfuucVqppcc3zTAZqaK0htMsFGB2qVFmjlHoYRimklDSKSafLJJHgIrA10K3lsVI8rBHtWdcSbpCVXC+9DSQKV90Z/2qdY8MrEmomLS8tEfyrWt5o2YKQK2Et7dov3jKKFG4OVuhw0kpgfuMUyTUgFI3EcVt6zbWxDbHWuRu7YrIUz07Gs5txNocs9SR7pJc4PNNWeWMAqTimWdsDIcnAq+yxJhTioV3qzR2Wg2zeSUjDHJNdDaWVw4BV8msSCSNW+QfSt7TLqQAYBxWsLdTKpfoSXCXNuvzK2MVn3GpXEQOeVIxg10Et5vjwyk/Wsq9+zkZdBVSXZmcXrqjGglnuJMhyAT1JrSKXKRZjOQOtUvPiRsRJjmraamgjKnIJqI6Gkk3sihLfXKy7C5FP+2zD7zmtGP7JNG0jAeYO3rWddxR7ty8e1DuGj6Egu3K4yKrzTTyOSuce1MEaudqsFNbNjBHCo8zDGizYXUTKSW4jGXY0w6lMsgy5rZv3txH90ZrnnIabCx4/CplpsVH3t0asOpsE+92596b/ae88HNZDyKj7SM+4qNifM4znFJzZapo37a9w+d2Kvm7SVMZya5dd/A6EVp6f5gx0Iq1JtGUoJDbxgkwbG4dcCoI7q4Eo2g4FW5rqOEnfGG9aove+Y+U+XnNJ7lJaHVaZqMyhQeBW1DqbdDJXn73Mixllf5vSo7XVWEjeaxz65q1VtozN0ebVHqEUplHLCllsTNFtUr9a89XxCUAUNj8at2viCZ3AWQ4z61ftYvRmboyWqNzVfDlzs3QKrfSs+y0a5j4nTZ65rYtNVkZATLReajuQ5OafLHcSlNaFV7aOFfm5x71554sKtqbbQMYrptSvZsnbnFcPq8rS3bFyc1z15aWR00INO7KKjnminRoT0zRXJZnXY0EAz1rv/hSB/btxuKlRYTZH4CvPthBFdz8LcLrV6WyANOnJPoMCuqj8aOfEfAzY1Hy1lypHXpUlnOpxu21RnVbmQhQcVKtp5UeQTW6fVHHZWsac13BEOStY2o6lBsIVhzVG8RpDgsQBWdd2aPF8rHIpSm2VGCT1NC11AO/8NS3d9G3yllFc4m+P5ajliMrAhjWfM7Gvs1c6ayeLqGGfWmahPIVJSTisSCOSIdWwadK0jJ8mTT5tAUNRFuB9oBmbco7Z61HLEJJS5fknNZs0EwclgQPWm/aHT7pPpWXN3NuXsXtgMpCNg1oxWCzopMo3VzQmkV8jJNXEvJExgnNEZIcoPodHHpccQ5lGa0LabytoyprklvpGYAk59anjeRnBVuM5NaKS6GTpt7no1pbrcoCCuayPEOmPGpIAx7VmWepz268E0291uaWNkdia1cotamEYSUtCODR5ZwChyauP4dnSLc8bYPtRoesCAA4zXQnxLvXBC4HrRFRa1KlKaehy8OjXIl+4cds1am0x0jO8c+uK3/+Ejt8fME3emKoajrkNwhVVHPpRyxXUXNNvVHNLZDzcqcmp5LW52/u8kD0q9p6wmRmmB2k1sJLawN+76GkoobmzAsNOluW/eKdwrQPh6YjJGB9K1o9VhSQeXGM9K7nw/DZ38IN2wAPYVpCnGWhnOpKOp4ze+HZw7FFLfQVmzaZdQ/eQgfSvqKy8NaEykqTn61ieIvC+ihGJkOacsJ1uKGM1s0fOsMcpbGw/Wr9uHQEL19K9HufDlq2428gxWSPDLvKfLGTWfsWjT20ZbnnupCTaT3NZSb1IJyK9Ov/AAq4TLqKyT4RaVD5ZyazlRlc2hXgkcNNLIyEL/OoFUk8sea62+8LzWy5lRgKzRom4EqHwKxlTkaxqwtoZsCRnuWI61dt2/55jBFX7PQ1fBdSPxq4dFIGIlYntVxgyJTiZ39pTQYXPGatx39xMm4HK+tR3ehTM+4I6gDoRVZrSaBdgJFP3luK0HsOvL6QLhq5u9JkuCxwM1tmxlYFnJNY19DtmI54rKrexrTSWiIonK9DRUajrkGisTUvqzdK7n4YE/2nqW7kf2Xcg/TArh1XkZIrt/hqoGpasV7aRct+grpofGjmxHwMufbYLd/kBzUzX/mx9MVzjMVlLORwavG5h8rBIz6VqpaGHIJdzohPzZptvdQsnQZ96z7gxOTg5NVwVUfeANK+pfJoad00Z/gH4VVDwxsCcZ9Kz5bhlbk5FMM4Y9s1DmilTdjUa+XAXaKgkvGQ5RRis2VXY7geKRxLFlZDtYHBB6ipdQtU0ixJes5wVqhK4ZvlHWo5HYk461EjEN7is5TTepqoWNKzAwd8fPrUrCIDI61Bb3DkbSOKld9oBKirurEWdyIKXP7sHdVgQ3KKp2nHeoUuwmdiiro1Y7BvAJprl7jlzdERido+GJqvcXfPHOalmnSbnA5qn5BLHHT1pN9gil1LdndtuxjApbjUHQELyKovDKhGO9CRkD95zRzPYOVbh9tkMm4sfpUyXsp6ECoW8shgF5zSQRZcA9Km7RbSZs22oyhDuPQU59Xl3AZGAefpVIwbUbBqhMGEmM4zVObRChFnRwat3YZPqK29J8UtCPvkAHpmuEt8qdp5q0hUHCjn2qo1WtiJUos9Vs/G8ijiQ/nVLW/GLzoQHOfrXBwxsRl2x7VFeKo5LHpWzrSsYrDx5jpYPFM6nG8kVdtvEtyTlWIFefwMVkyG4zWzbTfuzUQqNlzoxR0Oo+JLjy2/eZ9qyLTxPcRScSHGazbiT5T8uaxZnZpOBgilOq073Kp0YtWO+uvEfnw/vW3H0NZh19FyNoxXMSCSMKgdXLDPynOKr5JYkHmoddlRoRO0XUw43RnDVZ0vWpY5/wB4ARmuFS4kRfvYHpVq2vNq/Oxz2pqtqS6B65FrVs8OHiQk1k3sFtfyEqVQe1cAdVcKACfzqWHVpv4SfzrV109GZ/V2tUdrb6QY24dXT0zXE+Lk8jVXUKF46CrVtrk8eTvOfrWHrFy97dmWQ5Y8VlVnFx0NKUJRndlBWYniihevPFFctzrVy+PXrXb/AA1H+ma43AA0S7+YngfKP8/hXHWMBuJNq5OOSAK9D+G+m4uPErSOYwvh2+dN4wHYBPlBOBk5rqpaPmOTEP3GjjbsvnKtSWsT3D4BJNQ3ZbOBmn2Fz5DAnI+tSrX1Ks7aGmdKlKZVSTWfNp0yN+8DAe9bNvrm3AxVxL+3vBiYVs4xexjzzjucrJanbwCapXEDxknGAK7v7PZEAI2KjutPski3byWHII7VLo3KVexxUZmVcYOB60yczSHfICS3JJ711Vt9hYkOgA/2RgCq+ofYlXEVQ6em5aq67HKEMMkmmgHOTWpKbfBPU1mzOpcbelZShY3UrkkUhU5qVp2YDJBNVUKnI5zTzH0waFewaXEkYjkcVGHYstI+4E5BNMif95xkVLKLwmGeQMmlafAxioCDnIFNK7+O9XqibInN4xxxmnNOHGCM/SqRRkPINSxngYWldsLIvadZzXt7Ba2sbSXE8ixRovVmY4A/M19L+JfCmiPoNrp+h/2TLqXhO+tEuXtMedLGdqTGYbRyJcnqcAdq+Z7YFzjoferccbDrVcpE2fRvi/wLoOpeLN2t20uhyXviJrVJGn/4/oCrMXVSPlG4KoYDHzAcmqGseEtNvtN8F6dqehS6U0UWszwaObg+ZczIYjHD5h5y3X+VeEupC4PpVG4iZhleoolFkwPYr7wV4W0ubXL280y5f+z9GtNRm0pb0qbW4klCvAz4J4BBweRuxwa39Q8BeGtM8TRQ6Pa3lpPp3iqxsDO115hkjmAfgFflK8AHk8ck187uuAOuakt87gcGpSLa0PovTfBPhi61rRrTUrK8urrXdR1S2a6F2U8nyJDtbbtwx6dwOvBrHtvh7pFx8LbnVLqyf7cNHl1KG9t5ndCyPjy2J+QNjgoASMda8mCOFXIC7lBA9aoXKs7BQMn2rSUXYyjueh/FSHTE+Osseqx40svYLcrGdmIzbw7iCOhwSa7XUvhh4d0Ow1Z7ueSWbQYZ5r+MTY8zzN/2MD0yAmf96vn5gYyVIwatTQtaxxMzHa67hn61MU+hT6I93k+HmkWXgu21ZrJotStf7NuFuYZnkguPNljR+W+VvvE4UALwMmuf+M0MSeD/ABEyIikeOrpAVUDC/Z04+leQyZaEsM4BrLkHPSpmioIjfasg2FtveprVNxwO9VXbHQc5qS3uBGxJXJ7VnFpPU1ZZljCHBHNQT7dgCLgjkn1qTzvM5bOagfdznOKqVmJAFbAOOtTROqBgybmPr2qOFwW/SlllCngc0kla42yXcoXODmqkx+bIoEvB3A1Gx3N0pSdw2Dr3FFJ90njmipC6NmCaS2HmW8jxM3ykoxBxXoHw11G+nm8QJNeXUkKaHdSCJ5WZQwKcgZ68n9a4EsXcAhOmOBXd/CgL/aHiFWHH9h3GT/wOMf1rsotqSVzkxCTg9DkNT3LISBjNZ5lz1FdDrEYkbCLx61jtDGh2vkfSokmaQkmiisrBjg1YjumQZzTJFiIwm4tnvR5LFfuk/SpVzR26kh1GUEYY1I2qSuApPFU3hK/eBAqNiufpScpIXLF9DRjm+UnPWqdxNk8GoRJxntSFwQPlpOV0NRGmUnIpiLubkUrKUPTgihWKnnrU+pRLFCeSQc9qc6MpweKkgvNowVBFTySJcREBQHHSrsraE3d9ig3GRkk1EwHHY+tT7NxOajeI/lUtPcsdv+QDNLBGWkAzgmoipLKCKlD7EBA5HehPuJl66jCIMEHiqSliuCOO2KjedscmonnY9OlOUkxJW3NG1ka2mVpNrc4Kmtf7XBM6+Um0n+HOf1rld+euc0+K4ZJNy8YojUtoTKFzuLwI0COAuSvIHY1RsbZpiQ6Er3x1rKi1V9mDir1nrRhkyen0rZTjJmXJJKyLl3pbGQmPhcd6ktLBscFTUc2tLOuKjhugjbi3H1q/dvoL37al+4whjLrnaAMg+lZKKSzGRW2/7JGR+YpZ9QTJPJ5qJ7vevB60m0yoxaK16WaV3PQ96JLgypGDklF2/hnP9ahlnyxB+ZTTPtQjUAqKyuaJGzYWyPbSK7E78Y6cVFc2ASM/Lk+tU7O+beAOlW7u8kZQMjmtLxaM7STMSeAgmn21oZhwMGpZVcgkc5otJzAx3VjypPU2bdtA+zOjgMKtGyZofkTe5OAOlWY7yFsFgDV+K8gK4VcGtVCJjKcuxjyaTLGuQBWXPCysciunu7hdvBIrCu5N546VFSEVsXTlJ7meFPINJ35qTKg8nNRMfasGjYMbs9zRScqeaKQGzagLIGIDe1ej/DgWssHiOeOQreppMsbWrJkSwkqWcN6qwRdpHIkyD8przCMPn5SRXonwuikdvEwjGGGhzHP/AG2h4x+v4V1U3qcmJ+EwNTlKtwOKxprjIA2gnPWt+/sLkDMoIB9qx3sgTkZOPSnJMdNxsZgyDkdavRXLomGXio2tQHAUOD3zVuLSnlhLPKUBOPcD1qVdGjsyhcTO+TuX6VSDAE7vyrpfElqL7Urm5tYreCOWV5hFAmxI9zFtiL2UZwB2AArm7i2eKTDDOKzlfdji1bQCwI4FIvSmhG98UuDt4zUXNETiMEjNJPGu7g1GFduMmomV88k5q76bE21HhQG5NWISMrjjFUdpY5JqWIc9zSUhm1bLC7gsOver/wDZkEq7hIB7VgrMVTbnnORVmO5OzhiD6VvGS6mUoy6MsXtjDD0YH3rImiIBC9KkuZndvvGmDJXmok03YqKaWpWkXDYByO9ROvPHSpnQg8mo3QhetYs0IiDTkHem4OacoOKkRJzgcc5qwAQBzyagCHGCakCkcg00Uify2jADYyfepWc7eT06VW3Ejk03+LPXHUHvV81gsSk9Rnr2oJKqMGoeGYn7p9BQy/LyaSbCw1mbJ5pgJPU5pSh2sT0pgU1AIljJUcGnGR+CxzjpUKjjrzTlUnuad2BajuGKGoXJcjmmEN0HSl2HPem5NoLWJ8ccHmpIJJEYH0qBI2yCM08lwM84qk7El43W9CCuTVSdQx4BFS2suByoODU0jJK3CitN1uQtHsZRhzUbjFb6W0Dpk1jX0YjuGVOlZzhyq5Snd2KoyaKMEH1orMo3hGUO0ck9a9L+DEnlX+vysudukOCPbz4a4GdVLr5fX1r1j9n3TlvNb16KYgxNpTqwJx1mi/wrsor30cWJfuO46+W2v0AZAo9hXOahYwQkLbx8+teu6x4UhjUiywW+tZ+m+HbcSYvowWrvlSbdjghWS1R5Qmh+e4bkcdhRLpUifKvK+9fQlj4f0gQ4SFK5nXvD9jBPux8megoeHshrFczPKIdJR1wUJasTW9FaEkxoxz7V7paaTpMluuw7X7nNZuqaZaRsFBR1Peolh00VHEWZ8+nTZM4dWUYxnFRR2D5YMPlB6ivev7E0sgb1Rs9qpT+DIby7gh09Y1ad1jXccDJOBk9qweFtqdMcZfSxjW2nu/7ORiQ4I8Vb+fT7HivKb6zEBIY/NmvsBPhJqY+Gp8PNPY/af7U+35Ejbdvk7MZ2/ez+HvXgHiLwXLbalcWshRpYXMbFDuGQcHB71koKSfKae25X7x5nHbO+dgJqdbKTaW2kYFeg6V4ZaGXEqYH861L/AESJYcLENxHanHDaXY3iknZHknkOrFipqaOBpFAVea9Gh8LTSkZgyh71NH4SMcoKIMDqDTjh2DxMTzGW1dGw6sKmSD5eATXp2qeHk8gZi6DrWRa6WqNtaMZ7U/YWYLEpq5wrWMrZ+UgVDLa44zzXqTaIXAwE21DP4XtSm50Kt6ik8PcPrKvqeWXVvsCsuMnqB2qOGIt0Fdtf+HD5pWABlqjD4auhLgoQPpWLoNPY2VaO9zASBsEU2RGGfauvufDN1bweZLHtQ1nnR9x4HUUnRaHGtFnPZO3aOlNwc4ztrcn0WVVJXoOtUpLCRccZxUulJFqpFlFSoBzTyF28Z5qZbZixG0g1OtlJtxt5pKDG5Iy39B2pFBI5OKuGykZjlDxSpaE8EEGp5GHMimAewxSpuLBU6ngVbaIKQvU0yaAp8ydKbjYakmV2bGfrzQsmMNQQSORURBzzU2GXYbkA8irqy27IAec8/SsMZBqRHIHXiqVR9SHG5pzLHgmI062eENh/zqgjEozZHB6VE7HOelUprcXL0N6VoPL/AHbYNYl3ndvJ+UnANRmVx3qFmLcHNKc1IIx5Rc0U1QSeAfworMs6iVtoyAAfavRvhDrFxarq4JiEcdlhSsKB/wDWqeZMbiOW4Jx09BXmkjEjaWBHt3rrfA58rTtek54tkHHXl1rtotqenn+RxYiPNDXy/M9Ln8aNDEfn5xXN33jyYucNXCXd27EqSR9aj+zq8G/dzWzryexhHDxW56DZeP7hANznFPv/ABq9xC2Tn3ry5Ul37QTj1q00LxxkyPz6A0vbztYp4eF7nRHxhPFIwDnB966bxVu07wd4f1+21Zb5dVaVSiRMixFMZGWwSQSQeMccEjmvMY7RZAWZuK63X/E19eeCdN0O50DTrTTLUlrS6jhnV9zEF2DNIVJbHPHfjFZupMtUoDLDxM4kUytxXUL4ujSOMhgGBBBB6GvH7hivCPmlE0vlZyePemq7WgPDKWp93P46th8KT4qDpn7LkDPHn52bf++/0r5u0rUvtdxvmcOWOSSckmuQt/E2pz+BF8LqT9iN59uznnO3bt+mefrVOxmns3XcTj60qL5LsmrDm0ueuvbRuQ+cg+lV7qILyq9PWqnhe/a6hCgjIHVqteJpWhjbBBOOAK7rpq5x2alYzrjX/sjKny4o/tuKdM7gGrz3WHndy2SKz7a8lD8FjXP7Zp2OlUE1c9YhllvICFZSKzGtZVlO4gj+VZHhnUW88JIWCnriu2udLSMLJHL5m9Q+fY1rH3lcxa5HYzEtYDgm4ZX9O1UtU1D7CVR8OldA62EenmaSMbt+z3zjNed+IlmmmZo8+WKJvlWg6a5nqXLjVYRIJIsA9xUsnieGMKdqbhXHSW8mCyt+tZUvmF8ZxzXPKrJHSqMZHt3hHW7HX9c0nS7tVMd3cxQuB1wzgcfnXOzT6fDeP9xlBxkCqHw/8b67out6Cl1r2qx6Da3cLTQJcSGMQhwWXYDyuM8Y5rO1rxV4m1e0e0v9c1S7smbPlT3Ujq2DkZBODjFL20m9UHsIrZnVPPpU8fKqD60kOlafcIdjotedqLtVGd+BV+11KWBMbiDVqrfdEui18LNvVbOC3m2bEYn+KtnRNKsfL3XDIcjgV53fatM8pJkpF16aNAA56VKqwTvYt0ZuNrnf6xo1kyO1uyg/SsO10mFlYsVz05rCtfEEm4iR+Pc0+bVWcr5T4JodSD1EqdRaXNZfD0c0/ABNF54TkRCwUlQOeKz9N1iW3feZM88811Fn4qWTCOVINNezktQk6kdjhrjQ5lD7V+72xWW+m3AJ+XP4V6ffTWtzGWWQKx64rIimt7csDhvrUSoxLjXkcE+nTcHA+lMFlNjGzvXW3VxBNPnCqKgI+fgZXPBFZujG5oqsupzDQNG/K81HIr4PynH0ru7exhnKgRgk1qyeH7YxDzQBkdMULD32YPEJbo8oZWzxUbZr0O/8NFVJih+X1xXGapaG3uWjYYI7VjUouG5rCop7GcrFTkHBopSoorIuxssyg5HT0rt/ArD+x/ELHIxBFk59ZBXBZG/n1r0D4fw/afD/AIsQHA8m2w2OR+9z/Suyh8fyf5M5cTpC/mvzRz+qP+9wmDVFruVRtFa15pxRzg5NRppcgi3stJxlcUZRtqZSzzSHnINOad0HznNbVlHbojCYc0q6UtztKgAKCMj+I7icn04IH/Ac96rkl0D2kb7GG12xUBQa9n8SzXlv8Ghp03iXTPEV3dSQTywDUkmeyjXCpDBFuLFucsQAAARg8muEsPDiyyADjnk1r6n4UtY7AlWIYDOBR7Cclcl14J2PLruJ4JSvJTqjYI3D1Gf89qWCR9jbhkV0cWmLdypa5IIOEJbgc8j8f5/U1vSeCvKtfNWRW74B6VEaE3qi3XitGcYL2WHYU6Ac0f2pLIRubFW9R09rdipX1rJEDk52nj2pPmWha5ZanongHUCbpY3DS7uAi9Sa6jx3P5W7IZGOPmOcHivJvD91PZ36mOUwk/KXxkqD1IHc4rodd1SbVVCQGeRCc7puWBxjA9sAV0Qqe5bqc06X7y/QwNT1FvMZS2RVK1v2Vxhc1ZuNJuRzIjjPtVuy0TKgYJY1ilJs6LwSLenaoY5FkxhgciupfxXIbbCgKAADiqVj4W/c75lIHWpV0a1kiKR7t3piumKmkcsnTkyOXxQ0sGxgN+7Ofwx0/SsfUNReSMjdtBHXFbcXhSRjuwQPetSDwi08ONg49aOWchc9OLPNt8znar5FWbfS7iYjCFvwr0nTfA0QfdMQMV0dno9vYriOJW+oojh29ZDliV9k8o/s9oI1jKsXb7qDq3sK3vGHhb/hH/Esulw3CXQhihfzU5WQvErkqe65YgH0Fek6Pq76O8qQtAsM5/fRvbRybx6EspOPavRrm4g1p2t7Ka1fTzDEBG1pCy58tecFOoxj2xjtT9i3KyM3iEldo+WLtvIhIZOnFYEjJLJ6AmvovxB8LonQmFlIPvXl3iL4e3ems0ilSg9DSnRnutUXSxEGefahaxBMxcnHWsnyzketdJf2csIYMjY78VizrsYMAcVyzjrsdtOWg2KwaRSwIyOcVDKjRt8pyB3pzXhTIUkUzzN0Z3EnJqPd6FrmvqNhlbnOasiV0wyk1WEqBdhOBnnAqdJkC/MeB0zQgZZW9mCAljimveSMOOagkvItmAKrq6Nkhse1VzeZKit7EzSksCSc1o2F25DAKW2jceOgyB/MishnDMFJq9aEKcIcmnF66BJKx0+nX/lsN+BW6L9ZdpLcjsa4O4uRGBk4anW19IVYiTpWqqW0MHR5tTvb3WBHGA5GzHQV5p4ouUuNTeROhFXbrUHmGzcc1g3xxOcnJrKvUclY0o0lB3KueaKN1Fcp03NcgNISSPU4r0P4cKn/AAjHjJs4CxWXJ7fvj7/5/n53HAztlQTXovgiGWDwJ46l8tiFTT1YjtunIFdlHSV/J/kzjxWsLea/NAbqyzhiC1VdTvI/JAiYAYrnLsPHIX96hd5HjBBqnU6ERpLcfLdruOWyfSt/QNXgAVJRxXJAAthhj1NaOn2fmNlHwew9aUJu+hpOEbWZ6haX1gU/d4DVU1PWERZBkMAK5kWc0EQYk1FFbvcM4eQYPFdDm9jkVON73K8+qItyHT5DnORXQ2Orvc26OJd7EYkBIyD2OB2P065qi3hhJYt6Pk07S9NktLgrzsZcGoSmmXeDWhdlt4pEdp2UgiodK0aK8nCw4wx701wwkbeCR9Ks6JO0NyCDsUGqVm9RO6Wh09n8NYX2yzTJjrjFLqfh610tR5SqcDrVt/EXlQcSdB61lS3898C+cr6Vu1BaJHOnN/EyO1u4RKEniRl6ciuj0+00e4wVRFf19K4HUYp2YlFIx3qTQmuQ+C5Az1qYzs7WLlTurpnpU2mxhcRyKynjFWtO0W0h+dUBY+tckt/JAy4lzj3rf0XXRNMInIzW0ZRuYOLSJNagWIYACfSqYcQ2+MnJ71t69C4VJCpVSOrVzV07EqB0ziiWjCOqNfT/AJoyW5z3q4kIbuaraUpZAiY3YzgnFbUcRVCXwuKqKuhN2OQ8RBItoAw2eora8H3rwhQCcVz/AIgk87UAgPANaOjOIup6VEX7xUl7p6JPqPmx7d+D71zGt28sgLSgFKybvV1jl5bGPeph4lt5Y1jlYGtHJNWM1BrY5/V9NhuoSPJXn0FcreeCJHjZ4kOOvSvV47myktyVCg4qkdVjhzGSrCspU4vc2hUlHY8D1Hw5Jblg6HI9qw309kDbs8e1fRWqJa3cHMSEnvivNfE9lbQ52kAnsK5KuHS1R2UcS27M8tmiEb8mo3OR1rQ1CA+czAZGaoyRN3rhlFo9CLuQjqSTxSrweDUscLEHg0skJT8qmzDQWI5xxz61MknlnI4NVY5BHgjrU24Mct0q0xNDpJWkOWOfWlEmANhpIFDsRnitO30xZlyjA1UVKWxMpRjuZpcoc55qjcHfKWJrVvbCSE5PIrKlRg3NZz5loyk09UQ4x3oooqAudBp10kD4kgWXkEEswx+RFe0fCmybxH4P8aadYWiW8rGwMjJI7tMBK5AIYkALtYjAH3jnoK8NhXLDtX0n+ylMsH/CVyOTtxZjn/tvXXTbujhxnuwcl5fmc1q/wsvowzbXPr8tc7P4EvrYHEEj59Fr7IlvLZ4znaw9KxDBHJOWEahfpXZGEZ6tWPOWMmj5DbwVqLDDWko/4CarNoN5p7gmN1we4r7FlSxJ2yBK5nxNp+ky2zhokJ9apYeL2LWNk9Gj5qkvZVtzG+CayIpHRZW3YOa7nxXocUU7Na42+lefalDLEjeu7gVz1Lx3Oyk1LY3dO1eVV25yfSnXGqybw5O3nGK5q0mZSCwOavXSPNErhuBS520V7NJ6nVadqMEkZMyqT71n3Fwst0BAVCZxweRXORvLkoC2KvQ2U8eJFY461XPclw5XudHHbMyfO315rpdCsQ8eFkXFcAl7Kp8t2OD3rotHunt48rIea0hJXM5xdj0CPQYJYCJZAMjmsLUNItrUFbaTLHtWNJ4imhJUucVkT61ctciQn5O3+f8AP+GkqkehnGnM3jplzJn5W4BOfb1rPt2ms9SUs+ADTbnxNM0QWCR0kHRkJBB9iOhrAu5b65mNxLKzMTksxySfU1nKa6GkIyfxHuU2q2t3o1pEzSb1X5i7Z5zWPJqOm2ph86JJQoLNh8Z64/p/9evKDrE8UIUO2emKiW4mu1y7mqde+xKw9j0Ww8UW1rNPJNH5ispVRuI2578deKsaj49t5jGkasgZvmO7sMD+leSah58MpifcpHYjFU2jmADbsmsniJpWRqsNC92ezxz214PNjcGVm4Kg7Sv15yenStCVYre2tBKrZlZizq38I9B68f415Z4d1NraEhmORSazrlxctsV26Y/CtPbK1zJ0W3Y2NS1PzhIysQSc4z0rFivZyxbPAPr1rAlnnGeWzUEV7OhK5rndXXU6VS00O+h8RtDFt34PeqUviNmmGJOa5e/tdQtEgmv7a4giuF3xPJGVEi+qkjkcjpS2VhPcJLcwxSyRQhTLIqErGCcDcegyeBmn7VsaoxWp6Laa3JPCFBGa5bxNcSCQk4JqpbSSwTL8xC03WZDMnHJq5SbiZwgoyMN5DN0IB9Kalo8zLuH6VpaZp4lcZjOe9dbBpiLGP3X6VnGm5as2lVUNEcemmGMBtpYZyQKztRtZDM7bdqk5AxXpUennbjyySenFNn8NSSoXkQBSKp0LrQzWIs9TyM27Ek+gyaiKMOM102vaW1pK20HrgDFYCxkvtb1rklTs7HZGfMrkMe4Z7e9Xra+ltxgGobiAhflyMHmqb7s9TxSu4DspG59qa4jy54rEvRiapSx2bVJOKrzbyQrZ9c0pyvuEY8pCRyTRQDwRjPvRWYzWiPIr3z9n6SSHRfFbRMN2+z6H/rvXgSnkYBwK9x+B87Q+FvFDjgtNaAH8Jq7cN8aOLGq9N/11PSrjxQ2nviZsmn/8J4nlElhk1wmpwrcOWmnwfTNYl1HGI8JLz9a9CU2ebGlFnT634zkS4LpIdprGk8aPOCrOcGuR1dx5QXfz9aqWMInTaOT61i6sr2OiNGNrl/xBqksjFkc49K5+Qy3CLkck1q31hOiYKMw9cVjyx3ETgBWxj0rGV76nRBJLQrTLsbBGD7VZtHEg2E8U37Fd3MUkaK21ysmMfxKGC/o7D8fpVKISxvgAgis9U9i7XRt26xRSDzAK6RLixWyO5QTjiuIQyMw37uamdnJ8sP8AL35rWM7Gcqd3uLdzpJO3l8L2qezunjXBY1QkCp8qEE1GGcdTWezNOW5fuNRBfnkd60YpofshIGSRmuYuI2KFh3psFxJEhUscYHH4c/mcn2zgcUlOz1KdNNaGnDcD7SR/Opri+KjANY8hUjcHwaru+RncTilzNDUEy1LdGWXaDUqPNGMbuDVTTIfMnG44BNdb4b8OXPiLW4NM0xVkuZQxUMwUAKCzEn2AJpRXVjnZaHrPiay0HUPi1peu6pq2g3nh2cQW80Yvo5GBEG3LopyFDAZJ4HesjS9J8K6T/wAIta6td+Hr64SLVDftHeK8bsqg24ZgR1PC9M9q5ubwfcW9lrO0Je3Nk1oiG0mBUNO7KFZWAbcSvA4xnJ4Iqtqnw11uG6t0WXTp5JtRTSikNyH8q5ZS3lvxwQAc9QKl2tuJHZajd+ErnRLlRZaBazz+H4L9ntHCype+btaJAXIB2DJTGTnJrevrX4fyarpSRxaCNK+2wmO5+2RoxhKkMsqlt/XBJcDBHXtXnS/DHXobfzln0acNDNLGsV8jNKYc+bGgH3mXHOOBxzWJf+CNcOkJqDi0KeRFdyWiXA+0RW8jBUlZOynI7kjIyBQ7LqCTbNbx9f6JqXhLRLzTrbSbTVBc3ME8Ni2CYlK+WzqWJ5ycMetbRXwhD4IjuBHoboujxyJuYNfNqnmDcrJncYsbhyNu2sDTvhZdzeNJ7SedNO0aHVodLeW6uV815HKkxx4GHkCnPQDkVkWfhm51Dxte+H9LUTG2uZ4xJM4RVjjLbndugAVcmhe8U1Y6P42eIYNW+ILS2ZsbuwtI7cQ+S3mRSfukZgcMQfmypAx0x1rvvGXirTLe9+IOpQP4bv4ryDT3soRMJPtYEw3GRFfJdeTt4ICjIx188T4fXt+ubG+0Z7YyRwR3QuwIpZnztiU4zv8AlPBAxxnrS2/w3u7jRdKaDemrXN3eW91FO6rHbrbgbmJ7Y+bPXpxTcVpqSmem2h8AHWdaW0j0O5kF1AyQy3MaxG3aBGcRO7bciQuDg7hgD2ry++0G2a9umtyq2yzOIhv3fLuOOe/GOadYfDnVItRkRZ9PMKWa6gLs3KrA0BbbvDn34wcHjpSeJrK/8P6uNNvWiaTYkqvDJvR0YZVlPcEVrSstzGd/skmnQRWjAyKpHStwPE4UptArnJwXhQb8UQuzOkavjHeulO2hg431OnuJMxjygA1Me4kEJ8w54rM2SJgmUEVowxpcwEbsHFWRZI5vU7SO8ViRXC6ramJ1j2BQp+8Bya9MFr5UhV3BU1zniSwjl/1JywrCrT5lc6KVSzscNNFIUITJ96zLlfLOGBFddGFgjZGALVzuqDe5yvWuSpDS52Qk27FOIqBlzniq0jtvJ3cnqfWpUiY59KhkGDisGbDM89aKXAFFSBppIze3PSvWfhhdtbeDPEJULve5th19BL/jXk0WQ4P869O8DBv+EN1cjgG6i/RW/wAa7KD9448WrwsXdQmlkjZjJhvrXKX1/cQPw2R9a1r6UlCM81zd2rvIdorSpLsY0orqJNfvOV3de/Ndl4cktobZWYAtXnrRSiXocV0GkyMFAckUqc2nqXVgmtD1KK7hmttqxpk1X/siacMY7UNn0FY+hPulUs2FHvXpuh39vbom91xXbBKe5wSfJsc5Y+GnjtGaWHa3uK8/8RaT9lv2KpgMc4r3rWNRgayLRkZxXi3iC6a4u3I+8rUq8YpWRVCcm7mCsCCM7gAwFYWoxtFKWH3TWxfyvF80nArIvXe7jIReBXJO1jthe9zIE7CbnkVaZ2dMqKp4IfGOnWrdu29MJxWKd9DoZVeaUNyOAal2vMMoBwOaimjcSkHJBNbthbolvuZfmxmnGNxSkoq5imCcDleO9NSAtJwPwrRvblVbagxVSOZkfOM0mopgm2rlmC3aJQ2DWro+tXGg6jDqMNtb3MsWSI5w23kEZyrKwI6gggiq0czyxhQKp6iGVOOtW0kiE23qdle/FPxHq8l6bpLSIXQs13xo5eEWzs8exmYknc7ElyxPrW/4x+K+nrDYt4a00Lfx60utzzXFt5Mcsyoy8osrk5LEkhl6cAV5Jb+YSWIPSql40nmn5Tj1NZNJI1SuzurP4naxaQWG2209jZfbvKzG/P2v/Wbvn7fw4xjvmqE3xM1ybRl08Wun+cbaGxkvlhb7TNbxMGSJm3bccAEhQxAGSa49Y2ZSc1GMoTgkVD1ZaSPSbb4u62up3d5d6Zo1y02ppq6RzwyFLe5UBd8eJARwoBBJ6Vzmm+ONV0zxfca9apbC6uZJmmhePdDIsud6FSeVO4jrn3rm4wS2cZ+tWvse4grVWvsLRbnoui/Eq9t2McGiaDHZLNFcxWYgkMcM8edsy5k3F/mIO4kEADGBTrj4pataiyaGK1YwS3M0pmUv9qa4GJRIMgbW9BjByQegHAQKsZAYkFfSoHLvkOeGORVdCLJu52dx8TtWvBewra6fBa3GnDS0t4o2CW8AcP8Au/mzu3DOWLZz9MM1XxVda9dWt1eRQJLBaxWiiIEApGu0E5J5wOf5VxkNq005VGC/7xxmrsKyRLhRmnB2FNJ7G02rylwMdPeg6xIsgIGBWOfNJ3fpTzvkwuMGtOdkciOhGsyMPvfrVq21+SMFDwa45xJC4YHpSyTvIQw60/atEukmdNc+IJDJg9PrUVzqckvMajJGKw4wCoZuTVvTZEecK/HNPnbFyJbEc8dxK7Oyhfasi+LqCHTJHSvUrHSrS5hyxOaw9Z8OxpKzLkinOk7XQQrq9meceaeFK4qBx+8weAe9dFf6Xtf5UIFYN5EY5SCOlcdSLW52RkpbFUnmil2kdqKyKRpo2HGeea9V0SeysvhvftaXIuZ5byIuPKZPKPltlcn73PcV5OrcgZHXNei+F4vN+HeonpjUUyf+2Z/xrsobv0ZyYlaIwHvnkkYbqcZwsYOcmqN2UWRtp79qpTSSAccilzWGoJk8s7vPhTjmuj0u23QhnbmuPgkzNyea37e7kijGDkU4PqwqxeyNme4uIABCT1qe01u5jdVkkbisOfUZWdQozxzVOe6d3yB81Xz22MvZ33R6Je+KpRZbFfnFcgNWnmuTv/j4+vpVa386dMYz6e9QywXcbjEbAA9cVUpuWooU1HQW5vvtHDnI+tLaTogIyDmmpaxJ5jSHv0qgNplODgZrNtrU1ST0Qt6h8wshHNVbZmVjzipLksJVAYGqsblS2eoPFZN6m0U7Gj9qRUBcA1cGor5OFxjFc/K+45IFTJ90AEGrUmJ00Sy3SvLnFW7OeIuN61nSwqG4IzTRhPvNyPSpTadxuKasdK1zEqYjwDWTfTOTuBJX1qoZCQNrZpWjdk4J55qnJsmMOUsQ3AAyT+FQXNz5pyKbsVRlj+FVWYDODge9Q29i1FXuOV2FPYFudp5oQDruAqyJ4lGAQTSURt9ijuZWwDgVbiuGVcZ/GoJyrMGyM0rFTtXPIoV0xvXcfNMSc55qt5xDfMxyOlEhHKg81GzIsYH8WealsaWhat7rD5JrRW43xAZxXPo37zjvWlbhCBubmqhJsiUUalrIjKcnJFVpbzZKQD3qVDFGhwQOKyZDunJ3cZq5tpIiKTZeluCQQetRq8kYBfkEVHFOqtg4P1qzI6NGx+XpU763KtbQkgdHj5fHt61YtyFkDIeaxmYD7jg98ikF0yLgNjFNStuJwuek6Rq6xIA4xWy99bzR7iQTXkMerSKuA1XbbW3CkM/at44hbHPLDvc6TXL2AFlXGa4LUZCbhj29auXt3553buapXk8xQRNJmLO7aOmfXHrXNWnzHTShyIrodzAE49zRUYOOaKwNk11NBVw/ABGa9M8Lh3+GWolf+gsq4GeB5P8An/OK81hXLZz0r0nww7xfC28lTknWlVv+/BP+FdeH0b9DjxXwr1RxU4eKZ1K9/SgHcFXoT7VPqErSuxx+VUROEIz1qXozSOqLUdrEj5xmr4dSqoqCshrrI4NTW1wWYNuNWpdETKLerNiNjGSWjGD3xVe6kQOGCAVNHchoyrde1Z99gHLNx7VTdkZpXZs6VqUUEbSGMSFRkD/Hvj6An0BPFdTda1bSWOBEqkjocZH5Zry2K78vIGfap01B8DcTg0RrNKwpYe7uXNRnV7xiuQG7VXkCbMjrVe4ulYDC89zUVvOGPPUVm5amyg7D4oyGYt1HPNSSBQc7Bg8095EbA4J70uV+zjJ78Ui1czpFyx+UYParFvA5XKgDNRuMtx0HWgylF9KXmy9bGi9rlQTjJFULhSr7WA/CmfbG2DJ5FR7vMfOOKG09hRi1uPRgpBxTnlbAxxSBV6Ec0qjjG3Io1Gyu8hzg81G/JHHNWJ4xu4IzVdySSKiV0yhYyScHAp7cSMew71Agw+aklkyMDrSQDuWGeMUu8rjjOKhG7aSOgpo3YHJOaTYWJSwIJOM0wqCPSnKOecYq5FDCxBZsL1NNJsNinbRgy9OatlfK5fPNSLPaW9wTDGzAdCxpLi9+08MoC+gFVF2ViWm2VpJdwOM0xMk5q2LeJkBEoU+hpRCyLnZuGOooabeoXXQqlATuYfKOoqKRzuBHSn3LAeXtPbn61FyzkseahvsUkS5V5GaNAin+HOcf5/znrUcw3YxUkcR2ZJNMkjz0p2dhKxGIgOvWneWxViuMKMn6Zx/WnBMDmgKCQN2AevtUgQleeOlRyLzUzYXJBqFueexqXoMbiig0UhGhEGzkdc16NpEhi+EV2cFi2vBeB0/0br/n1rgpxtbI4bocdDXeaU+PhBNuIwfEGPr/AKN0/wA//r66WjfocuJ2XqcY9yQ5Djiqs5EhG0HPtT7yUFmAx1qCOTaRg4Oc59KzkzeK6jYy6kkHnGK1LO2/dgnqapB15cnJNSLdSNhV7VcdNxSu9i7NbzAlgcKKgdhyJG7U43EhjClvqaoTiQng596cn2JS7iLHvk4OBVi4jjjQDdzVRg8RILAkdwc0jyhoRuXLeuaz5kjSzZOxUQfKcnNQKcsWPANRmT9220jPpTQzshFJyGkW1G0NnjPSp1UtZEkn71UQzbRk5Iqx9pxCoB75NFxkSuQzAZHrTZeQeuTwKY0pLZBpQ5ZwV+6PWi4w2kUqk7vapLjnkYAIqurkHgik9GJMtsh2Bhye9KWZYuMVWFw2QO1PaclcAdKrmQWY7y2ZzkjpxUTIwzzjFHnbW9qZJKTnBHNS7DAqe/Wmv1+lCyEZBxQxO7rUsEw+Y8AE0uD0zz6UqHn68ZpjN85x+dMBATk+1PMhwAe9QNkNzQzk4qbsaH5Yn1pyOwGKhDMORTt3cZpCuWS5wNw61LBNIgBViBmqYLsCw6CpEuJGjEJKiPOTxV8wi809vMQsiYz0YdaDZbubeRZB+Rqi64OAwYDuKljMkJV0I596SYFyGNgmx0dZGOOnFU5g6s6twQcGrK6jNEMb8n1qlNOXJJ5JOTVSYkNZjzg80m4Y5HOKYWyOOKaSc1FygbOaRgenpS/Maa2cmkFxMYopM8UUCudhY2cF3Gzz3MEXPyiRwp/L0roL2/06w+G39kJcpNqL60bzbEwZFg+zhMk/3i2ePSuSSFGRsjvUUUKFiCOma6uayskc8oc0rtlZ5shxt69DTEYY6DNWXhRVyBzU0dtG0eSOay5WbXSKCnj2FSxTKoK9vWrcFrE6sSD19ap30axHCCqaaVwTTdhskp3EA5A7il81SoBYDPXNMhlaNXK7csNpyM8e3pUH3mAPQ4qHJj0Y5mGcBgQPSniRWBUAdKbcgF2GMbRgYqtuO3tUXsG5LuAyKmWUbOAKrZ4FSIBsY00ymSGTORjiox09fanRjNNnOzBXg0Pa4DQe1KH2cUKAQCep5qaOJGPIoWoPREUkpYYqIvzU06AHgVBgbhSdwuKG556U52x0NPvolgu54kztR2UZ9AaiuAAwwOwoYXELZOTQGG05H0pjjBxTkApAODcdqaWO7NIelKWIG0YwaAJS+ABjmkJ6VDmnLyMn0ouMl3EhuB0qI/hSfxYpcZIFIBM+1ODELjjFNPGcetA7UAKD2FOUEc44qMGngk/KTwO1MESBjGeRweoNIsw35Yce1S36hZFA4+UfyqqvQ0ASkMV3Nwp6VGeGxSAnPXpSHoD3ouSToVERPG7OMVG+MZ70w9M0ueHyAeOD6cjmgewBvmBxSMQaKaTQAtFJ2opCuf/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ultrasound examination of the sigmoid colon in collagenous colitis. The sigmoid colon is normal size but the layers are more pronounced. 1 = lamina muscularis; arrow = submucosa; and 2 = mucosa. The distance between the crosses is 1.7 mm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of C F Dietrich, MD and Wolfgang F Caspary, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_50_18208=[""].join("\n");
var outline_f17_50_18208=null;
var title_f17_50_18209="Patient information: Encephalitis in adults (The Basics)";
var content_f17_50_18209=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?31/1/31762\">",
"         Patient information: Bacterial meningitis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/34/28194\">",
"         Patient information: Viral meningitis (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Encephalitis in adults (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/encephalitis-in-adults-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H19549281\">",
"      <span class=\"h1\">",
"       What is encephalitis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Encephalitis is a rare condition that causes inflammation of the brain. It is most often caused by a virus.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H19549296\">",
"      <span class=\"h1\">",
"       What are the symptoms of encephalitis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Symptoms include: &nbsp;",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Fever",
"       </li>",
"       <li>",
"        Headache",
"       </li>",
"       <li>",
"        Confusion or trouble thinking",
"       </li>",
"       <li>",
"        Trouble swallowing or speaking",
"       </li>",
"       <li>",
"        Saying things that do not make sense",
"       </li>",
"       <li>",
"        Clumsiness or trouble walking",
"       </li>",
"       <li>",
"        Weak muscles on one side of the body",
"       </li>",
"       <li>",
"        Seizures - Seizures are waves of abnormal electrical activity in the brain. They can make people pass out, or move or behave strangely.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H19549311\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your doctor will learn about your symptoms and do an exam. He or she will do tests to see what caused your encephalitis and to check that you do not have a different condition. Tests include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Blood tests",
"       </li>",
"       <li>",
"        A lumbar puncture (sometimes called a &ldquo;spinal tap&rdquo;) &ndash; During this procedure, a doctor puts a thin needle into your lower back and removes a small amount of spinal fluid. Spinal fluid is the fluid that surrounds the brain and spinal cord. He or she will do lab tests on the spinal fluid.",
"       </li>",
"       <li>",
"        Imaging tests &ndash; These include an MRI or CT scan (a special kind of X-ray), which create pictures of the inside of the brain.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H19549326\">",
"      <span class=\"h1\">",
"       How is encephalitis treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The treatment is given in a hospital with medicines that go into a vein through a tube called an &ldquo;IV.&rdquo; Treatments can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?26/16/26881?source=see_link\">",
"         Acyclovir",
"        </a>",
"        (brand name: Zovirax&reg;), which is used to treat infections caused by viruses",
"       </li>",
"       <li>",
"        Antibiotics, which are medicines to treat other types of infections",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H19549341\">",
"      <span class=\"h1\">",
"       Can encephalitis be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Sometimes. Some of the viruses that cause encephalitis are spread by mosquito bites. You can lower your chances of getting encephalitis by avoiding mosquito bites. To do this, you can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Stay inside at dawn and dusk, when mosquitoes are more likely to be around.",
"       </li>",
"       <li>",
"        Wear shoes, long-sleeved shirts, and long pants when you go outside, especially at dusk.",
"       </li>",
"       <li>",
"        Wear bug spray.",
"       </li>",
"       <li>",
"        Drain areas of standing water near your home, such as wading pools and buckets. Mosquitoes breed in standing water.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H19549356\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/1/31762?source=see_link\">",
"       Patient information: Bacterial meningitis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/34/28194?source=see_link\">",
"       Patient information: Viral meningitis (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?17/50/18209?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 17213 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-210.101.131.232-DB21B48F7E-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_50_18209=[""].join("\n");
var outline_f17_50_18209=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19549281\">",
"      What is encephalitis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19549296\">",
"      What are the symptoms of encephalitis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19549311\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19549326\">",
"      How is encephalitis treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19549341\">",
"      Can encephalitis be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19549356\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/1/31762?source=related_link\">",
"      Patient information: Bacterial meningitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/34/28194?source=related_link\">",
"      Patient information: Viral meningitis (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_50_18210="Normal blood smear";
var content_f17_50_18210=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F59683&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F59683&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Normal peripheral blood smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a normal peripheral blood smear. Several platelets (black arrows) and a normal lymphocyte (blue arrow) can also be seen. The red cells are of relatively uniform size and shape. The diameter of the normal red cell should approximate that of the nucleus of the small lymphocyte; central pallor (red arrow) should equal one-third of its diameter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_50_18210=[""].join("\n");
var outline_f17_50_18210=null;
var title_f17_50_18211="Lentigo maligna melanoma 2";
var content_f17_50_18211=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F74664&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F74664&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lentigo maligna melanoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_50_18211=[""].join("\n");
var outline_f17_50_18211=null;
var title_f17_50_18212="AUDIT questionnaire";
var content_f17_50_18212=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F72626&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F72626&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 617px\">",
"   <div class=\"ttl\">",
"    The alcohol use disorders identification test: Self-report version",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 597px; height: 750px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. The Alcohol Use Disorder Identification Test: Guidelines for Use in Primary Care, Second Edition. World Health Organization, 2001. Available at: file://whqlibdoc.who.int/hq/2001/who_msd_msb_ 01.6a.pdf.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_50_18212=[""].join("\n");
var outline_f17_50_18212=null;
var title_f17_50_18213="Ulcerative colitis endosc";
var content_f17_50_18213=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F81755&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F81755&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1128px;\">",
"  <div class=\"figure\" style=\"width: 558px\">",
"   <div class=\"ttl\">",
"    Ulcerative colitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 538px; height: 181px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic appearance of ulcerative colitis. Extensive ulceration of the mucosa is the most common endoscopic finding (panel A). The surface is irregular, friable, and erythematous, with loss of the normal vascular markings. Pseudopolyps may form as a reaction to inflammation (panel B); these can become quite extensive (panel C).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James B McGee, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal sigmoid colon",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 216px; height: 216px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic appearance of the normal sigmoid colonic mucosa. The fine vasculature is easily visible, and the surface is shiny and smooth. The folds are of normal thickness.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James B McGee, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_50_18213=[""].join("\n");
var outline_f17_50_18213=null;
var title_f17_50_18214="Myeloblasts with Auer rod";
var content_f17_50_18214=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F78291&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F78291&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Myeloblasts with Auer rod in acute myeloid leukemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 366px; height: 251px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Peripheral smear from a patient with acute myeloid leukemia. There are two myeloblasts, which are large cells with high nuclear-to-cytoplasmic ratio and nucleoli. Each myeloblast has a pink/red rod-like structure (Auer rod) in the cytoplasm (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Brunning, RD, McKenna, RW. Tumors of the bone marrow. Atlas of tumor pathology (electronic fascicle), Third series, fascicle 9, 1994, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal peripheral blood smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a normal peripheral blood smear. Several platelets (black arrows) and a normal lymphocyte (blue arrow) can also be seen. The red cells are of relatively uniform size and shape. The diameter of the normal red cell should approximate that of the nucleus of the small lymphocyte; central pallor (red arrow) should equal one-third of its diameter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_50_18214=[""].join("\n");
var outline_f17_50_18214=null;
var title_f17_50_18215="Endoscopic staging upper GI-GVHD";
var content_f17_50_18215=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F86936&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F86936&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 539px\">",
"   <div class=\"ttl\">",
"    Endoscopic and histological staging of upper gastrointestinal graft-versus-host disease (GI-GVHD)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 519px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Upper panel: Endoscopic views of duodenum with the four grades of GI-GVHD. Grade 1 = loss of vascular markings and/or focal mild erythema; grade 2 = moderate edema and/or erythema; grade 3 = edema, erythema, erosions, and/or bleeding; grade 4 = ulceration, exudates, and bleeding.",
"    <br/>",
"    Lower panel: Photomicrographs of the duodenum corresponding to the above endoscopic images. Grade 1 = increased crypt apoptosis (arrow); grade 2 = apoptosis with crypt abscess (arrow); grade 3 = individual crypt necrosis (arrows); grade 4 = total denudation of areas of mucosa (hematoxylin and eosin [H &amp; E]; x220).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Cruz-Correa M, Poonawala A, Abraham SC, et al. Endoscopic findings predict the histologic diagnosis in gastrointestinal graft-versus-host disease. Endoscopy 2002; 34:808. Copyright &copy; 2002 Thieme Publishers.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_50_18215=[""].join("\n");
var outline_f17_50_18215=null;
var title_f17_50_18216="Pyogenic granuloma dermoscopy";
var content_f17_50_18216=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F57957%7EDERM%2F67395&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F57957%7EDERM%2F67395&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 603px\">",
"   <div class=\"ttl\">",
"    Pyogenic granuloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 583px; height: 232px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Clinical (left) and dermoscopic (right) image of pyogenic granuloma. On dermoscopy, pyogenic granulomas typically appear as pink homogeneous papules with a white collarette and white intersecting lines representing the fibrous septa seen at histopathology. In a minority of cases, as in the one shown in this picture, a bluish homogeneous structure can be seen. These cases are often clinically and dermoscopically misdiagnosed as melanomas.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dr. Ashfaq Marghoob.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pyogenic granuloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A red, protruding vascular papule consistent with a pyogenic granuloma is present on the chest.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_50_18216=[""].join("\n");
var outline_f17_50_18216=null;
var title_f17_50_18217="Hematopoietic cell transplantation in aplastic anemia";
var content_f17_50_18217=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hematopoietic cell transplantation in aplastic anemia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/50/18217/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/50/18217/contributors\">",
"     Robert S Negrin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/50/18217/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/50/18217/contributors\">",
"     Stanley L Schrier, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/50/18217/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/50/18217/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/50/18217/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 20, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical outcome for patients with aplastic anemia is dependent upon the severity of the pancytopenia and patient age. The criteria for",
"    <strong>",
"     severe",
"    </strong>",
"    aplastic anemia (SAA) are [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A marrow biopsy showing less than 25 percent of normal cellularity",
"      <strong>",
"       OR",
"      </strong>",
"     </li>",
"     <li>",
"      A marrow showing less than 50 percent normal cellularity in which fewer than 30 percent of the cells are hematopoietic and at least two of the following are present: absolute reticulocyte count",
"      <span class=\"nowrap\">",
"       &lt;40,000/microL;",
"      </span>",
"      absolute neutrophil count (ANC)",
"      <span class=\"nowrap\">",
"       &lt;500/microL;",
"      </span>",
"      or platelet count",
"      <span class=\"nowrap\">",
"       &lt;20,000/microL.",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The patient is considered to have",
"    <strong>",
"     very severe",
"    </strong>",
"    aplastic anemia (vSAA) if the ANC is",
"    <span class=\"nowrap\">",
"     &lt;200/microL.",
"    </span>",
"    Unless patients with SAA or vSAA are successfully treated, over 70 percent will die within one year due to complications resulting from the marked pancytopenia, mainly infection and bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic review will discuss the use of hematopoietic cell transplantation in the treatment of aplastic anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/2\">",
"     2",
"    </a>",
"    ]. A review of the historical advances in the treatment of this disease has been published [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/3\">",
"     3",
"    </a>",
"    ]. An overview of the treatment and prognosis of aplastic anemia is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/14/29930?source=see_link\">",
"     \"Aplastic anemia: Prognosis and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BENEFITS OF TRANSPLANTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;HCT is the most effective therapy for aplastic anemia, but its usefulness declines with age because of fatal complications [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/4\">",
"     4",
"    </a>",
"    ]; as a result, other therapies have usually been considered first in patients over the age of 30 to 40 years. However, patient survival has improved over time, due primarily to reduced mortality in the first three months posttransplantation. The use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    to prevent severe graft-versus-host disease (GvHD) accounts for most of the increase in survival as well as strategies to overcome graft rejection. Thus, for selected patients over this age, who are otherwise in excellent health and have a fully HLA-matched sibling donor, allogeneic HCT could be the first choice of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Clinical trials'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H5\">",
"     'Subjects over 40 years of age'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/11/10425?source=see_link\">",
"     \"Prevention and treatment of acute graft-versus-host disease: Recommendations\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    HCT is particularly desirable in patients with SAA since these patients have an increased risk of infection and bleeding and are less likely to respond to immunosuppressive therapy. In early studies, a major problem was the risk of graft failure. Multiple factors were thought to contribute to this problem, including allosensitization of the recipient through the transfusion of red cells and platelets. As a result, it is recommended that transfusions be avoided as much as possible in patients with aplastic anemia who are being considered for HCT; transfusion of cells from the transplant donor should",
"    <strong>",
"     always",
"    </strong>",
"    be avoided prior to HCT. The addition of antithymocyte globulin (ATG) to the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    preparative regimen has also contributed to the lower risk of graft failure [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If transfusions are medically indicated it is acceptable to transfuse patients with SAA except that the donor&rsquo;s cells should not be employed for such transfusions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Clinical trials",
"    </span>",
"    &nbsp;&mdash;&nbsp;The improvement in outcome after HCT for aplastic anemia was illustrated in a review of 1305 HLA-identical sibling transplants performed in 179 centers [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/8\">",
"     8",
"    </a>",
"    ]. Patient survival improved from 48 percent in the 1976 to 1980 cohort to 66 percent in the 1988 to 1992 cohort. The higher long-term disease-free survival was mainly due to improvements in the first three months after transplantation, with the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    being the most important factor.",
"   </p>",
"   <p>",
"    The largest single center experience with HCT in aplastic anemia comes from the Fred Hutchinson Cancer Research Center in Seattle; the results have been updated in a number of reports highlighting the increased survival achieved by using improved prophylaxis regimens for GVHD and the addition of ATG to the preparative regimen [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/5,9\">",
"     5,9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The preparative regimen most frequently used consists of four daily doses of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      (50",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day for 4 days, total dose: 200",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"      alternating with three doses of ATG (total, 90",
"      <span class=\"nowrap\">",
"       mg/kg),",
"      </span>",
"      followed by an HLA-identical hematopoietic cell graft. Bone marrow has been found to be preferred over mobilized peripheral blood progenitor cells as the source of the hematopoietic stem cells. (See",
"      <a class=\"local\" href=\"#H950260\">",
"       'Preferred stem cell source'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       Methotrexate",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      are typically given for graft-versus-host disease prophylaxis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/11/10425?source=see_link\">",
"       \"Prevention and treatment of acute graft-versus-host disease: Recommendations\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Long-term follow-up showed an 88 percent estimated overall survival at eight years post-transplant (",
"      <a class=\"graphic graphic_figure graphicRef75283 \" href=\"UTD.htm?7/54/8046\">",
"       figure 1",
"      </a>",
"      ). Excellent results have been observed by other groups using similar approaches (eg, 18 of 20 patients aged 17 to 37 in sustained hematologic remission at 9.5 years) [",
"      <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/10,11\">",
"       10,11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Another series of 133 patients transplanted using an HLA-identical sibling donor from January 1978 to December 2001 also found excellent results with the",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"      cyclophosphamide",
"     </a>",
"     /ATG",
"    </span>",
"    preparative regimen [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/12\">",
"     12",
"    </a>",
"    ]. The overall 10-year survival estimate was 64 percent. Four factors were associated with lower survival: use of thoracoabdominal irradiation, any treatment prior to transplantation (eg, androgens or immunosuppression), grade II-IV GVHD, and older age.",
"   </p>",
"   <p>",
"    A cohort of 97 patients with acquired AA treated between February 1998 and October 2007 with",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"      cyclophosphamide",
"     </a>",
"     /ATG",
"    </span>",
"    revealed similar results, with 77 percent of patients surviving at four years [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A trial in 134 patients with SAA randomly assigned patients to receive Cy alone or",
"    <span class=\"nowrap\">",
"     Cy/ATG",
"    </span>",
"    followed by a T replete bone marrow graft from an HLA-matched sibling. Five-year probabilities of overall survival for the Cy alone group and the",
"    <span class=\"nowrap\">",
"     Cy/ATG",
"    </span>",
"    group were similar at 74 and 80 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/14\">",
"     14",
"    </a>",
"    ]. Graft failure and graft versus host disease rates were also similar in the two groups and no differences in outcomes could be found.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Identical twin transplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a more limited experience with identical twin transplants in aplastic anemia. One review described the outcome in 40 such patients, 23 of whom did not receive pretransplant conditioning [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/15\">",
"     15",
"    </a>",
"    ]. The actuarial 10-year survival was 78 percent, with higher values being seen in the patients who did not have conditioning before the first transplant (87 versus 70 percent). Sustained hematologic recovery was more likely in the patients who underwent conditioning but this was not associated with a survival advantage. Most of the patients (15 of 23) who did not receive conditioning before the first transplant required subsequent transplants in which conditioning was performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Subjects over 40 years of age",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Fred Hutchinson Cancer Research Center has reported on its experience in 23 consecutive patients with severe aplastic anemia over the age of 40 (range: 40 to 68 years) who received HCT from an HLA-identical sibling. Approximately one-half of the patients had received immunosuppressive therapy prior to HCT. The conditioning regimen was",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    (200",
"    <span class=\"nowrap\">",
"     mg/kg)",
"    </span>",
"    plus horse ATG;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    were given for post-graft immunosuppression. Results included [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/16\">",
"     16",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Documented infections within one month before HCT were significantly associated with the risk of early transplant-related mortality.",
"     </li>",
"     <li>",
"      The cumulative incidences of grades II, III, and IV acute GVHD were 30, 4, and zero percent, respectively. Chronic GVHD was noted in 26 percent. The median time to discontinuation of immunosuppression for GVHD was 6.2 months.",
"     </li>",
"     <li>",
"      At a median follow-up of 9.1 years, overall survival was 65 percent for the entire group, and was 79 percent for those who did",
"      <strong>",
"       not",
"      </strong>",
"      have a documented infection within one month before HCT conditioning was started. All of the long-term survivors were in complete remission of severe aplastic anemia with normal blood counts, and did not require transfusion or G-CSF support. No deaths occurred beyond day 223 after HCT.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    By way of comparison, in an EBMT study, the five-year survival after immunosuppression therapy was 72 percent for those &lt;49 years of age, 57 percent for those 50 to 59 years of age, and 50 percent for those &gt;60 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/17\">",
"     17",
"    </a>",
"    ]. Thus, the survival rates for HCT in this study appear to be at least as good as survival rates for those of a similar age range treated with immunosuppressive regimens. The authors concluded, as have others [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/5\">",
"     5",
"    </a>",
"    ], that HCT from an HLA-identical sibling could be offered to those with severe aplastic anemia who are &gt;40 years of age and are without significant medical comorbidities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950260\">",
"    <span class=\"h3\">",
"     Preferred stem cell source",
"    </span>",
"    &nbsp;&mdash;&nbsp;Typically, HCT from a related donor is performed using bone marrow as the hematopoietic stem cell source. Given the outstanding results achieved using this stem cell source and the higher risks of GVHD with the use of mobilized peripheral blood progenitor cells, it is recommended to continue to utilize bone marrow for these patients. As examples:",
"   </p>",
"   <p>",
"    Data from the Center for International Blood and Marrow Transplant Research were retrospectively collected concerning transplant results in 296 patients with severe aplastic anemia who received either bone marrow (BM, n = 225) or peripheral blood progenitor cells (PBPC, n = 71) from adult unrelated donors matched at the allele level for HLA-A, -B, -C, and &ndash;DRB1 (ie, 8 of 8 HLA-matched). Results included the following [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/18\">",
"     18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The probabilities of neutrophil recovery at day 28 post-HCT were similar with the two stem cell sources, although the day 100 probability of platelet recovery for PBPC was significantly higher than with BM (91 versus 81 percent).",
"     </li>",
"     <li>",
"      Risks for grade II to IV acute graft-versus-host disease (GVHD) were significantly higher after transplantation of PBPC compared with BM (48 versus 31 percent at day 100; HR 1.68; 95% CI 1.10-2.55).",
"     </li>",
"     <li>",
"      Risks for chronic GVHD were not significantly different between the two stem cell sources after adjusting for age at transplantation.",
"     </li>",
"     <li>",
"      Three-year probabilities of overall survival, adjusted for performance score and transplant conditioning regimen, were significantly greater after BM compared with PBPC (76 versus 61 percent; HR 1.62; 95% CI 1.01-2.58).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a study of 1886 patients who had received a first HLA identical sibling transplant between 1999 and 2009 for acquired aplastic anemia, significant survival advantages for those receiving bone marrow rather than peripheral blood were seen in those age 1 to 19 years (90 versus 76 percent), those &ge;20 years of age (74 versus 64 percent), and those &gt;50 years of age (69 versus 39 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/19\">",
"     19",
"    </a>",
"    ]. Acute and chronic GVHD were both significantly more frequent in those receiving peripheral blood transplants, as was death from GVHD (6 versus 2 percent). As such, it is recommended that bone marrow be used rather than peripheral blood as a stem cell source.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Comparison with immunosuppression",
"    </span>",
"    &nbsp;&mdash;&nbsp;The outcomes with HCT appear to be superior to those achieved with immunosuppressive therapy. However, patient selection criteria complicate this type of analysis. Following immunosuppressive therapy many of these patients continue to have marginal cytopenias, and relapse of aplasia is relatively common. A review of 719 patients treated with immunosuppressive therapy noted an actuarial relapse rate of 35 percent at 14 years [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/20\">",
"     20",
"    </a>",
"    ]. Relapse was not predicted by age or the severity of disease. Fifty-three percent of relapsing patients responded to a second course of immunosuppressive therapy and had an actuarial survival rate of 80 percent; this value was similar to that in patients who did not relapse (86 percent) and significantly better than that in patients not achieving a second response (49 percent).",
"   </p>",
"   <p>",
"    Despite the frequency of persistent low-grade or recurrent disease, the advantage of the immunosuppressive approach is that it can be applied to every patient and does not carry the risk of graft-versus-host disease. The difficulty with comparing HCT with immunosuppressive therapy is the long follow-up required, the variability of the patients treated with the two approaches as those with more severe disease are generally referred for HCT, and the improvements which are being achieved with immunosuppressive treatments and supportive therapy following transplantation.",
"   </p>",
"   <p>",
"    A number of studies have attempted to compare results achieved using HCT and immunosuppressive therapy with the use of ATG or more recently ATG,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    . One report, for example, reviewed the course of 155 patients with aplastic anemia who were treated with ATG [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/21\">",
"     21",
"    </a>",
"    ]. The following results were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Six-year survival varied with the severity of the disease, being 71, 48, and 38 percent in those with moderate, severe, and very severe aplastic anemia, respectively. Malignancy occurred in 9 of 77 patients (12 percent) followed for more than two years (see",
"      <a class=\"local\" href=\"#H10\">",
"       'Late malignancy'",
"      </a>",
"      below).",
"     </li>",
"     <li>",
"      The outcome of patients with severe and very severe aplasia was compared with those who underwent HCT. Among patients transplanted after 1984 (ie, in the more modern era when outcomes were improved), six-year survival was higher in the transplanted patients (72 versus 45 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Similar results were noted in a large retrospective study from Seattle which assessed the outcomes of 395 patients with severe aplastic anemia who received either HCT (168 patients) or immunosuppressive drugs (227 patients) as primary therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/22\">",
"     22",
"    </a>",
"    ]. The mean patient age was 22 and 25 years in the two groups but some patients were transplanted as late as age 53. Actuarial survival at 15 years was significantly higher in the HCT group (69 versus 38 percent with immunosuppressive therapy) (",
"    <a class=\"graphic graphic_figure graphicRef75806 \" href=\"UTD.htm?33/20/34125\">",
"     figure 2",
"    </a>",
"    ). The relative survival benefit of HCT was greatest in children but disappeared in patients over age 40. In addition to HCT, the factors that predicted improved outcome were younger age, no prior history of transfusions, and a higher absolute neutrophil count.",
"   </p>",
"   <p>",
"    Somewhat different results in children were noted in a report from Memorial Sloan-Kettering in which 10-year survival with HCT and immunosuppressive therapy were equivalent (76 and 74 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/23\">",
"     23",
"    </a>",
"    ]. However, it was still concluded that HCT was preferred for the following reasons: the outcome with HCT improved over the last five years; and it was presumed that the HCT patients would be stable, since no survivor had chronic graft-versus-host disease, while patients treated with immunosuppressive therapy remain at risk for relapse or the development of clonal disease.",
"   </p>",
"   <p>",
"    A prospective multicenter trial in children with SAA or vSAA who failed to respond to immunosuppressive (IS) therapy compared a second course of IS with transplantation. At five years from the initiation of second line therapy, estimated failure-free survival was significantly higher for the transplanted patients than for those treated with a second course of IS therapy (84 versus 9.5 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Use of cyclophosphamide alone",
"    </span>",
"    &nbsp;&mdash;&nbsp;The dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    used for transplantation (190 to 200",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    given in divided doses over four days), with or without",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    , may induce remission directly without the infusion of hematopoietic cells [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/25\">",
"     25",
"    </a>",
"    ]. In one study, 7 of 10 patients with SAA treated with this regimen achieved a complete response, with six of these patients being alive and in continuous complete remission at 7 to 18 years.",
"   </p>",
"   <p>",
"    Additional studies using",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    alone have been reported. In 19 previously untreated patients overall survival at 24 months was 84 percent with treatment-free remission and complete remission rates of 73 and 65 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/26\">",
"     26",
"    </a>",
"    ]. An additional cohort of patients who had either not responded or relapsed following one or more courses of immunosuppression showed that at a median of 29 months 10 of 17 patients treated with cyclophosphamide alone were alive; nine achieved a drug-free remission, with four complete and five partial responders [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/14/29930?source=see_link\">",
"     \"Aplastic anemia: Prognosis and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Matched unrelated donor HCT",
"    </span>",
"    &nbsp;&mdash;&nbsp;An alternative approach that has been evaluated in children and young adults with relapsing or resistant disease is the use of matched unrelated HCT. Overall five-year survivals with this procedure have ranged from 28 to 94 percent, with significant heterogeneity between studies [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/29-32\">",
"     29-32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/38/26218?source=see_link\">",
"     \"Donor selection for hematopoietic cell transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One series from Seattle described 141 patients who failed treatment with immunosuppressive agents, most of whom received a radiation-containing preparative regimen prior to transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/30\">",
"     30",
"    </a>",
"    ]. Sustained engraftment was achieved in 89 percent and 36 percent were alive at a median follow-up of three years. Major causes of death were non-engraftment, graft-versus-host disease, and infection.",
"   </p>",
"   <p>",
"    In a later study from Seattle, which used low-dose total body irradiation (optimal dose 200 cGy), ATG, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    conditioning, engraftment was achieved in 95 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/33\">",
"     33",
"    </a>",
"    ]. At a median follow-up of 7 years, overall survival was 40 and 61 percent for those receiving HLA-nonidentical or HLA-identical unrelated donor transplants, respectively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/18/11562?source=see_link&amp;anchor=H8#H8\">",
"     \"Hematopoietic cell transplantation for idiopathic severe aplastic anemia and Fanconi anemia in children\", section on 'HCT from matched unrelated donors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is possible that the results with matched unrelated transplants can be improved by better typing and preparative regimens. In the preceding series, patients matched with donors by both serology and allele level DRB1 typing had a significantly higher three-year survival than DRB1-mismatched patients (56 versus 15 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/30\">",
"     30",
"    </a>",
"    ]. In one center, for example, use of a more aggressive conditioning regimen with T cell depletion of the donor marrow resulted in a 54 percent survival at almost three-year follow-up in 28 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The possible benefit of these improved approaches was underscored in a retrospective analysis of 154 patients with severe aplastic anemia who received transplants in the Japan Marrow Donor Program [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/35\">",
"     35",
"    </a>",
"    ]. Matching of HLA class I alleles and addition of ATG to the preparative regimen were both associated with improved long-term survival. Allele matching at the DRB1 locus was not critical, suggesting different roles for individual HLA loci in ethnic groups with lesser degrees of genetic diversity [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/36,37\">",
"     36,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    With the improvement of overall outcomes in patients receiving HCT from unrelated donors selected via molecular typing, it is likely that results in patients with SAA will also improve. This was shown in an analysis of 498 patients transplanted between 1990 and 2005. In that study, five-year survival significantly improved from 32 &plusmn; 8 percent before 1998 to 57 &plusmn; 8 percent after that date [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/38\">",
"     38",
"    </a>",
"    ]. There was no evidence that the improvement was due to better patient selection and it was speculated that the better results were largely due to improved donor selection.",
"   </p>",
"   <p>",
"    Several reports have evaluated the outcomes of patients undergoing unrelated donor transplantation for aplastic anemia. In one report focusing on children who had failed immunosuppressive therapy, five-year probabilities of survival were significantly better following a fully matched than a mismatched transplant (57 versus 39 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The selection of a preparative regimen is not as clear in the setting of unrelated donor transplantation. The use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    and ATG alone has resulted in a high risk of graft rejection and transplant-related mortality (TRM). While total body irradiation (TBI) has also been used, the dose required is uncertain. In one report of 40 patients, three different doses of TBI were utilized including 1200 (5 patients), 1000 (9 patients) and 800 cGy (26 patients) with an overall survival at three years of 40, 44, and 92 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one study, total lymphoid irradiation (TLI) was utilized along with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    (200",
"    <span class=\"nowrap\">",
"     mg/kg)",
"    </span>",
"    and TBI for patients receiving transplants from unrelated donors. At a median follow-up of seven years overall survival was 81 percent and was not significantly different between the patients receiving related transplants and those receiving unrelated transplants [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Bone Marrow Transplant Clinical Trials Network (BMT-CTN) is pursuing a study in patients with SAA utilizing unrelated donors and exploring novel conditioning strategies in a de-escalating format of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    dosing. Other conditioning strategies have included non-total body irradiation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/42\">",
"     42",
"    </a>",
"    ] as well as non-myeloablative conditioning using varying combinations of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9545?source=see_link\">",
"     fludarabine",
"    </a>",
"    , cyclophosphamide, irradiation, and ATG, with promising results [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/43-50\">",
"     43-50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23435346\">",
"    <span class=\"h3\">",
"     Umbilical cord blood transplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Umbilical cord blood has been used as a hematopoietic stem cell source for patients with severe aplastic anemia with encouraging results in those patients for whom a suitable related or unrelated donor cannot be identified, as well as in those who have failed immunosuppressive therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/51-55\">",
"     51-55",
"    </a>",
"    ]. Such treatment, as well as the use of haploidentical donors, is still considered experimental [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/56,57\">",
"     56,57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Fanconi anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allogeneic stem cell transplantation is the only current therapy that can restore normal hematopoiesis in children with the autosomal recessive disorder Fanconi anemia. The outcome appears to be better with HLA-identical sibling donors. This was illustrated in a report from the International Bone Marrow Transplant Registry that evaluated 151 HLA-identical sibling and 48 alternative related or unrelated bone marrow transplants [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/58\">",
"     58",
"    </a>",
"    ]. The two-year probability of survival was 66 and 29 percent in the two groups, respectively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/18/11562?source=see_link&amp;anchor=H9#H9\">",
"     \"Hematopoietic cell transplantation for idiopathic severe aplastic anemia and Fanconi anemia in children\", section on 'Fanconi anemia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     LATE MALIGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A significant long-term problem following successful treatment for aplastic anemia has been the development of new malignancies and, with immunosuppressive therapy, of paroxysmal nocturnal hemoglobinuria and myelodysplasia (MDS). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/14/29930?source=see_link&amp;anchor=H28#H28\">",
"     \"Aplastic anemia: Prognosis and treatment\", section on 'Occurrence of clonal disorders'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These complications appear to be more common with immunosuppressive therapy. A report from the European Blood and Marrow Transplantation-Severe Aplastic Anaemia Working Party estimated a 10-year incidence of malignancy of 19 percent in 860 patients treated with immunosuppressive therapy, mostly MDS or acute leukemia (5.2 times the overall cancer risk in an age-matched population) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/59\">",
"     59",
"    </a>",
"    ]. A much lower value, 3 percent (consisting primarily of solid tumors), was seen after HCT. The incidence of solid tumors was similar with the two procedures but hematologic malignancy was much less common following bone marrow transplantation.",
"   </p>",
"   <p>",
"    Another report analyzed 700 patients transplanted for aplastic anemia or Fanconi anemia in Seattle or Paris [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/60\">",
"     60",
"    </a>",
"    ]. Twenty-three patients developed a malignancy at a median of 91 months following the transplant. These included five lymphoid malignancies (which occurred early; median three months) and 18 solid tumors (which occurred late; median 99 months). The Kaplan-Meier estimate of the malignancy risk was 14 percent at 20 years. Among the patients who were transplanted and did not have Fanconi anemia, the major risk factors were the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    for prevention or therapy of GVHD and radiation in the preparative regimen.",
"   </p>",
"   <p>",
"    Since",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    and radiation are no longer routinely used in HCT preparative regimens, it is reasonable to expect that the risk of new malignancies may drop with subsequent cohorts of patients. As an example, in a report of 61 consecutive patients with severe aplastic anemia who were conditioned prior to allogeneic HCT with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    and antithymocyte globulin between 1991 and 2010, only one patient developed a malignancy (Hodgkin lymphoma) at a median follow-up of 73 months (range: 8 to 233 months) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     LONG-TERM SURVIVAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Late Effects Working Committee of the International Bone Marrow Transplant Registry studied 1029 patients with aplastic anemia who were treated with allo-HCT between 1980 and 1993 and who were alive and free of aplastic anemia for at least two years after transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/62\">",
"     62",
"    </a>",
"    ]. At a median follow-up of 11 years, 60 of these patients had died (5.8 percent). The causes of death were:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      GvHD &mdash; 38 patients",
"     </li>",
"     <li>",
"      Infection without GvHD &mdash; 7 patients",
"     </li>",
"     <li>",
"      Organ failure (liver, cardiac, pulmonary, renal) &mdash; 5 patients",
"     </li>",
"     <li>",
"      Other (hemorrhage, interstitial pneumonia, drug reaction, miscellaneous) &mdash; 7 patients",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The relative risks for late death were 4.5, 3.0, 2.2, and 2.1 for the presence of active chronic GvHD at two years, delayed time to transplant (&gt;1 year), history of acute GVHD, and resolved chronic GvHD at two years, respectively. A Karnofsky performance score of less than 90 percent was noted in 12 percent of survivors in this group (",
"    <a class=\"graphic graphic_table graphicRef58785 \" href=\"UTD.htm?2/11/2236\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Of special interest were the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      There were no cases of relapse of aplastic anemia",
"     </li>",
"     <li>",
"      The incidence of new cancer was 2 percent (1 patient)",
"     </li>",
"     <li>",
"      The risk of death by the sixth year posttransplant did not differ significantly from that of a normal population",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    One patient has been described with late graft failure at eight years [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/63\">",
"     63",
"    </a>",
"    ]. At that time, examination of the marrow revealed that 85 percent of hematopoietic cells were of donor origin. The patient was successfully retransplanted from the same donor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     LATE MEDICAL AND SOCIAL OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The quality of life in 212 patients who were alive at least two years after HCT for aplastic anemia was reviewed in a series with 26-year follow-up; the median age at transplant was 18 with the oldest patient being 42 [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/64\">",
"     64",
"    </a>",
"    ]. The major predictor of 20-year survival was the absence of chronic graft-versus-host disease (89 versus 69 percent in the one-third of patients with chronic graft-versus-host disease). At least one-half of the patients preserved or regained the ability to become pregnant or father a child, which is in marked contrast to other patients who undergo transplantation with more aggressive regimens. Patients rated their quality of life as excellent and symptoms as minimal or mild. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/25/23962?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and grading of chronic graft-versus-host disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The University of Minnesota evaluated the late medical and social outcomes in 94 patients under the age of 21 who were transplanted for severe aplastic anemia between 1975 and 1996 [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18217/abstract/65\">",
"     65",
"    </a>",
"    ]. Of the 58 patients surviving for &ge;3 years posttransplant, 37 participated in a self-assessment questionnaire study, and were compared with 146 age- and sex-matched controls. There were no significant differences between the two groups with respect to overall health status, psychosexual function, educational achievement, employment history, or personal income. Chronic health problems that were more common in the transplant group included cataracts, short stature in men, hypothyroidism, and gonadal dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Treatment overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hematopoietic cell transplantation (HCT) is an effective and potentially curative treatment option for patients with severe (SAA) or very severe aplastic anemia (vSAA). HCT compares favorably to immunosuppression, the other major treatment option for aplastic anemia, under a number of different clinical situations, depending upon patient age, prior treatment, presence of medical comorbidities, and the availability of a matched related or matched unrelated transplant donor. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Benefits of transplantation'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/14/29930?source=see_link&amp;anchor=H36#H36\">",
"     \"Aplastic anemia: Prognosis and treatment\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Initial treatment of AA in any patient includes withdrawal of potentially offending agents, supportive care (eg, transfusion, antibiotics), and some form of definitive therapy (eg, hematopoietic cell transplantation, immunosuppressive regimens). Blood and platelet transfusions should be used selectively in patients who are candidates for HCT to avoid sensitization and should never be used from the potential HCT donor prior to transplantation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/14/29930?source=see_link\">",
"     \"Aplastic anemia: Prognosis and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Recommendations",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1344608\">",
"    <span class=\"h3\">",
"     Stem cell source",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wherever possible, we recommend the use of bone marrow rather than peripheral blood as the source of stem cells for hematopoietic cell transplantation in patients with aplastic anemia (",
"    <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"     Grade 1B",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H950260\">",
"     'Preferred stem cell source'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Under age 20",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with SAA or vSAA &lt;20 years of age with an HLA-matched sibling, we recommend treatment with allogeneic HCT over treatment with an immunosuppressive regimen (",
"    <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"     Grade 1B",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Comparison with immunosuppression'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    For those who do not have a matched sibling donor we suggest the use of immunosuppressive therapy over the use of matched unrelated, mismatched related, or mismatched unrelated HCT (",
"    <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"     Grade 2C",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    However, matched unrelated donor identification should proceed. If such a donor can be identified in a timely manner, it is possible that younger patients with a fully-matched unrelated donor may do as well as, or better than, those receiving immunosuppressive agents. However, this has not been fully tested in a randomized setting. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Benefits of transplantation'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H8\">",
"     'Matched unrelated donor HCT'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/18/11562?source=see_link&amp;anchor=H8#H8\">",
"     \"Hematopoietic cell transplantation for idiopathic severe aplastic anemia and Fanconi anemia in children\", section on 'HCT from matched unrelated donors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Age 20 to 50 years",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with SAA or vSAA 20 to 50 years of age in otherwise excellent health with a fully HLA-matched sibling donor, we recommend treatment with allogeneic HCT over treatment with an immunosuppressive regimen (",
"    <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"     Grade 1C",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    For those without a matched sibling donor, we suggest the use of immunosuppressive therapy over the use of matched unrelated, mismatched related, or mismatched unrelated HCT (",
"    <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"     Grade 2C",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Matched unrelated donor HCT'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Age over 50",
"    </span>",
"    &nbsp;&mdash;&nbsp;For most patients with SAA or vSAA over the age of 50, we suggest the use of immunosuppressive therapy over HCT because of the very high risk of graft versus host disease and other transplant-related complications in this group of patients (",
"    <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"     Grade 2B",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Treatment overview'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    For patients over the age of 50 who are free of significant medical comorbidities and have an HLA-identical sibling donor, we suggest HCT rather than immunosuppressive therapy (",
"    <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"     Grade 2C",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Subjects over 40 years of age'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Patients failing to respond to immunosuppression",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients who have not adequately responded to one to two courses of immunosuppressive therapy, or who relapse following such therapy, we recommend matched unrelated donor HCT over further repeated course(s) of immunosuppressive therapy (",
"    <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"     Grade 2C",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Matched unrelated donor HCT'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/18/11562?source=see_link&amp;anchor=H8#H8\">",
"     \"Hematopoietic cell transplantation for idiopathic severe aplastic anemia and Fanconi anemia in children\", section on 'HCT from matched unrelated donors'",
"    </a>",
"    .)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/1\">",
"      Rozman C, Mar&iacute;n P, Nomdedeu B, Montserrat E. Criteria for severe aplastic anaemia. Lancet 1987; 2:955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/2\">",
"      Aljurf M, Al-Zahrani H, Van Lint MT, Passweg JR. Standard treatment of acquired SAA in adult patients 18-40 years old with an HLA-identical sibling donor. Bone Marrow Transplant 2013; 48:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/3\">",
"      Armand P, Antin JH. Allogeneic stem cell transplantation for aplastic anemia. Biol Blood Marrow Transplant 2007; 13:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/4\">",
"      Gupta V, Eapen M, Brazauskas R, et al. Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors. Haematologica 2010; 95:2119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/5\">",
"      Young NS. Aplastic anaemia. Lancet 1995; 346:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/6\">",
"      Storb R, Etzioni R, Anasetti C, et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 1994; 84:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/7\">",
"      Kahl C, Leisenring W, Deeg HJ, et al. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up. Br J Haematol 2005; 130:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/8\">",
"      Passweg JR, Soci&eacute; G, Hinterberger W, et al. Bone marrow transplantation for severe aplastic anemia: has outcome improved? Blood 1997; 90:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/9\">",
"      Storb R, Blume KG, O'Donnell MR, et al. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers. Biol Blood Marrow Transplant 2001; 7:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/10\">",
"      Reiter E, Keil F, Brugger S, et al. Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia. Bone Marrow Transplant 1997; 19:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/11\">",
"      Locatelli F, Bruno B, Zecca M, et al. Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial. Blood 2000; 96:1690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/12\">",
"      Ades L, Mary JY, Robin M, et al. Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood 2004; 103:2490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/13\">",
"      Ladeb S, Abdelkefi A, Torjman L, et al. Allogeneic hematopoietic stem cell transplantation for acquired aplastic anemia using cyclophosphamide and antithymocyte globulin: a single center experience. Bone Marrow Transplant 2009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/14\">",
"      Champlin RE, Perez WS, Passweg JR, et al. Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. Blood 2007; 109:4582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/15\">",
"      Hinterberger W, Rowlings PA, Hinterberger-Fischer M, et al. Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. Ann Intern Med 1997; 126:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/16\">",
"      Sangiolo D, Storb R, Deeg HJ, et al. Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age. Biol Blood Marrow Transplant 2010; 16:1411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/17\">",
"      Tichelli A, Soci&eacute; G, Henry-Amar M, et al. Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party. Ann Intern Med 1999; 130:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/18\">",
"      Eapen M, Le Rademacher J, Antin JH, et al. Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia. Blood 2011; 118:2618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/19\">",
"      Bacigalupo A, Soci&eacute; G, Schrezenmeier H, et al. Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups. Haematologica 2012; 97:1142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/20\">",
"      Schrezenmeier H, Marin P, Raghavachar A, et al. Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party. Br J Haematol 1993; 85:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/21\">",
"      Paquette RL, Tebyani N, Frane M, et al. Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation. Blood 1995; 85:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/22\">",
"      Doney K, Leisenring W, Storb R, Appelbaum FR. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team. Ann Intern Med 1997; 126:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/23\">",
"      Gillio AP, Boulad F, Small TN, et al. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation. Biol Blood Marrow Transplant 1997; 3:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/24\">",
"      Kosaka Y, Yagasaki H, Sano K, et al. Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia. Blood 2008; 111:1054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/25\">",
"      Brodsky RA, Sensenbrenner LL, Jones RJ. Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation. Blood 1996; 87:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/26\">",
"      Brodsky RA, Sensenbrenner LL, Smith BD, et al. Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia. Ann Intern Med 2001; 135:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/27\">",
"      Brodsky RA, Chen AR, Brodsky I, Jones RJ. High-dose cyclophosphamide as salvage therapy for severe aplastic anemia. Exp Hematol 2004; 32:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/28\">",
"      Brodsky RA, Jones RJ. Aplastic anaemia. Lancet 2005; 365:1647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/29\">",
"      Davies SM, Wagner JE, Defor T, et al. Unrelated donor bone marrow transplantation for children and adolescents with aplastic anaemia or myelodysplasia. Br J Haematol 1997; 96:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/30\">",
"      Deeg HJ, Seidel K, Casper J, et al. Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy. Biol Blood Marrow Transplant 1999; 5:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/31\">",
"      Marsh JC, Gordon-Smith EC. Treatment options in severe aplastic anaemia. Lancet 1998; 351:1830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/32\">",
"      Peinemann F, Grouven U, Kr&ouml;ger N, et al. Unrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review. Haematologica 2009; 94:1732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/33\">",
"      Deeg HJ, O'Donnell M, Tolar J, et al. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood 2006; 108:1485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/34\">",
"      Margolis D, Camitta B, Pietryga D, et al. Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults. Br J Haematol 1996; 94:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/35\">",
"      Kojima S, Matsuyama T, Kato S, et al. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood 2002; 100:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/36\">",
"      Morishima Y, Kodera Y, Hirabayashi N, et al. Low incidence of acute GVHD in patients transplanted with marrow from HLA-A,B,DR-compatible unrelated donors among Japanese. Bone Marrow Transplant 1995; 15:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/37\">",
"      Yagasaki H, Kojima S, Yabe H, et al. Acceptable HLA-mismatching in unrelated donor bone marrow transplantation for patients with acquired severe aplastic anemia. Blood 2011; 118:3186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/38\">",
"      Viollier R, Soci&eacute; G, Tichelli A, et al. Recent improvement in outcome of unrelated donor transplantation for aplastic anemia. Bone Marrow Transplant 2008; 41:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/39\">",
"      Perez-Albuerne ED, Eapen M, Klein J, et al. Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia. Br J Haematol 2008; 141:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/40\">",
"      Kim SY, Lee JW, Lim J, et al. Unrelated donor bone marrow transplants for severe aplastic anemia with conditioning using total body irradiation and cyclophosphamide. Biol Blood Marrow Transplant 2007; 13:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/41\">",
"      Inamoto Y, Suzuki R, Kuwatsuka Y, et al. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen. Biol Blood Marrow Transplant 2008; 14:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/42\">",
"      Lee JH, Choi SJ, Lee JH, et al. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 2005; 35:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/43\">",
"      Srinivasan R, Takahashi Y, McCoy JP, et al. Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation. Br J Haematol 2006; 133:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/44\">",
"      Resnick IB, Aker M, Shapira MY, et al. Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen. Br J Haematol 2006; 133:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/45\">",
"      George B, Mathews V, Viswabandya A, et al. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia. Bone Marrow Transplant 2007; 40:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/46\">",
"      George B, Mathews V, Viswabandya A, et al. Fludarabine-based reduced intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia and fungal infections. Clin Transplant 2009; 23:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/47\">",
"      George B, Mathews V, Viswabandya A, et al. Fludarabine based reduced intensity conditioning regimens in children undergoing allogeneic stem cell transplantation for severe aplastic anemia. Pediatr Transplant 2008; 12:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/48\">",
"      Bacigalupo A, Socie' G, Lanino E, et al. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party. Haematologica 2010; 95:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/49\">",
"      Kang HJ, Shin HY, Park JE, et al. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study. Biol Blood Marrow Transplant 2010; 16:1582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/50\">",
"      Maury S, Aljurf M. Management of adult patients older than 40 years refractory to at least one immunosuppressive course: HLA-identical sibling HSCT using fludarabine-based conditioning. Bone Marrow Transplant 2013; 48:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/51\">",
"      Yoshimi A, Kojima S, Taniguchi S, et al. Unrelated cord blood transplantation for severe aplastic anemia. Biol Blood Marrow Transplant 2008; 14:1057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/52\">",
"      Chan KW, McDonald L, Lim D, et al. Unrelated cord blood transplantation in children with idiopathic severe aplastic anemia. Bone Marrow Transplant 2008; 42:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/53\">",
"      Kang HJ, Lee JW, Kim H, et al. Successful first-line treatment with double umbilical cord blood transplantation in severe aplastic anemia. Bone Marrow Transplant 2010; 45:955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/54\">",
"      Yamamoto H, Kato D, Uchida N, et al. Successful sustained engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with severe aplastic anemia. Blood 2011; 117:3240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/55\">",
"      Liu HL, Sun ZM, Geng LQ, et al. Unrelated cord blood transplantation for newly diagnosed patients with severe acquired aplastic anemia using a reduced-intensity conditioning: high graft rejection, but good survival. Bone Marrow Transplant 2012; 47:1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/56\">",
"      Peffault de Latour R, Rocha V, Soci&eacute; G. Cord blood transplantation in aplastic anemia. Bone Marrow Transplant 2013; 48:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/57\">",
"      Ciceri F, Lupo-Stanghellini MT, Korthof ET. Haploidentical transplantation in patients with acquired aplastic anemia. Bone Marrow Transplant 2013; 48:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/58\">",
"      Gluckman E, Auerbach AD, Horowitz MM, et al. Bone marrow transplantation for Fanconi anemia. Blood 1995; 86:2856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/59\">",
"      Soci&eacute; G, Henry-Amar M, Bacigalupo A, et al. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med 1993; 329:1152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/60\">",
"      Deeg HJ, Soci&eacute; G, Schoch G, et al. Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 1996; 87:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/61\">",
"      Konopacki J, Porcher R, Robin M, et al. Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning. Haematologica 2012; 97:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/62\">",
"      Soci&eacute; G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 1999; 341:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/63\">",
"      Dufour C, Dallorso S, Casarino L, et al. Late graft failure 8 years after first bone marrow transplantation for severe acquired aplastic anemia. Bone Marrow Transplant 1999; 23:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/64\">",
"      Deeg HJ, Leisenring W, Storb R, et al. Long-term outcome after marrow transplantation for severe aplastic anemia. Blood 1998; 91:3637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18217/abstract/65\">",
"      Eapen M, Ramsay NK, Mertens AC, et al. Late outcomes after bone marrow transplant for aplastic anaemia. Br J Haematol 2000; 111:754.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7089 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.80.101-C15F01F966-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_50_18217=[""].join("\n");
var outline_f17_50_18217=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BENEFITS OF TRANSPLANTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Clinical trials",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Identical twin transplantation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Subjects over 40 years of age",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H950260\">",
"      - Preferred stem cell source",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Comparison with immunosuppression",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Use of cyclophosphamide alone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Matched unrelated donor HCT",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23435346\">",
"      - Umbilical cord blood transplantation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Fanconi anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      LATE MALIGNANCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      LONG-TERM SURVIVAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      LATE MEDICAL AND SOCIAL OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Treatment overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Recommendations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1344608\">",
"      - Stem cell source",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Under age 20",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Age 20 to 50 years",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Age over 50",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Patients failing to respond to immunosuppression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/7089\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7089|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/54/8046\" title=\"figure 1\">",
"      Improved BMT outcomes in AA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/20/34125\" title=\"figure 2\">",
"      BMT v immunosuppression in AA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7089|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/11/2236\" title=\"table 1\">",
"      Karnofsky performance status scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/14/29930?source=related_link\">",
"      Aplastic anemia: Prognosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/25/23962?source=related_link\">",
"      Clinical manifestations, diagnosis, and grading of chronic graft-versus-host disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/38/26218?source=related_link\">",
"      Donor selection for hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/18/11562?source=related_link\">",
"      Hematopoietic cell transplantation for idiopathic severe aplastic anemia and Fanconi anemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/11/10425?source=related_link\">",
"      Prevention and treatment of acute graft-versus-host disease: Recommendations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_50_18218="Pathogenesis of renal osteodystrophy";
var content_f17_50_18218=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis of renal osteodystrophy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/50/18218/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/50/18218/contributors\">",
"     Wajeh Y Qunibi, MD, FACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/50/18218/contributors\">",
"     William L Henrich, MD, MACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/50/18218/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/50/18218/contributors\">",
"     Jeffrey S Berns, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/50/18218/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/50/18218/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/50/18218/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION AND OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Changes in mineral metabolism and bone structure develop early in the course of chronic kidney disease (CKD) and worsen with progressive loss of kidney function. The magnitude of these changes may also be influenced by various therapeutic interventions, such as vitamin D administration [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/1-4\">",
"     1-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Four main types of renal bone disease can be seen in patients with CKD with many patients showing evidence of more than one defined bone lesion (called mixed uremic osteodystrophy).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Osteitis fibrosa cystica, in which bone turnover is increased due to secondary hyperparathyroidism. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Secondary hyperparathyroidism and osteitis fibrosa'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Adynamic bone disease, in which bone turnover is low. Although aluminum deposition may cause this disorder, most current cases result from excessive suppression of the parathyroid glands. This represents the major bone lesion in peritoneal dialysis and hemodialysis patients. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Adynamic bone disease'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Osteomalacia, in which bone turnover is also low in combination with an increased volume of unmineralized bone (osteoid). This problem, which is now uncommon, was due primarily to aluminum deposition in bone at a time when aluminum-containing antacids were used as phosphate binders. The mineralization lag time is prolonged in osteomalacia: greater than 100 days, in comparison to less than 35 days in normal subjects and those with pure osteitis fibrosa. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Osteomalacia'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Mixed uremic osteodystrophy, in which elements of both high and low bone turnover may be observed. This is also characterized by marrow fibrosis and increased unmineralized osteoid.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A fifth but different type of uremic bone disease, with a unique pathogenesis, occurs in patients on long-term dialysis and presents as bone cysts, which result from beta2-microglobulin-associated amyloid deposits (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/30/5609?source=see_link\">",
"     \"Dialysis-related amyloidosis\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Despite progressive lesions, symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    signs due to the various bone disorders, such as fractures and bone pain, generally do not occur until the patient is already on maintenance dialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/1\">",
"     1",
"    </a>",
"    ]. However, subclinical changes in bone remodeling begin early in the course of kidney disease. Alterations in bone quality in both high turn-over and low turn-over bone diseases may contribute to the diminished mechanical competence of bone in CKD. Bone quality refers to the structural and material parameters that enable bone to bear load and resist fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/5\">",
"     5",
"    </a>",
"    ]. One study reported that low turnover is manifested by changes in microstructural parameters while bone with high turnover is manifested by changes in material composition and nanomechanical properties [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a position statement, the National Kidney Foundation (NKF) stated that the term, renal osteodystrophy, should be exclusively used to define bone morphology alterations observed in CKD [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/7\">",
"     7",
"    </a>",
"    ]. These alterations can be assessed further by histomorphometry, including aspects of bone turnover, mineralization, and volume. The statement considers renal osteodystrophy as only one measure of the skeletal component of the newly described syndrome of chronic kidney disease-mineral and bone disorders (CKD-MBD), a term used to define a broader syndrome in patients with CKD, in which abnormalities in bone and mineral metabolism",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    extra-skeletal calcification are observed [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/7\">",
"     7",
"    </a>",
"    ]. Similarly, Kidney Disease: Improving Global Outcomes (KDIGO) recommended that the term \"renal osteodystrophy\" be restricted to describing the bone pathology associated with CKD and that 'CKD-MBD' should be used to describe the broader clinical syndrome encompassing mineral, bone, and calcific cardiovascular abnormalities that develop as a complication of CKD [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prevention and treatment of renal osteodystrophy involves multiple issues, the importance of which will be better appreciated after the following discussion on the pathogenesis of uremic bone disease. Management issues include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prevention and treatment of hyperphosphatemia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33690?source=see_link\">",
"       \"Treatment of hyperphosphatemia in chronic kidney disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Administration of calcitriol, vitamin D analogs,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a calcimimetic agent to directly suppress the secretion of parathyroid hormone.",
"     </li>",
"     <li>",
"      Parathyroidectomy, which is performed infrequently, in patients with severe and refractory hyperparathyroidism. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/3/9273?source=see_link\">",
"       \"Indications for parathyroidectomy in end-stage renal disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The pathogenesis of the major types of renal osteodystrophy will be reviewed here. Clinical issues related to adynamic bone disease are also discussed in this topic review. The use of bone biopsy to establish a specific diagnosis is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/43/28343?source=see_link\">",
"     \"Bone biopsy and the diagnosis of renal osteodystrophy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The current spectrum of bone lesions in patients with CKD is considerably different from that described previously. Over the last few decades, the prevalence of osteitis fibrosa among dialysis patients has markedly decreased, while non-aluminum-induced adynamic bone disease has significantly increased, with variations based in part upon geographic region evaluated [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/9-12\">",
"     9-12",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a 1996 to 1998 study of 56 dialysis patients from Thailand, bone biopsy in combination with other analysis revealed that adynamic bone disease, hyperparathyroidism, mixed osteodystrophy, mild lesion, osteomalacia, and osteosclerosis were observed in approximately 41, 29, 20, 5, 4, and 2 percent, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a 2003 trial of 98 dialysis patients in Europe, bone biopsy revealed adynamic bone disease and osteitis fibrosa in approximately 20 percent of patients each, with osteomalacia only being observed in a few percent [",
"      <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/10\">",
"       10",
"      </a>",
"      ]. The remainder had mixed lesions.",
"     </li>",
"     <li>",
"      In a 2008 study, the high prevalence of adynamic bone was confirmed in 119 hemodialysis patients from Portugal where bone biopsies revealed that adynamic bone disease was the most frequent bone abnormality, being present in 59 percent of the patients [",
"      <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/13\">",
"       13",
"      </a>",
"      ]. This high prevalence was observed despite treating most patients in accordance with",
"      <span class=\"nowrap\">",
"       K/DOQI",
"      </span>",
"      guidelines and having serum mineral parameters within recommended ranges.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Even among CKD patients not yet on dialysis, the prevalence of adynamic bone disease has increased. In a bone biopsy study in 84 unselected patients with stage 5 CKD, adynamic bone disease was the most prevalent type of renal osteodystrophy, particularly in diabetic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This change in prevalence toward an increasing number of patients with adynamic bone disease is probably the result of multiple factors, including changes in patients' demographics (older and increased number of diabetic patients) and changes in therapeutic strategies such as the increased and earlier use of vitamin D analogs, calcium-containing phosphate binders and differences in dialysis techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is possible, however, that the spectrum of bone lesions seen in dialysis patients may change yet again in the future, particularly with the current use of non-calcium-containing phosphate binders and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/23/26998?source=see_link\">",
"     cinacalcet",
"    </a>",
"    . In addition, the tendency for targeting a higher parathyroid (PTH) hormone level as recommended by the Kidney Disease: Improving Global Outcomes (KDIGO, which recommend target PTH levels at two to nine times the upper limit of normal) may also result in resurgence of the predominant lesions of osteitis fibrosa [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SECONDARY HYPERPARATHYROIDISM AND OSTEITIS FIBROSA",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteitis fibrosa cystica is a disorder in which bone turnover is increased due to secondary hyperparathyroidism. Secondary hyperparathyroidism begins quite early in the course of CKD, frequently when kidney function declines to less than 60",
"    <span class=\"nowrap\">",
"     mL/minute/1.73m(2).",
"    </span>",
"    This occurs in response to a series of abnormalities that initiate and maintain increased PTH secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/18\">",
"     18",
"    </a>",
"    ]. The main abnormalities that contribute to the pathogenesis of secondary hyperparathyroidism are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Phosphate retention",
"     </li>",
"     <li>",
"      Decreased free calcium level",
"     </li>",
"     <li>",
"      Decreased 1,25-dihydroxyvitamin D (Calcitriol) level",
"     </li>",
"     <li>",
"      The reduced expression of vitamin D receptors, calcium-sensing receptors, FGF receptors and Klotho in the parathyroid glands (",
"      <a class=\"graphic graphic_algorithm graphicRef83940 \" href=\"UTD.htm?40/38/41582\">",
"       algorithm 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The relative importance of these abnormalities in triggering PTH production can be understood by examining the changes in their levels in relation to the increase in PTH during the course of CKD. Increased PTH levels first become evident when the estimated glomerular filtration rate (eGFR) drops below 60",
"    <span class=\"nowrap\">",
"     mL/min/1.73m(2).",
"    </span>",
"    At that time, serum calcium and phosphate levels are normal and remain within normal ranges until eGFR decrease to approximately 20",
"    <span class=\"nowrap\">",
"     mL/min/1.73m(2)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/19\">",
"     19",
"    </a>",
"    ]. However, low levels of calcitriol are common at higher levels of eGFR. In one study, low levels of calcitriol occurred earlier in the course of eGFR decline than did elevations in iPTH levels [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/19\">",
"     19",
"    </a>",
"    ], suggesting that low calcitriol levels may be the initial trigger for the increase in PTH production.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Phosphate retention and hyperphosphatemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;A tendency to phosphate retention, beginning early in the disease as the fall in glomerular filtration rate (GFR) decreases the filtered phosphate load, plays a central role in the development of secondary hyperparathyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/4,16,20\">",
"     4,16,20",
"    </a>",
"    ]. Three major and not mutually exclusive theories have been proposed to explain how phosphate retention initially promotes PTH release [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/1,2,21\">",
"     1,2,21",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The induction of hypocalcemia",
"     </li>",
"     <li>",
"      Decreased formation or activity of calcitriol (1,25-dihydroxyvitamin D, the active form of vitamin D that is produced by the kidney)",
"     </li>",
"     <li>",
"      A direct effect of hyperphosphatemia to increase PTH gene expression. By comparison, it stimulates the secretion of the FGF-23, which acts to suppress PTH secretion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Phosphate retention contributes to secondary hyperparathyroidism in early CKD (",
"    <a class=\"graphic graphic_figure graphicRef68602 \" href=\"UTD.htm?28/43/29373\">",
"     figure 1",
"    </a>",
"    ), at least in part by decreasing serum free calcium level and calcitriol synthesis. If, for example, phosphate retention is prevented by restricting phosphate intake in proportion to the reduction in GFR, the rise in plasma parathyroid hormone (PTH) concentration can be prevented (",
"    <a class=\"graphic graphic_figure graphicRef68602 \" href=\"UTD.htm?28/43/29373\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/21-23\">",
"     21-23",
"    </a>",
"    ]. Even in patients with moderate renal insufficiency and already established secondary hyperparathyroidism, lowering the plasma phosphate concentration with oral phosphate binders can partially reverse the hypocalcemia, hyperparathyroidism, and calcitriol deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33690?source=see_link\">",
"     \"Treatment of hyperphosphatemia in chronic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    From the viewpoint of phosphate homeostasis, the initial elevation in PTH secretion is appropriate since the ensuing increase in phosphate excretion lowers the plasma phosphate concentration toward normal. The inhibitory effect of PTH on proximal phosphate reabsorption results in a reduction in the fraction of the filtered phosphate that is reabsorbed from the normal 80 to 95 percent to as low as 15 percent in patients with severe renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/18,26\">",
"     18,26",
"    </a>",
"    ]. The hyperparathyroidism will also tend to correct both the hypocalcemia (by increasing bone resorption) and the calcitriol deficiency (by stimulating the 1-hydroxylation of calcidiol (25-hydroxyvitamin D) in the proximal tubule). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/15/9462?source=see_link\">",
"     \"Metabolism of vitamin D\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, the hyperparathyroidism is maladaptive over the long-term, producing bone disease and contributing to dysfunction in other organs [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/21\">",
"     21",
"    </a>",
"    ]. Furthermore, there is a changing effect of PTH on phosphate balance in advanced renal failure. Since phosphate reabsorption by the renal tubules cannot be lowered further, continued PTH-induced release of phosphate from bone can exacerbate the hyperphosphatemia.",
"   </p>",
"   <p>",
"    In addition to its indirect effects, there is increasing evidence in both animals and humans for a direct effect of hyperphosphatemia (independent of the plasma concentrations of calcium and calcitriol) on PTH synthesis and secretion in advanced renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/27-30\">",
"     27-30",
"    </a>",
"    ]. A study in experimental animals with ESRD demonstrated that dietary phosphate restriction to normalize the plasma phosphate concentration lowered plasma PTH levels from 130 to 35",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/28\">",
"     28",
"    </a>",
"    ]. This occurred without change in the plasma calcium or calcitriol concentrations. Parathyroid size also decreased, suggesting that hyperphosphatemia stimulates parathyroid growth in renal failure. This effect is apparently through the reduction of PTH messenger RNA (mRNA) levels via increasing posttranscriptional PTHmRNA message stability [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These observations appear to be applicable to humans as illustrated by the following findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One report evaluated 15 patients on maintenance hemodialysis [",
"      <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/29\">",
"       29",
"      </a>",
"      ]. Phosphate was added to the dialysate for 12 weeks to raise the plasma phosphate concentration by 2.4",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (0.75",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      above the previous baseline of 4.7 to 5.9",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1.5 to 1.9",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"      Seven of the patients showed a significant elevation in plasma PTH levels without change in the plasma concentrations of ionized calcium or calcitriol (the latter was low initially and remained low throughout the study).",
"     </li>",
"     <li>",
"      An in vitro study using hyperplastic parathyroid tissue from patients with renal failure found exposure to high phosphate concentrations increased preproPTH mRNA and enhanced PTH secretion from this tissue [",
"      <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Decreased calcitriol activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plasma calcitriol levels clearly fall below normal when the GFR is less than 30",
"    <span class=\"nowrap\">",
"     mL/min.",
"    </span>",
"    Low calcitriol levels have also been found in most studies of patients with mild to moderate CKD (GFR 40 to 80",
"    <span class=\"nowrap\">",
"     mL/min)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/19,21,32-34\">",
"     19,21,32-34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to the reduction in renal mass, several other factors contribute to the low calcitriol levels in CKD. Phosphate retention (or perhaps increased phosphate levels in the proximal tubule) can directly suppress the renal synthesis of calcitriol [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/21\">",
"     21",
"    </a>",
"    ]. This process begins early when the GFR drops to below 70",
"    <span class=\"nowrap\">",
"     mL/min.",
"    </span>",
"    Also, experimental studies suggest that the conversion of calcidiol to calcitriol can be diminished by substances retained in renal failure, including uremic toxins and uric acid [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. A similar phenomenon appears to occur in humans [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This traditional view of the cause of the low calcitriol level in CKD has been challenged by the discovery of FGF-23. In the kidney, FGF-23 inhibits phosphate reabsorption and decreases the synthesis of calcitriol by suppressing the activity of 1-alpha-hydroxylase enzyme [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Increased dietary phosphate load and increased calcitriol stimulate the secretion of the FGF-23 predominantly by bone osteocytes which then act on its target tissues by binding to and activating its receptor in the presence of its co-receptor, Klotho [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/39\">",
"     39",
"    </a>",
"    ]. Concentrations of this bone-derived phosphaturic hormone increase early after renal injury and progressively increase as kidney function worsens likely as a physiologic adaptation to maintain normal serum phosphate by enhancing its excretion in the urine. Thus, the increase of FGF-23, while important for maintaining phosphate balance in early CKD, results in a &ldquo;trade-off&rdquo; of reduced calcitriol levels which may act as the initial trigger for the increase in PTH production.",
"   </p>",
"   <p>",
"    Low calcitriol level can lead to increased PTH secretion by indirect as well as by direct mechanisms. Indirect effects on PTH are achieved through decreased intestinal absorption of calcium, which leads to hypocalcemia, which in turn stimulates PTH secretion. Calcitriol deficiency may also change the set point in the relationship between PTH and the plasma free calcium concentration so that normal levels of calcium are not sufficient to suppress PTH secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/21\">",
"     21",
"    </a>",
"    ]; however, other studies have not been able to confirm an alteration in the set point calcium-regulated PTH release in patients with chronic renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Even normal plasma calcitriol levels do not necessarily preclude a role for initial calcitriol deficiency, since the ensuing secondary hyperparathyroidism will increase calcitriol synthesis. However, not all PTH fragments stimulate the 1-alpha-hydroxylase and increase calcitriol synthesis. In rats, the PTH (1-34) increased calcitriol levels whereas rat PTH (1-84) did not. Moreover, infusion of C-terminal PTH fragments actually reduced the synthesis of calcitriol by a posttranscriptional mechanism [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    More importantly, low calcitriol level can increase PTH secretion by removing the inhibitory effect of calcitriol on the parathyroid gland [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/21,42\">",
"     21,42",
"    </a>",
"    ]. The administration of calcitriol, on the other hand, can partially reverse the hyperparathyroidism both in early [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/33\">",
"     33",
"    </a>",
"    ] and advanced disease [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/42\">",
"     42",
"    </a>",
"    ]. Calcitriol and other vitamin D analogues can reduce parathyroid cell proliferation in vitro in part by blocking the increase in the growth-promoting factor transforming growth factor-alpha (TGF-alpha) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/43,44\">",
"     43,44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is also evidence that decreased responsiveness to calcitriol contributes to the development of hyperparathyroidism. In particular, physiologic concentrations of calcitriol may be unable to normally suppress PTH secretion, perhaps due to a reduction in the number of calcitriol receptors in the parathyroid gland [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. This change can be demonstrated relatively early (when the plasma creatinine concentration has only doubled) in experimental animals [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/35\">",
"     35",
"    </a>",
"    ]. Low calcitriol levels appear to play an important role in the decline in calcitriol receptors, since the defect can be largely corrected by calcitriol supplementation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/46\">",
"     46",
"    </a>",
"    ]. At a later stage, retained uremic toxins may also contribute by decreasing both receptor synthesis and the ability of the active hormone-receptor complex to bind to vitamin D response elements in the nucleus [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/35,47\">",
"     35,47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Studies in patients on maintenance dialysis reveal that the decrease in receptor density is most prominent in areas of nodular rather than diffuse hyperplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/45\">",
"     45",
"    </a>",
"    ]. Thus, a reduced number of calcitriol receptors may contribute both to the progression of hyperparathyroidism and to the proliferation of parathyroid cells, leading to nodule formation (see",
"    <a class=\"local\" href=\"#H12\">",
"     'Tertiary hyperparathyroidism'",
"    </a>",
"    below). It may also explain the observation that supraphysiologic levels of calcitriol (via intravenous or intraperitoneal administration) can markedly suppress PTH release in patients on maintenance dialysis, while conventional oral doses are relatively ineffective in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/58/32681?source=see_link\">",
"     \"Management of secondary hyperparathyroidism and mineral metabolism abnormalities in adult predialysis patients with chronic kidney disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38474?source=see_link\">",
"     \"Management of secondary hyperparathyroidism and mineral metabolism abnormalities in dialysis patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Hypocalcemia and calcium-sensing receptor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Calcium is a major regulator of PTH secretion acting through a specific membrane receptor, the calcium-sensing receptor, which is located on the surface of the chief cells of the parathyroid glands [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/48\">",
"     48",
"    </a>",
"    ]. Total serum calcium usually decreases during the course of CKD due to phosphate retention, decreased calcitriol level, and resistance to the calcemic actions of PTH on bone. PTH secretion varies inversely with serum calcium [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/27\">",
"     27",
"    </a>",
"    ]. Persistently low serum calcium levels also appear to directly increase PTH mRNA levels via posttranscriptional actions and stimulate the proliferation of parathyroid cells over days or weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/27,33\">",
"     27,33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/56/36744?source=see_link\">",
"     \"Parathyroid hormone secretion and action\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/51/19258?source=see_link\">",
"     \"Disorders of the calcium-sensing receptor: Familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In CKD, the number of calcium-sensing receptors may be reduced in hypertrophied parathyroid glands, particularly in areas of nodular hypertrophy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/49-51\">",
"     49-51",
"    </a>",
"    ]. Decreased expression of the calcium-sensing receptor appears related to the proliferation of parathyroid tissue, with both possibly related to increased phosphorus [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/50,52\">",
"     50,52",
"    </a>",
"    ]. This change in receptor number can lead to inadequate suppression of PTH secretion by calcium, resulting in inappropriately high PTH levels in the setting of normal or high calcium levels. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/56/36744?source=see_link\">",
"     \"Parathyroid hormone secretion and action\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The role of the calcium-sensing receptor in regulating parathyroid gland function has direct therapeutic implications. The administration of a calcimimetic agent increases the sensitivity of the receptor to extracellular calcium and can lower PTH secretion from the parathyroid gland [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/48,53\">",
"     48,53",
"    </a>",
"    ]. Calcimimetic agents also mediate reductions in serum PTH levels by decreasing PTH gene expression [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/54\">",
"     54",
"    </a>",
"    ] and indirectly through increasing the vitamin D receptor expression in the parathyroid glands [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/55\">",
"     55",
"    </a>",
"    ]. The administration of calcimimetic agents reduces plasma PTH concentrations by more than 50 percent in both humans and animal models of renal failure and can suppress parathyroid cell hyperplasia in animals. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38474?source=see_link&amp;anchor=H25#H25\">",
"     \"Management of secondary hyperparathyroidism and mineral metabolism abnormalities in dialysis patients\", section on 'Calcimimetics'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The therapeutic benefits of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/23/26998?source=see_link\">",
"     cinacalcet",
"    </a>",
"    in patients with ESRD are well-established [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/56\">",
"     56",
"    </a>",
"    ]. However, the use of this agent in early stages of CKD is highly controversial. This is because cinacalcet was reported to cause hypocalcemia, increased urinary calcium excretion, and hyperphosphatemia in patients with stages 3 and 4 CKD. These findings were first observed in a phase-2 trial in which treatment with cinacalcet led to a significant increase in serum phosphorus after four weeks of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/57\">",
"     57",
"    </a>",
"    ]. These results were confirmed in a long-term, randomized, double-blind, placebo-controlled trial of cinacalcet in 404 patients with stages 3 and 4 CKD. In this trial, cinacalcet reduced the mean PTH level by 43.1 percent after 32 weeks of treatment but led to an 8.9 percent decrease in serum calcium level, a 21.4 percent increase in serum phosphorus level and a 14 percent decrease in urinary phosphorus excretion. Moreover, cinacalcet induced greater than 50 percent increase in calcium excretion from baseline [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/58\">",
"     58",
"    </a>",
"    ]. Similar findings were also reported in renal transplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/59\">",
"     59",
"    </a>",
"    ]. Given the well-documented association between hyperphosphatemia and increased mortality risk, it may be best to avoid use of cinacalcet in hyperparathyroid patients with stages 3 and 4 CKD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Fibroblast growth factor 23",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fibroblast growth factor 23 (FGF-23) is a circulating peptide that plays a key role in the control of serum phosphate by regulating renal phosphate excretion [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/18,60,61\">",
"     18,60,61",
"    </a>",
"    ]. Increased dietary phosphate load and increased calcitriol levels stimulate the secretion of the FGF-23 predominantly by bone osteocytes. FGF-23 reduces renal phosphate reabsorption and increases urinary phosphate excretion by reducing the abundance of the",
"    <span class=\"nowrap\">",
"     Na/Pi",
"    </span>",
"    IIa cotransporter (and possibly also",
"    <span class=\"nowrap\">",
"     Na/Pi",
"    </span>",
"    IIc transporter) in proximal renal tubular cells [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/62\">",
"     62",
"    </a>",
"    ]. FGF-23 also inhibits the 1-alpha-hydroxylase enzyme and leads to decreased calcitriol synthesis by the kidney [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/38\">",
"     38",
"    </a>",
"    ]. Patients with CKD have significantly increased FGF-23 levels due to phosphate retention and decreased clearance [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/37,63,64\">",
"     37,63,64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to these effects, FGF-23 has direct actions on the parathyroid gland where it suppresses PTH secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/65\">",
"     65",
"    </a>",
"    ]. However, the presence of high PTH levels in CKD despite high FGF-23 levels suggests that the parathyroid is relatively resistant to the elevated levels of FGF-23 in uremia. This may be related to the markedly decreased expression of FGF Receptor 1 and Klotho protein in hyperplastic parathyroid gland [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/66,67\">",
"     66,67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Klotho, a transmembrane protein produced by the osteocyte, is required for FGF-23 receptor activation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/39\">",
"     39",
"    </a>",
"    ]. The klotho extracellular domain does not directly bind to FGF-23, but it enhances FGF-23 binding to its receptor complex with a much higher affinity than to fibroblast growth factor receptor (FGFR) alone [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/68\">",
"     68",
"    </a>",
"    ]. Given that FGF-23 is produced by bone osteocytes, it is easy to appreciate the existence of a physiologic bone-parathyroid axis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/65,69\">",
"     65,69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Skeletal resistance to PTH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skeletal resistance to the calcemic action of PTH is another factor that appears to contribute to the genesis of secondary hyperparathyroidism in chronic renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/30\">",
"     30",
"    </a>",
"    ]. Resistance to PTH is primarily due to downregulation of PTH receptors induced by the high circulating PTH levels, although both calcitriol deficiency and hyperphosphatemia may play a contributory role [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/70\">",
"     70",
"    </a>",
"    ]. Finally, the potential antagonistic actions of PTH fragment, PTH-(7-84) to those of PTH-(1-84), may contribute to the higher levels PTH in patients with CKD [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Metabolic acidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone function can also be impaired by the metabolic acidosis that is typically present in advanced CKD. Initially, metabolic acidosis stimulates physicochemical mineral dissolution, a process that helps in buffering some of the excess hydrogen ions by bone carbonate but leads to the release of calcium and a gradual reduction in bone calcium stores [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/27,72\">",
"     27,72",
"    </a>",
"    ]. Subsequently, acidosis stimulates cell-mediated bone resorption by stimulating osteoclastic activity [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/73\">",
"     73",
"    </a>",
"    ]. There is evidence in humans on maintenance dialysis that attainment of a normal plasma bicarbonate concentration with alkali therapy can slow the rate of progression of uremic bone disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/24/41353?source=see_link\">",
"     \"Pathogenesis, consequences, and treatment of metabolic acidosis in chronic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Extraosseous calcification",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to producing bone disease, the persistent increase in PTH secretion can also contribute to calcium phosphate precipitation into arteries, joints, soft tissues, and the viscera (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef79544 \" href=\"UTD.htm?38/53/39775\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/1,2,74\">",
"     1,2,74",
"    </a>",
"    ]. A more severe form of metastatic calcification, called calciphylaxis, is associated with marked arterial calcium deposition and tissue ischemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/42/15017?source=see_link\">",
"     \"Calciphylaxis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Extraosseous calcifications result in part from the changing effect of PTH on phosphate balance as renal failure progresses. As previously noted, the inhibitory effect of PTH on proximal phosphate reabsorption results in a reduction in the fraction of the filtered phosphate that is reabsorbed to as low as 15 percent in severe renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/26\">",
"     26",
"    </a>",
"    ]. At this point, PTH is unable to further increase phosphate excretion but continues to cause calcium phosphate release from bone. The net effect is that PTH now exacerbates the hyperphosphatemia [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/75\">",
"     75",
"    </a>",
"    ]. In this setting, the use of oral phosphate binders may be relatively ineffective in lowering the plasma phosphate concentration, a goal that can be achieved only by parathyroidectomy. This procedure will reduce both the plasma calcium and phosphate concentrations due to decreased bone resorption and to the deposition of calcium phosphate in bones previously demineralized by chronic hyperparathyroidism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/3/9273?source=see_link\">",
"     \"Indications for parathyroidectomy in end-stage renal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    High PTH levels may induce vascular calcification independent of uremia [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/76\">",
"     76",
"    </a>",
"    ]. In dialysis patients, markedly high levels may enhance coronary artery calcification. In one study of 197 hemodialysis patients, multislice computed tomography showed a significant increase in coronary artery calcification scores in the patients with high serum PTH levels, particularly those with serum levels greater than 600",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/77\">",
"     77",
"    </a>",
"    ]. By contrast, in those with PTH values between 0 and 150",
"    <span class=\"nowrap\">",
"     pg/mL,",
"    </span>",
"    calcification scores were higher than normal but significantly lower than in the groups with high serum PTH levels. Interestingly, PTH (1-34) was found to protect against vascular calcification and bone demineralization in experimental renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Tertiary hyperparathyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;In some patients, CKD is associated with marked and refractory oversecretion of PTH, often associated with hypercalcemia that cannot be explained by the administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/32/42504?source=see_link\">",
"     calcium carbonate",
"    </a>",
"    or calcitriol supplements. This entity, called tertiary hyperparathyroidism, is in part a reflection of severe parathyroid hyperplasia that is no longer adequately responsive to the plasma calcium concentration. This appears to represent a state of autonomous function of parathyroid tissue which results from the increase in parathyroid gland mass rather than an alteration in the set point of PTH release [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/79\">",
"     79",
"    </a>",
"    ]. Set point abnormalities are present in familial hypocalciuric hypercalcemia (in which it is the primary defect) and primary hyperparathyroidism (in which there is both a set point error and increased gland mass) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/79\">",
"     79",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/51/19258?source=see_link\">",
"     \"Disorders of the calcium-sensing receptor: Familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia\"",
"    </a>",
"    .) In these patients, decreased expression of calcium-sensing receptors and vitamin D receptors results in a lack of suppression of PTH by increasing calcium or vitamin D analogues [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/80\">",
"     80",
"    </a>",
"    ]. The state of prolonged stimulation of parathyroid cell growth in CKD patients due to high phosphate, low calcitriol, and hypocalcaemia results in nodular hyperplasia. Nodular parathyroid glands do not undergo involution despite resolution of some of the triggering mechanisms. This is best illustrated by the high PTH levels and hypercalcemia that may persist in CKD patients after receiving renal transplant.",
"   </p>",
"   <p>",
"    Another important pathogenetic factor in many cases of tertiary hyperparathyroidism is neoplastic transformation, leading to overgrowth by a monoclonal parathyroid adenoma [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/81,82\">",
"     81,82",
"    </a>",
"    ]. The mechanisms responsible for the switch to monoclonal proliferation are not well understood [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/82\">",
"     82",
"    </a>",
"    ]. One factor may be vitamin D receptor density, which appears to be markedly reduced in areas of nodular transformation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/45\">",
"     45",
"    </a>",
"    ]. This change would further reduce the normal inhibitory effect of calcitriol on PTH secretion and perhaps parathyroid growth [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     ADYNAMIC BONE DISEASE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adynamic or aplastic bone disease currently represents the principal form of bone lesion in both peritoneal dialysis and hemodialysis patients, particularly diabetics [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/3,9,11,14,15,83-86\">",
"     3,9,11,14,15,83-86",
"    </a>",
"    ]. The prevalence is also increased in non dialysis-dependent CKD patients [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/14,87\">",
"     14,87",
"    </a>",
"    ]. Adynamic bone disease has largely replaced that proportion of renal osteodystrophy previously resulting from osteomalacia and exceeded that of secondary hyperparathyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/15,85\">",
"     15,85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In adynamic bone disease, bone turnover is markedly reduced and there is a lack of bone cell activity (both osteoblasts and osteoclasts). In contrast to osteomalacia, both the rate of collagen synthesis by osteoblasts and its subsequent mineralization are subnormal; thus, there is no increase in osteoid formation as seen in osteomalacia. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Multiple risk factors for adynamic bone disease have been identified, including increased age and diabetes. The principal factor underlying adynamic bone disease appears to be oversuppression of PTH release, which may be induced by the relatively high doses of vitamin D analogues and possibly of calcium-based phosphate binders [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/12,88-91\">",
"     12,88-91",
"    </a>",
"    ]. In an animal model, adynamic bone was reversed with the administration of the non-calcium based phosphate binder, sevelamer [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/92\">",
"     92",
"    </a>",
"    ]. A prospective bone biopsy study in 119 hemodialysis patients compared the effects of calcium-based phosphate binders on bone histology with that of sevelamer. At the end of one year treatment with either phosphate binder, a second bone biopsy was performed. The results showed no statistically significant differences in bone turnover or mineralization in patients treated with sevelamer compared with those treated with calcium carbonate, but bone formation increased and trabecular architecture improved only with sevelamer [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although excess suppression of PTH is responsible in most cases, some patients treated with intermittent calcitriol develop adynamic bone disease despite persistent hyperparathyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/90\">",
"     90",
"    </a>",
"    ]&nbsp;(see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33690?source=see_link\">",
"     \"Treatment of hyperphosphatemia in chronic kidney disease\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Clinical manifestations and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many patients with adynamic bone disease are asymptomatic and require no specific therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/82\">",
"     82",
"    </a>",
"    ]. However, fractures and hypercalcemia can occur [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/12,88\">",
"     12,88",
"    </a>",
"    ]. In a review of over 1000 dialysis patients, the incidence of hip fracture, compared to that observed in the general population, was 14 and 17 times greater for men and women with ESRD, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/93\">",
"     93",
"    </a>",
"    ]. Although bone disease was not verified by biopsy, multivariate analysis revealed that a plasma PTH value of less than 195",
"    <span class=\"nowrap\">",
"     pg/dL,",
"    </span>",
"    a value likely to be associated with adynamic bone disease, significantly predicted fracture risk. Another observational study in over 9000 dialysis patients from the USRDS Dialysis Morbidity and Mortality Study (DMMS) Waves 1 to 4 identified a weak association between PTH concentration and risk for vertebral and hip fractures that was U shaped, with the lowest risk observed around a PTH concentration of 300",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    <span class=\"nowrap\">",
"     (ng/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/94\">",
"     94",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to the risk of fractures, patients with adynamic bone disease are at increased risk of hypercalcemia, cardiovascular calcification and mortality. The rise in plasma calcium is due in part to a marked reduction in the bone uptake of calcium after a calcium load, as with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/32/42504?source=see_link\">",
"     calcium carbonate",
"    </a>",
"    to treat hyperphosphatemia [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/95\">",
"     95",
"    </a>",
"    ]. In one study in hemodialysis patients, an association was found between low bone turnover and vascular calcification [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/96\">",
"     96",
"    </a>",
"    ]. In another study in dialysis patients, there was a significant interaction between the dosage of calcium-based phosphate binders and bone activity such that calcium load had a significantly greater impact on aortic calcification and stiffness in patients with adynamic bone disease when compared with patients with active bone disease [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/97\">",
"     97",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As recommended in the",
"    <span class=\"nowrap\">",
"     K/DOQI",
"    </span>",
"    guidelines, adynamic bone disease (as determined either by bone biopsy or intact serum PTH &lt;100",
"    <span class=\"nowrap\">",
"     pg/mL)",
"    </span>",
"    should be treated by allowing PTH secretion to rise [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/3\">",
"     3",
"    </a>",
"    ]. This can be achieved by decreasing the doses of calcium-based phosphate binders, vitamin D, a low dialysate calcium concentration, and perhaps by the use of non-calcium-based phosphate binders [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/98,99\">",
"     98,99",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are no large studies that examined the impact on bone biopsies in dialysis patients of using high doses of active vitamin D analogues. Two studies in children on peritoneal dialysis who had high turnover bone disease at baseline showed that calcitriol decreased the bone formation rate and induced adynamic bone disease [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/90,100\">",
"     90,100",
"    </a>",
"    ]. The survival benefit associated with the use of vitamin D reported from observational studies, even in the presence of low PTH levels, suggests that a physiologic dose of vitamin D may be appropriate even in patients with adynamic bone disease [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/101,102\">",
"     101,102",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     OSTEOMALACIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteomalacia is characterized by reductions in bone turnover, the number of bone-forming and bone-resorbing cells, and a marked increase in the volume of unmineralized bone [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. It had been assumed that vitamin D deficiency played an important role in the genesis of this lesion; however, until a decade ago, the most common cause of osteomalacia in patients with ESRD was aluminum toxicity, which is known to inhibit bone mineralization.",
"   </p>",
"   <p>",
"    This problem was largely created by attempts to bind dietary phosphate in the gut with aluminum-containing antacids in an effort to prevent or minimize the development of secondary hyperparathyroidism. The incidence of osteomalacia has decreased with the abandonment of aluminum-based phosphate binders and the introduction of more efficient techniques for treatment of water used in preparing the dialysate [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/3,10,11,15\">",
"     3,10,11,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Treatment of aluminum-induced osteomalacia consists of cessation of aluminum-containing antacids and aluminum removal from the body. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/14/5352?source=see_link\">",
"     \"Aluminum toxicity in end-stage renal disease\"",
"    </a>",
"    .) The diagnosis of aluminum toxicity can be challenging since aluminum toxicity is a function of tissue accumulation, not serum level of aluminum. While serum levels and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/10/22695?source=see_link\">",
"     deferoxamine",
"    </a>",
"    stimulation tests may be helpful, definitive diagnosis rests with bone biopsy. Documenting the presence of aluminum toxicity is particularly important in patients being considered for parathyroidectomy, since lowering PTH levels can lead to accelerated aluminum deposition in bone in patients with concurrent osteomalacia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/3/9273?source=see_link\">",
"     \"Indications for parathyroidectomy in end-stage renal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     ASSOCIATIONS WITH OTHER FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of additional factors may underlie bone abnormalities in patients with ESRD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Vitamin K deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities in vitamin K may be another factor underlying bone disease in patients with advanced renal failure. Vitamin K is essential in humans for the proper carboxylation of bone matrix proteins, including osteocalcin [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/103,104\">",
"     103,104",
"    </a>",
"    ]. Increased under-carboxylated osteocalcin levels were detected in dialysis patients compared with healthy controls, suggesting vitamin K deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/105\">",
"     105",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among patients without renal disease, biochemical markers indicative of low vitamin K activity may correlate with decreased bone mineral density and an increased risk of fracture. In 72,000 women with no renal disease, the risk of hip fractures was significantly lower in patients consuming higher amounts of vitamin K [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/106\">",
"     106",
"    </a>",
"    ]. Also, in double-blind, placebo-controlled clinical trials, bone loss were reduced by 35 percent with vitamin K1 over a three-year period and by 100 percent with vitamin K2 [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/107\">",
"     107",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The association between deficiency of vitamin K and bone abnormalities has been extended to patients on hemodialysis. As an example, serum vitamin K levels and a history of bone fractures were evaluated in one study of 68 patients undergoing chronic hemodialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/108\">",
"     108",
"    </a>",
"    ]. At study entry, low serum levels of phylloquinone were significantly associated with a history of bone fracture. Subsequent follow-up at four years found that no fractures had occurred among patients with levels of phylloquinone above 1.2",
"    <span class=\"nowrap\">",
"     nmol/L",
"    </span>",
"    while those with lower levels experienced bone fractures at a rate of 6 percent per year.",
"   </p>",
"   <p>",
"    A deficiency of vitamin K may therefore be a reversible cause of bone fracture among dialysis patients [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/109\">",
"     109",
"    </a>",
"    ]. The possible efficacy and safety of vitamin K administration in such patients has not yet been documented.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Bone morphogenetic protein-7",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal osteoblast differentiation is prevented by secondary hyperparathyroidism and osteitis fibrosa. This is due in part to decreased levels of one of the bone morphogenetic proteins, BMP-7, which is expressed at high levels in the normal functioning kidney, circulates in blood, and induces osteoblast growth and differentiation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/110\">",
"     110",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/5/34906?source=see_link\">",
"     \"Normal skeletal development and regulation of bone formation and resorption\"",
"    </a>",
"    .) In an in vitro model of osteoblastic differentiation, BMP-7 induced expression of osteoblast-associated genes and matrix mineralization by bone marrow-derived human mesenchymal stem cells [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/111\">",
"     111",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In high turn-over bone disease, there is fibrosis in the peritrabecular bone marrow space, the etiology of which has remained elusive. The absence of BMP-7 in patients with markedly decreased renal mass may underlie the abnormal development of osteoblasts into more fibroblast-like cells, thereby leading to collagen deposition and osteitis fibrosa. This was supported by an animal model of chronic renal failure and secondary hyperparathyroidism, in which the administration of BMP-7 prevented peritrabecular fibrosis, induced normal osteoblast development, and decreased bone resorption [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/112\">",
"     112",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     BONE BIOPSY AND BONE MINERAL DENSITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone biopsy is the gold standard for diagnosing the various types of bone disease in patients with CKD. However, because it is invasive and requires special equipment and a great deal of expertise, most physicians do not perform bone biopsies outside clinical research. Despite that, bone biopsy is done in patients for whom a specific diagnosis of the bone disease has significant implications. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      To document the presence of adynamic bone disease in symptomatic patients with serum PTH levels below 100",
"      <span class=\"nowrap\">",
"       pg/mL.",
"      </span>",
"     </li>",
"     <li>",
"      To determine the presence of aluminum toxicity prior to chelation therapy with DFO and in patients being considered for parathyroidectomy, since lowering PTH levels can lead to accelerated aluminum deposition in bone in patients with concurrent osteomalacia.",
"     </li>",
"     <li>",
"      Unexplained skeletal fracture or bone pain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The 2009 KDIGO guidelines suggest bone biopsy in the following settings [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/17\">",
"     17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Unexplained fractures, unexplained hypercalcemia,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      unexplained hypophosphatemia",
"     </li>",
"     <li>",
"      Persistent bone pain",
"     </li>",
"     <li>",
"      Possible aluminum toxicity",
"     </li>",
"     <li>",
"      Before therapy with bisphosphonates",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The ultimate goal of diagnosing the type of renal bone disease is to prevent fractures. Measurement of bone mineral density (BMD) by dual energy x-ray absorptiometry (DXA) is routinely used to predict fractures in the general population.",
"   </p>",
"   <p>",
"    Although BMD is lower in patients with CKD than in the general population, the utility of DXA in patients with CKD is limited. This is because DXA neither predicts the type of bone lesion nor it is able to predict fractures in these patients. Moreover, its interpretation is confounded by the presence of extraosseous calcification and focal areas of osteosclerosis which may lead to artifactual increase in BMD. However, measurement of BMD may be useful after renal transplantation and in CKD patients who are being considered for bisphosphonate therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/50/18218/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Detailed discussions of these issues are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/43/28343?source=see_link\">",
"     \"Bone biopsy and the diagnosis of renal osteodystrophy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Four main types of renal bone disease can be seen in patients with chronic kidney disease (CKD). These are osteitis fibrosa cystica, adynamic bone disease, osteomalacia, and mixed renal osteodystrophy, with the last disorder being a mixture of the first three. Patients with any of these lesions are at greater risk of bone fractures than the general population because of changes in bone quality. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction and overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The prevalence of the different types of bone disease has changed over the last several decades. At present, the most common disorder is adynamic bone disease, with osteitis fibrosa, osteomalacia, and mixed disease less frequently observed. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Osteitis fibrosa cystica is a disorder in which bone turnover is increased due to secondary hyperparathyroidism. The three main abnormalities that contribute to the pathogenesis of secondary hyperparathyroidism are phosphate retention, a decreased free calcium level, and a decreased 1,25-dihydroxyvitamin D (Calcitriol) level. However, increased FGF-23 concentration, by downregulating renal 1-alpha-hydroxylase enzyme and exacerbating calcitriol deficiency, play a major role in the pathogenic mechanisms that initiate secondary hyperparathyroidism in patients with CKD. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Secondary hyperparathyroidism and osteitis fibrosa'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      With adynamic bone disease, bone turnover is markedly reduced and there is a lack of bone cell activity (both osteoblasts and osteoclasts). The principal factor underlying adynamic bone disease appears to be oversuppression of parathyroid hormone (PTH) release, which may be induced by the relatively high doses of vitamin D analogues and possibly of calcium-based phosphate binders. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In addition to the risk of fractures, patients with adynamic bone disease are at increased risk of hypercalcemia, cardiovascular calcification and mortality. Adynamic bone disease (as determined either by bone biopsy or intact serum PTH &lt;100",
"      <span class=\"nowrap\">",
"       pg/mL)",
"      </span>",
"      should be treated by allowing PTH secretion to rise. This can be achieved by decreasing the doses of calcium-based phosphate binders",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      vitamin D analogs, a low dialysate calcium concentration, and perhaps by the use of non-calcium-based phosphate binders. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Clinical manifestations and treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Osteomalacia is characterized by reductions in bone turnover, the number of bone-forming and bone-resorbing cells, and a marked increase in the volume of unmineralized bone. This was largely due to the accumulation of aluminum in bone. Due to the abandonment of aluminum-based phosphate binders, the incidence of osteomalacia has markedly decreased. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Osteomalacia'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/1\">",
"      Hruska KA, Teitelbaum SL. Renal osteodystrophy. N Engl J Med 1995; 333:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/2\">",
"      Fournier A, Morini&egrave;re P, Ben Hamida F, et al. Use of alkaline calcium salts as phosphate binder in uremic patients. Kidney Int Suppl 1992; 38:S50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/3\">",
"      National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/4\">",
"      Martin KJ, Gonz&aacute;lez EA. Metabolic bone disease in chronic kidney disease. J Am Soc Nephrol 2007; 18:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/5\">",
"      Felsenberg D, Boonen S. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. Clin Ther 2005; 27:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/6\">",
"      Malluche HH, Porter DS, Monier-Faugere MC, et al. Differences in bone quality in low- and high-turnover renal osteodystrophy. J Am Soc Nephrol 2012; 23:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/7\">",
"      Moe S, Dr&uuml;eke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 69:1945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/8\">",
"      Introduction and definition of CKD-MBD and the development of the guideline statements. Kidney Int 2009; 76:S3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/9\">",
"      Martin KJ, Olgaard K, Coburn JW, et al. Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis 2004; 43:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/10\">",
"      D'Haese PC, Spasovski GB, Sikole A, et al. A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int Suppl 2003; :S73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/11\">",
"      Changsirikulchai S, Domrongkitchaiporn S, Sirikulchayanonta V, et al. Renal osteodystrophy in Ramathibodi Hospital: histomorphometry and clinical correlation. J Med Assoc Thai 2000; 83:1223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/12\">",
"      Sherrard DJ, Hercz G, Pei Y, et al. The spectrum of bone disease in end-stage renal failure--an evolving disorder. Kidney Int 1993; 43:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/13\">",
"      Ferreira A, Fraz&atilde;o JM, Monier-Faugere MC, et al. Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients. J Am Soc Nephrol 2008; 19:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/14\">",
"      Spasovski GB, Bervoets AR, Behets GJ, et al. Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis. Nephrol Dial Transplant 2003; 18:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/15\">",
"      Moe SM, Dr&uuml;eke TB. A bridge to improving healthcare outcomes and quality of life. Am J Kidney Dis 2004; 43:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/16\">",
"      National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/17\">",
"      KDIGO clinical practice guidelines for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 2009; 76(Suppl 113):S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/18\">",
"      Cunningham J, Locatelli F, Rodriguez M. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 2011; 6:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/19\">",
"      Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007; 71:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/20\">",
"      Kates DM, Sherrard DJ, Andress DL. Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure. Am J Kidney Dis 1997; 30:809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/21\">",
"      Llach F. Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited. Am J Kidney Dis 1995; 25:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/22\">",
"      Slatopolsky E, Bricker NS. The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. Kidney Int 1973; 4:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/23\">",
"      Slatopolsky E, Caglar S, Pennell JP, et al. On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest 1971; 50:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/24\">",
"      Llach F, Massry SG. On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency. J Clin Endocrinol Metab 1985; 61:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/25\">",
"      Portale AA, Booth BE, Halloran BP, Morris RC Jr. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 1984; 73:1580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/26\">",
"      Slatopolsky E, Robson AM, Elkan I, Bricker NS. Control of phosphate excretion in uremic man. J Clin Invest 1968; 47:1865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/27\">",
"      Silver J, Levi R. Cellular and molecular mechanisms of secondary hyperparathyroidism. Clin Nephrol 2005; 63:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/28\">",
"      Slatopolsky E, Finch J, Denda M, et al. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 1996; 97:2534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/29\">",
"      Fine A, Cox D, Fontaine B. Elevation of serum phosphate affects parathyroid hormone levels in only 50% of hemodialysis patients, which is unrelated to changes in serum calcium. J Am Soc Nephrol 1993; 3:1947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/30\">",
"      Naveh-Many T, Rahamimov R, Livni N, Silver J. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest 1995; 96:1786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/31\">",
"      Almaden Y, Hernandez A, Torregrosa V, et al. High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro. J Am Soc Nephrol 1998; 9:1845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/32\">",
"      Koenig KG, Lindberg JS, Zerwekh JE, et al. Free and total 1,25-dihydroxyvitamin D levels in subjects with renal disease. Kidney Int 1992; 41:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/33\">",
"      Wilson L, Felsenfeld A, Drezner MK, Llach F. Altered divalent ion metabolism in early renal failure: role of 1,25(OH)2D. Kidney Int 1985; 27:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/34\">",
"      Guti&eacute;rrez OM, Isakova T, Andress DL, et al. Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease. Kidney Int 2008; 73:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/35\">",
"      Hsu CH, Patel SR, Young EW, Vanholder R. The biological action of calcitriol in renal failure. Kidney Int 1994; 46:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/36\">",
"      Vanholder R, Patel S, Hsu CH. Effect of uric acid on plasma levels of 1,25(OH)2D in renal failure. J Am Soc Nephrol 1993; 4:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/37\">",
"      Gutierrez O, Isakova T, Rhee E, et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 2005; 16:2205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/38\">",
"      Saito H, Kusano K, Kinosaki M, et al. Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. J Biol Chem 2003; 278:2206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/39\">",
"      Urakawa I, Yamazaki Y, Shimada T, et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 2006; 444:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/40\">",
"      Goodman WG, Belin T, Gales B, et al. Calcium-regulated parathyroid hormone release in patients with mild or advanced secondary hyperparathyroidism. Kidney Int 1995; 48:1553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/41\">",
"      Usatii M, Rousseau L, Demers C, et al. Parathyroid hormone fragments inhibit active hormone and hypocalcemia-induced 1,25(OH)2D synthesis. Kidney Int 2007; 72:1330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/42\">",
"      Slatopolsky E, Weerts C, Thielan J, et al. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest 1984; 74:2136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/43\">",
"      Dusso AS, Pavlopoulos T, Naumovich L, et al. p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth. Kidney Int 2001; 59:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/44\">",
"      Cozzolino M, Lu Y, Finch J, et al. p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Int 2001; 60:2109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/45\">",
"      Fukuda N, Tanaka H, Tominaga Y, et al. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993; 92:1436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/46\">",
"      Denda M, Finch J, Brown AJ, et al. 1,25-dihydroxyvitamin D3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats. Kidney Int 1996; 50:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/47\">",
"      Patel SR, Ke HQ, Vanholder R, et al. Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins. J Clin Invest 1995; 96:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/48\">",
"      Rodriguez M, Nemeth E, Martin D. The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism. Am J Physiol Renal Physiol 2005; 288:F253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/49\">",
"      Gogusev J, Duchambon P, Hory B, et al. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 1997; 51:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/50\">",
"      Yano S, Sugimoto T, Tsukamoto T, et al. Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism. Kidney Int 2000; 58:1980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/51\">",
"      Ca&ntilde;adillas S, Canalejo A, Santamar&iacute;a R, et al. Calcium-sensing receptor expression and parathyroid hormone secretion in hyperplastic parathyroid glands from humans. J Am Soc Nephrol 2005; 16:2190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/52\">",
"      Brown AJ, Ritter CS, Finch JL, Slatopolsky EA. Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate. Kidney Int 1999; 55:1284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/53\">",
"      Nagano N. Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism. Pharmacol Ther 2006; 109:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/54\">",
"      Levi R, Ben-Dov IZ, Lavi-Moshayoff V, et al. Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: correlation with posttranslational modification of the trans acting factor AUF1. J Am Soc Nephrol 2006; 17:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/55\">",
"      Rodriguez ME, Almaden Y, Ca&ntilde;adillas S, et al. The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands. Am J Physiol Renal Physiol 2007; 292:F1390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/56\">",
"      Block GA, Martin KJ, de Francisco AL, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004; 350:1516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/57\">",
"      Charytan C, Coburn JW, Chonchol M, et al. Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis. Am J Kidney Dis 2005; 46:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/58\">",
"      Chonchol M, Locatelli F, Abboud HE, et al. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis. Am J Kidney Dis 2009; 53:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/59\">",
"      Borchhardt KA, Heinzl H, Mayerw&ouml;ger E, et al. Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation. Transplantation 2008; 86:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/60\">",
"      Liu S, Gupta A, Quarles LD. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Curr Opin Nephrol Hypertens 2007; 16:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/61\">",
"      Liu S, Quarles LD. How fibroblast growth factor 23 works. J Am Soc Nephrol 2007; 18:1637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/62\">",
"      Miyamoto K, Ito M, Tatsumi S, et al. New aspect of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter. Am J Nephrol 2007; 27:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/63\">",
"      Imanishi Y, Inaba M, Nakatsuka K, et al. FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int 2004; 65:1943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/64\">",
"      Larsson T, Nisbeth U, Ljunggren O, et al. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 2003; 64:2272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/65\">",
"      Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, et al. The parathyroid is a target organ for FGF23 in rats. J Clin Invest 2007; 117:4003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/66\">",
"      Komaba H, Goto S, Fujii H, et al. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int 2010; 77:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/67\">",
"      Canalejo R, Canalejo A, Martinez-Moreno JM, et al. FGF23 fails to inhibit uremic parathyroid glands. J Am Soc Nephrol 2010; 21:1125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/68\">",
"      Kuro-o M. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Curr Opin Nephrol Hypertens 2006; 15:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/69\">",
"      Krajisnik T, Bj&ouml;rklund P, Marsell R, et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 2007; 195:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/70\">",
"      Rodriguez M, Felsenfeld AJ, Llach F. Calcemic response to parathyroid hormone in renal failure: role of calcitriol and the effect of parathyroidectomy. Kidney Int 1991; 40:1063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/71\">",
"      Slatopolsky E, Finch J, Clay P, et al. A novel mechanism for skeletal resistance in uremia. Kidney Int 2000; 58:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/72\">",
"      Bushinsky DA. The contribution of acidosis to renal osteodystrophy. Kidney Int 1995; 47:1816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/73\">",
"      Krieger NS, Frick KK, Bushinsky DA. Mechanism of acid-induced bone resorption. Curr Opin Nephrol Hypertens 2004; 13:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/74\">",
"      Milliner DS, Zinsmeister AR, Lieberman E, Landing B. Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 1990; 38:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/75\">",
"      Llach F. Parathyroidectomy in chronic renal failure: indications, surgical approach and the use of calcitriol. Kidney Int Suppl 1990; 29:S62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/76\">",
"      Neves KR, Graciolli FG, dos Reis LM, et al. Vascular calcification: contribution of parathyroid hormone in renal failure. Kidney Int 2007; 71:1262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/77\">",
"      Coen G, Manni M, Mantella D, et al. Are PTH serum levels predictive of coronary calcifications in haemodialysis patients? Nephrol Dial Transplant 2007; 22:3262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/78\">",
"      Sebastian EM, Suva LJ, Friedman PA. Differential effects of intermittent PTH(1-34) and PTH(7-34) on bone microarchitecture and aortic calcification in experimental renal failure. Bone 2008; 43:1022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/79\">",
"      Indridason OS, Heath H 3rd, Khosla S, et al. Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism. Kidney Int 1996; 50:1663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/80\">",
"      Grzela T, Chudzinski W, Lasiecka Z, et al. The calcium-sensing receptor and vitamin D receptor expression in tertiary hyperparathyroidism. Int J Mol Med 2006; 17:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/81\">",
"      Arnold A, Brown MF, Ure&ntilde;a P, et al. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 1995; 95:2047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/82\">",
"      Dr&uuml;eke TB. The pathogenesis of parathyroid gland hyperplasia in chronic renal failure. Kidney Int 1995; 48:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/83\">",
"      Cunningham J, Sprague SM, Cannata-Andia J, et al. Osteoporosis in chronic kidney disease. Am J Kidney Dis 2004; 43:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/84\">",
"      Rocha LA, Higa A, Barreto FC, et al. Variant of adynamic bone disease in hemodialysis patients: fact or fiction? Am J Kidney Dis 2006; 48:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/85\">",
"      Brandenburg, VM, Floege, J. Adynamic bone disease - bone and beyond. NDT Plus 2008; 1:135.",
"     </a>",
"    </li>",
"    <li>",
"     Morrow B, Qunibi W. Specific Bone and Mineral Disorders in Patients with Chronic Kidney Disease. Clinical Reviews in Bone and Mineral Metabolism 2011.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/87\">",
"      Coen G, Ballanti P, Bonucci E, et al. Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH. Nephron 2002; 91:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/88\">",
"      Malluche HH, Monier-Faugere MC. Risk of adynamic bone disease in dialyzed patients. Kidney Int Suppl 1992; 38:S62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/89\">",
"      Hercz G, Pei Y, Greenwood C, et al. Aplastic osteodystrophy without aluminum: the role of \"suppressed\" parathyroid function. Kidney Int 1993; 44:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/90\">",
"      Goodman WG, Ramirez JA, Belin TR, et al. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 1994; 46:1160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/91\">",
"      Cannata-And&iacute;a JB. Hypokinetic azotemic osteodystrophy. Kidney Int 1998; 54:1000.",
"     </a>",
"    </li>",
"    <li>",
"     Mathew, S, Lund, RJ, Strebeck, F, et al. Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy. J Am Soc Nephrol 2007;.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/93\">",
"      Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 2000; 36:1115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/94\">",
"      Danese MD, Kim J, Doan QV, et al. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis 2006; 47:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/95\">",
"      Kurz P, Monier-Faugere MC, Bognar B, et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 1994; 46:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/96\">",
"      London GM, Marty C, Marchais SJ, et al. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 2004; 15:1943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/97\">",
"      London GM, Marchais SJ, Gu&eacute;rin AP, et al. Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 2008; 19:1827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/98\">",
"      Mathew S, Lund RJ, Strebeck F, et al. Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy. J Am Soc Nephrol 2007; 18:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/99\">",
"      Ok, E, Asci, G, Duman, S, et al. Reduction of Calcium Exposure Slows down Progression of Vascular Calcification and Improves Adynamic Bone Disease. Late-Breaking Clinical Trials at Renal Week 2008. CJASN 2008; 3:RB01.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/100\">",
"      Kuizon BD, Goodman WG, J&uuml;ppner H, et al. Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int 1998; 53:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/101\">",
"      Teng M, Wolf M, Ofsthun MN, et al. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005; 16:1115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/102\">",
"      Kalantar-Zadeh K, Kuwae N, Regidor DL, et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006; 70:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/103\">",
"      Knapen MH, Hamuly&aacute;k K, Vermeer C. The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion. Ann Intern Med 1989; 111:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/104\">",
"      Szulc P, Arlot M, Chapuy MC, et al. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 1994; 9:1591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/105\">",
"      Pilkey RM, Morton AR, Boffa MB, et al. Subclinical vitamin K deficiency in hemodialysis patients. Am J Kidney Dis 2007; 49:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/106\">",
"      Feskanich D, Weber P, Willett WC, et al. Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr 1999; 69:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/107\">",
"      Braam LA, Knapen MH, Geusens P, et al. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int 2003; 73:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/108\">",
"      Kohlmeier M, Saupe J, Shearer MJ, et al. Bone health of adult hemodialysis patients is related to vitamin K status. Kidney Int 1997; 51:1218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/109\">",
"      Krueger T, Westenfeld R, Ketteler M, et al. Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification? Kidney Int 2009; 76:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/110\">",
"      Franceschi RT, Wang D, Krebsbach PH, Rutherford RB. Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. J Cell Biochem 2000; 78:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/111\">",
"      Lavery K, Swain P, Falb D, Alaoui-Ismaili MH. BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. J Biol Chem 2008; 283:20948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/50/18218/abstract/112\">",
"      Gonz&aacute;lez EA, Lund RJ, Martin KJ, et al. Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7. Kidney Int 2002; 61:1322.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1969 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-5A1610FE52-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_50_18218=[""].join("\n");
var outline_f17_50_18218=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION AND OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SECONDARY HYPERPARATHYROIDISM AND OSTEITIS FIBROSA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Phosphate retention and hyperphosphatemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Decreased calcitriol activity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Hypocalcemia and calcium-sensing receptor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Fibroblast growth factor 23",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Skeletal resistance to PTH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Metabolic acidosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Extraosseous calcification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Tertiary hyperparathyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      ADYNAMIC BONE DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Clinical manifestations and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      OSTEOMALACIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      ASSOCIATIONS WITH OTHER FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Vitamin K deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Bone morphogenetic protein-7",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      BONE BIOPSY AND BONE MINERAL DENSITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/1969\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/1969|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?40/38/41582\" title=\"algorithm 1\">",
"      Pathogenesis of secondary hyperparathyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/1969|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?38/53/39775\" title=\"diagnostic image 1\">",
"      Hand radiograph showing metastatic calcification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/1969|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/43/29373\" title=\"figure 1\">",
"      Relationship between GFR and PTH",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/14/5352?source=related_link\">",
"      Aluminum toxicity in end-stage renal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/43/28343?source=related_link\">",
"      Bone biopsy and the diagnosis of renal osteodystrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/42/15017?source=related_link\">",
"      Calciphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/30/5609?source=related_link\">",
"      Dialysis-related amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/51/19258?source=related_link\">",
"      Disorders of the calcium-sensing receptor: Familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/3/9273?source=related_link\">",
"      Indications for parathyroidectomy in end-stage renal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/58/32681?source=related_link\">",
"      Management of secondary hyperparathyroidism and mineral metabolism abnormalities in adult predialysis patients with chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38474?source=related_link\">",
"      Management of secondary hyperparathyroidism and mineral metabolism abnormalities in dialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/15/9462?source=related_link\">",
"      Metabolism of vitamin D",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/5/34906?source=related_link\">",
"      Normal skeletal development and regulation of bone formation and resorption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/56/36744?source=related_link\">",
"      Parathyroid hormone secretion and action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/24/41353?source=related_link\">",
"      Pathogenesis, consequences, and treatment of metabolic acidosis in chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33690?source=related_link\">",
"      Treatment of hyperphosphatemia in chronic kidney disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_50_18219="Induction in renal transplant";
var content_f17_50_18219=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F73471&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F73471&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Induction immunosuppressive strategies in renal transplantation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        High dose conventional agents",
"       </td>",
"       <td class=\"subtitle1\">",
"        Antibody induction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Calcineurin inhibitor: Cyclosporine or tacrolimus",
"       </td>",
"       <td>",
"        Calcineurin inhibitor: Cyclosporine or tacrolimus (lower doses than conventional agent strategy)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Corticosteroid",
"       </td>",
"       <td>",
"        Corticosteroid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antimetabolite: Mycophenolate mofetil or azathioprine",
"       </td>",
"       <td>",
"        Antimetabolite: Mycophenolate mofetil or azathioprine (lower doses than conventional agent strategy)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"5\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Plus one of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        ALG",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        ATG",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        OKT3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-TAC: Daclizumab or basiliximab",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_50_18219=[""].join("\n");
var outline_f17_50_18219=null;
var title_f17_50_18220="Suicide risk assessment2";
var content_f17_50_18220=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F67228&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F67228&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Suicide risk assessment for children and adolescents",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Factors related to intent (motivation)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        How strong is the intent (motivation)?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        If all the things you needed to kill yourself were available right here and you were alone, would you kill yourself right now?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Has the child or adolescent done anything to prepare?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Have you already written a note to your loved ones?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Have you practiced or come close already?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Factors related to emotional/behavioral regulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        What is the level of hopelessness and helplessness? Despair?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Are intoxicants present?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Does the child or adolescent have any psychiatric disorders or comorbidities?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Does the child or adolescent have the capacity for self-regulation or is he or she impulsive?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Is the child or adolescent able to cope and solve problems?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Factors related to stressors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Are there any recent or anticipated stressors?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Factors related to support systems",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Does the child or adolescent have a strong support system?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Among your family and friends, is there anyone who makes you feel less likely to kill yourself? More?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Can the child or adolescent build an alliance? Is he or she ready to participate in treatment?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        If I asked you to promise me or your family members to tell one of us when you were thinking about killing yourself, would you be able to keep that promise?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Are you willing to promise to tell one of us if you are feeling worse?",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Jacobs DG, Brewer M, Klein-Benheim M. Suicide assessment: An overview and recommended protocol. In: Harvard Medical School Guide to Assessment and Intervention in Suicide, Jacob D (Ed), Jossey-Bass, San Francisco 1998. p.3.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_50_18220=[""].join("\n");
var outline_f17_50_18220=null;
var title_f17_50_18221="Rapid overview for pediatric anaphylaxis treatment";
var content_f17_50_18221=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F74242&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F74242&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Rapid overview: Emergent management of anaphylaxis in infants and children*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        DIAGNOSIS IS MADE CLINICALLY:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The most common signs and symptoms are cutaneous (eg, sudden onset of generalized urticaria, angioedema, flushing, pruritus). However, 10 to 20 percent of patients have no skin findings.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span style=\"color: #ff0000;\">",
"         <strong>",
"          Danger signs: Rapid progression of symptoms, evidence of respiratory distress (eg, stridor, wheezing, dyspnea, increased work of breathing, retractions, persistent cough, cyanosis), signs of poor perfusion",
"         </strong>",
"         <sup>",
"          &bull;",
"         </sup>",
"         <strong>",
"          , dysrhythmia, hypotension, collapse.",
"         </strong>",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        ACUTE MANAGEMENT:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The first and most important therapy in anaphylaxis is epinephrine. There are",
"        <strong>",
"         NO absolute contraindications",
"        </strong>",
"        to epinephrine in the setting of anaphylaxis.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Airway:",
"        </strong>",
"        Immediate intubation if evidence of impending airway obstruction from angioedema; delay may lead to complete obstruction; intubation can be difficult and should be performed by the most experienced clinician available; cricothyrotomy may be necessary.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         IM Epinephrine (1 mg/mL preparation):",
"        </strong>",
"        Give epinephrine 0.01 mg per kilogram intramuscularly (maximum per dose: 0.5 mg), preferably in the mid-anterolateral thigh, can repeat every 5 to 15 minutes as needed. If signs of poor perfusion",
"        <sup>",
"         &bull;",
"        </sup>",
"        are present or symptoms are not responding to epinephrine injections, prepare IV epinephrine for infusion (see below).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Place patient in recumbent position",
"        </strong>",
"        , if tolerated, and elevate lower extremities.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Oxygen:",
"        </strong>",
"        Give 6 to 8 liters per minute via face mask, or up to 100 percent oxygen as needed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Normal saline rapid bolus:",
"        </strong>",
"        Treat poor perfusion",
"        <sup>",
"         &bull;",
"        </sup>",
"        with rapid infusion of 20 mL per kilogram; reevaluate and repeat fluid boluses (20 mL per kilogram) as needed; massive fluid shifts with severe loss of intravascular volume can occur; monitor urine output.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Albuterol:",
"        </strong>",
"        For bronchospasm resistant to IM epinephrine, give albuterol 0.15 mg per kilogram (minimum dose: 2.5 mg) in 3 mL saline inhaled via nebulizer; repeat as needed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         H1 antihistamine:",
"        </strong>",
"        Consider giving diphenhydramine 1 mg per kilogram (max 40 mg) IV.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         H2 antihistamine:",
"        </strong>",
"        Consider giving ranitidine 1 mg per kilogram (max 50 mg) IV.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Glucocorticoid:",
"        </strong>",
"        Consider giving methylprednisolone 1 mg per kilogram (max 125 mg) IV.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Monitoring:",
"        </strong>",
"        Continuous noninvasive hemodynamic monitoring and pulse oximetry monitoring should be performed; urine output should be monitored in patients receiving IV fluid resuscitation for severe hypotension or shock.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        TREATMENT OF REFRACTORY SYMPTOMS:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Epinephrine infusion",
"        </strong>",
"        <sup>",
"         &Delta;",
"        </sup>",
"        <strong>",
"         :",
"        </strong>",
"        Patients with inadequate response to IM epinephrine and IV saline, give epinephrine continuous infusion at 0.1 to 1 microgram per kilogram per minute, titrated to effect.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Vasopressors",
"        </strong>",
"        <sup>",
"         &Delta;",
"        </sup>",
"        <strong>",
"         :",
"        </strong>",
"        Patients may require large amounts of IV crystalloid to maintain blood pressure; if response to epinephrine and saline is inadequate, dopamine (5 to 20 micrograms per kilogram per minute) can be given as continuous infusion, titrated to effect.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * A child is defined as a prepubertal patient weighing less than 40 kg.",
"     <br>",
"      <font class=\"bullet\">",
"       &bull;",
"      </font>",
"      See the topic \"Assessment of perfusion in pediatric resuscitation\".",
"      <br>",
"       &Delta; All patients receiving an infusion of epinephrine and/or another vasopressor require continuous noninvasive monitoring of blood pressure, heart rate and function, and oxygen saturation. We suggest that pediatric centers provide instructions for preparation of standard concentrations and also provide charts for established infusion rate for epinephrine and other vasopressors in infants and children.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_50_18221=[""].join("\n");
var outline_f17_50_18221=null;
var title_f17_50_18222="Prognosis RCC by UISS stage";
var content_f17_50_18222=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F66352&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F66352&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 485px\">",
"   <div class=\"ttl\">",
"    Prognosis of renal cell cancer stratified by University of California Los Angeles Integrated Staging System (UISS) stage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 465px; height: 300px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Kaplan-Meier survival curves indicating the different postnephrectomy outcome for patients with renal cell cancer stratified by UISS categories. These categories incorporate TNM classification as well as performance status, and tumor histologic grade. Black triangles mark the point in each group where ten patients remain at risk.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Zisman, et al. J Clin Oncol 2001; 19:1654.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_50_18222=[""].join("\n");
var outline_f17_50_18222=null;
var title_f17_50_18223="Spontaneous echo contrast seen in the left atrium on TEE";
var content_f17_50_18223=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F66980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F66980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Spontaneous echo contrast seen in the left atrium on TEE",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 286px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEeAWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5aFFFFIAooooAKKKKACiiigQUUUUAAooopAFFFFABRRRQAUUUUAAooooAKO9FFABRRRTAKKKKQBRRRTAO1FFFABRRRQAUUUUAFFFFA7BQaKKAsFFLSUhC0lLSUAFFLRQAgooFFAMKKKKYwpaSigAooooAKKKKBBRRRQAUUUUAFFFFABRRRQMKWkooEFFLSUAFOCk5IVjgZOBnA96dbxNcXEUKFA8rhAXYKoJOOSeAPc17r4Qi8BeCtDvLDxDrMd3q+oRG2vl0+4LqYiwJjWRAVA4GTnJ+lVCEpuyMa1ZUl3Z4NUs0E0KxmaKSMSLvQuhXevqM9R71sXCWGj+JoZk+z6lpgk85IlfdmMk4R+nzAYyOnvW74n1nT7rR5Y3vxqU0+GtlCMptfXduGFPbCkj3rSNG6d3axE8RJSjyxun1OGpKKKxOkKKWkoAKKKKACiiigYUdqKKACiiigApaSigBaSlooAKPxoooASj8KWkoABRRRSEFFLSUxhRS0lABRRRQAUUtJQIKKKKACiiloASiiigAooNFAwoop8bmORXQgMpDDIBGR7HrQI3fDfhw61a6pI13HZyWkcTx/aPkjkLuFG6Q8IMEnJ61F410WLw74nvtKtr1b6K2YKLhV2iQ7QSQPTJIz3qz4h8ceJfERmGtaxPd+dCkEgYKoeNG3KpAA4DEmsO8uLi7l+0XcjyyMAu9u4AwB+Aq/dt5mUVU57yenb7v+CWNasLfT7mKK11K11GN4UlMtuHCozDJQ71B3Dv2rPpSMY5HNJUvyNUFFLSUgCiijtQAUUUUAB4Bpm8+1PP3TUNCGP3n2o3n2plFMB+8+1G8+1MooAfvPtRvPtTKKAH7z7Ubz7UyigB+8+go3n0FMooAfvPtRvPtTKKAH7z7Ubz7UyigCYc4NFL2X6CipYCUtJRTAKKWkoAKKKKACiiigQUUtFACUUtFABSUUUALSUtavhbUNP0rXbW+1fSU1izhJZrJ5jEkpxxuYAnAPOO+MHjNCBmTU9lbSXl1Hbw7fMkOFDHGT6fWrunQW+s+IViu7u10m3upWZ55EJitwcnoozjoOBVS/hhhu5Y7W4+0wocLMF27/cA9qrl+4ly6dTa1HVJbPw9/wjcVu1vGlx9ovFuI42kecDaCrbQ6KBxsyecnvWNBA0yITuS3Vwsk7AmOMn1wKrHr1565q+23+zvNFo+1vkaV2yCw7j0+nNWrN6aGbXIkurKk6bJCnHHGR396iq9B9nNuRcFhIoHlpjIbPU57Y9O9MFhObae4VD9nhYK7nAwT0z35qXHqVGaWjKtH4UemaO1QaFkW7/ZllMbmM/xgEgH69qrlSBkqdpOAex/GrcURWAXDO6oowhKnGc9FPt7VDdLIHVpX8wuNwYnJIrSUdLmUZa2uQUUuKDWZqIehqGpj901DTGFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAE/ZfoKKB0X6UVIK/QSiilpgJQaWkoAWkoooAWkpaKBBQaBRQAUUUfSgAooNFABV/RLCLUb4RT3kVnbKpkmuHBYRoOpCjljyAAKr2lv9okCtIkUX8Tu2AB7eprf8Ya9Drl9FcCxsbcW8SW0UNtCI08pVwpJXBZ+pJPsOnFXGN1d7Gc568q3/Ik+IL6QmrR23hl430WOJBEyqcu+AGZsjOSfy6VyxGOpqTadnmLjbnGAefypGcuV3EAgYBAx+dOVm9FYVOLhG17jBjGMVYsZIVnjF4JGtg2WCNj/I/Wq565rU8OXN1a6hI9hFvuWgkRSFLFMjBYAd8Z/OlD4rFVPhZSv4zDdzRtD5PzZCZPyjt1yfzq/o9tPqE7W0EVvLdTglDcSJGBtH95yF6epqmsAbylEVwWKkyFh1P+zRZJIbgKiKS58rEgB6/Xp9atO0r9DN6wt1RNqYiW5ZraNEi2jKbt2Gxg8nrz6ZqtujjlhMTI/wAoDF0woPf1zj1rbhsRcW0enwKiXiSfvkcgvu6Dyx/ECOwqhrOmtpuoG0NzZzSIitut5N455wT2Ydx2pyXX+vzZFOafu3/ruZ8hI3IXEgU8EE4+oqWyWJmkSRZizoQmwgAH1bIOR9MU1cMC5kczZ5G3JI9frWlcPaWenzW9pumnldT9o2rxHjOARyGz1FTGN9en9djScre6tzNs4RcXcELNsSSRYy+3O3JxnHf6V1nxI+HmteA7+GPVYc2N3uayu1IKzoPp91sEHacHmsnRbew84LdQ31y5aNkWH5NmG+beMHII4BGMV95SaRpHjv4d2Wn63pka2dxbr/o7TBntSB8rBx/EPWplBpXI9r79kfniRxzTdort/in8PtT+H/iGSwvVkmsXO6zvgmEuE/kGHcVxRqDojJSV0M2j0prgA8VIKjk+9TKGUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBMOg+lFA6D6UVLBBRS0lMAo6UtJQAvekpaKAEpRRRQIKSlFFAAKWijFAwrf8ADPhm61uC6vA8MGmWjIl1cyTxr5DSZWMlCdzAtjO0HAzWJAqvKqyP5ac5bGccUzGD7jvTS7kSu01F2ZqS2ckd8NPjEElzE5T5JAyNjqVYnGDVK5/fTs8ccabj91MBVPoBUUb7TuCruDBgT2x7dDU9zJDNNmGMQKwyR1Ct3weTitG01/X+ZmouLGKEFuS7r5oPyxlcgjuc9vpUIHuMjnmg59cgdKktiouIy54Bzym8E9gQeoqG7mlrJsn0jTrvV9SgsNPhaa6nbaiKpOT+Haur8NXt/wCGLjXJ9ItZllt4liuvOUs0JBww+XGFJyMkcVgWrX9sLrVbRprKaJ8F7dNgj39sggqPTANVrW6UpdC6a6mnlA8sCT5XOeRJ3YfjWsEotX3/AK7o5qqdVNdP6/Q2/EuivbXCXVtbXsuntCk7eZKryxBhk7lHKLnoWAzWfbac9yLkwhvKiRbiUyXEY/d5xxzy1P0vU4F0m90u+ilC3LK8c0Uu3a44HmZB3IB24PvVeMjSrlS1my3KFZFa4AYcc52EbWB9803a6aJipxTi91t5/ibmg6ImueI4bJFlsIikskM8gTzHIGVBLMFP1zVuS2tdT8LXZ8u3M+nxhllW5KquGwwdCOSx6YJ/CotVhttS8Nrf3rWVhqa/vvKR2WS8UkjcEHyR+gUAZ9Kh0+Oe9fTBPPpts0boiyBUCwJnl5FXlmHowNXdWf8AX6/8P5nO23aV9v6363/AwLFHe8kTesUcisknljgjHKr711L6hZiOeDX5IXnjsBBbQWlv/wAe8mAVOcgb+obINUL97GDVpE02axu4rSSQLJNBtN6SeCU6AegOAKd4lOqrJFqGp2lhaWu4pDYQoqxpkckIuQPXNJR5fl/XZ6d9S5P2jV9L/J/1/XkYYuLizkH2ppCXK79jkOF7r+I7Gvsz4NeJNJvzcwRzW0dvJCqWts8o8yJAPu8HDDn+HOO+K+Lb+Ce0dI5g4EiiUFujg9GB7iuj8AarLpk7rptvNcai8qMqK4AaJTkogxneSBjB/A1Ktdxf9dexVaGiqx3X3PofXnxs8PLrvhddN1G8sNP0GJvNluZmBmRx91Y88Z/pXxDqVhLZTYYOYZCxhlZSolUHG4A19j+J4rTxZdaHdaraO2lSWILRXE20RTscMrRDgy9gccVpt8NvD2qeBR4e1q3toch3huCFM1mM8MHPfoOac4LlXcxoV5Kq+XY+GO1RS/e/Cuo8f+GJvB/iu90Se6gu2tyCs8OdrqRkHkDn17ZrmJfvfhXO007M9WMlNcyI6KKKCgooooAKKKKACiiigAooooAKKKKAJh0FFA6CipDUR+BxUeT6mnydKjqgFyfU0ZPqaSigBcn1NGT6mkooAXJ9TRuPqaSigBdx9TRk+ppKKAJYiS3J7V3vh7wZqNlolp4v17wxeap4UkLoUhlMTv8AKcPlQSqBh16HFcboscEt2VuftONhKGBQSGBGCQe3WvqL4KfF5tRln8N+IbcTzzAiz8oiFJEA/wBWFJwG9u9UqUpq8f6+f/BOetW9nofMOn3FtBemW5s1ubVsgwlyCAemGHQjjmq0gUOSmdhOVBPOPevoT4p/Cyx1iN9Y8EW85vLgu4tFIImKffUL2kHoODjpmvn11eJ3jkQrIpKMrrhlIPIwehoacfdkFGrGr70RnGBxz9aO1BBwG4weKKm5shKmtokmmVHkSNCMsz9AO/1+lR4JBbqB1rpfh9rdl4d1/wDtO/tDfBImiS2Crhy4Kk7mBAxn0/KmtXYmpJxi2lqZ/iPURql5FNJd3d06xpCZ7hAuVUYGAO315rNGxc7fMJByHHGPwro/HmmnTNYykGoW0Uqq0S3lqIXII9iQR/niuYB9SauejMqFpU1yiyKASNwb3HepJ52uCGmZ5JQNpdmzkDoPwqIUuDjOOKzv2N7Lqdv4c1GXU9CsfD1o9jb3CSvI5uECRyp1/eueTjsBWbew4u21O1GmKI5BGIIUKxuw4+VSSSvfccfSsTT7j7PKQRFtkwpdlBZBkHKHqp9xXpWpJJo07wXd/odpDqlmscdxYkm3kQHcVuBGDmQ8djz6V0wlzJf1+q/rzPPqr2M3br+Pfp/wSvoFzawXmrtpc2jWSSWzW0n9pjdNbqQN80ZAw7H5gAOelctqN+1zDeaamrmWygAeB5bfZJcAAAD1H0JNYMyjeWRomL5wq87R+PStk3ceo6RbQyQxWEVvxPeRxbjcN1G7HJYZ45Apc17pf1+H5v8A4NeyULS3/T+vL/gmK7K7R+YHQAYPzbj+vSvaf2VfCtv4k8UavLdGX/Q7YGPZIUAZjgk468Z4rxi68sXErWru9vnCyNHtLfUc4P416x+zDY3158QJzaaymk2kVoz3bmQK0kfTC5OMjrk5AxWMt9Teor02rfI9B8K3FqvxO1LQJtLltrHw9uNosUheK3/vPJz8zt2r0vxbLIYLSPS57S2jUAE3DZkmZudrH09v1rF8Gx+FdJ8aa+3huFr26vCqy3FxKXt2A6yOxHQkkDbkGjxF4k0Gy8RSaZqNxp8WoSMrTajCG2AgHbGhxjd1+UfjXdd8zvt0/q/9fieM0uX3fn+utv6/AyfiB4Z0rxHY2+j63C0utzqwt9Tig2x2jnlQzA5Kn0Oa+UvFmhXvhvX7vSdTEf2q1bY5ibch7gg9wc19g2Piqz1eOW00rSF+wafE1wZLshQ8hyN7tyR7Dkn2rnPFfhm28T+CLez8YXkY8RqnmWt9FZ4aLPK24UcsDwAvbrWdSnz7b/1vq/8AgG+GxSouzd4/1/XmfJNLtPoa1NX0u80i/lstTtJbS7iPzwzIVYfhVI1x+R7SaauiHafQ0bW9D+VTUlIZFtPoaTB9DUwopgQkEdQaMVPRmlcCDB9DRg+hqbtRQBDtPoacUYAEqwBGeRUlX76eZ7eJJDFtEaYwBuwBxzVxV02yJSaaSM8dBRR3orMsbJ92o6lk6VFVAFFFFABRRRQAUUUUAFFFFAEsBKuSCQcdjitI3zG0it44yhQh94c53j+Meh7VmQ/e/CpgcfjxTUnHYiUFLVnYaN43vtL02Fba4uoNUtboXcFyJNys3HDIfbqe9ep65o+i/HDQ5fEHhkW2m+P7aLfqOlBtqXgXgume/TB+gPY18+n7owc+o9K0/DOu6h4Z1y11fR5hDfWxLIxGQcjBBHcEGqnL2llPp1/r8jFUVTvKno2ZeCrcjDA8gjkexpSuM/nxXpGreBb7XtAl8a+FYLe/02Q/6bZQyNLcWUpGXLqQCQTyCM9fSvOV+U5GQQePrUaJ8tzSE+ZXsSwQK2TPMtupUlWdSQ/sMVo+F7pLXVrUz389jZGVVuJokEhRc5J2H749RWU8juPmcnHQelM6GqUknoDjzJqR03ibxRf3dxqNja6hv0aWdnSGGPy4Tk/eSM52Z7gVzK43DfnbnnHXFJV210q/u9NvtQtrSaWxsfL+1TohKQ7ztTce2SMClKTk7jhTjBWRTO3J25I7E+lOijeZwkQLOeij2q/p+harqGm32oWOnXVxY2IBubiOMskIPTcR06VndOlIr0JonjjDF4UlJUrhycKfUY71c0oeb5Fs9zEInnANvK21fdsngenrWdn2GKckmw5CqxxyGGQfwqoyszOUOZFjUUFrqFzDCGjUMV2nsPT3FPGpyxtJLFIYZnTymjijVUZMYORVSctv3SYBbkelP8/Fq0BxjdvBAHJ9z6VXNq7C5E4q+o25Ys4y4YYGNowB+Fa3hLUYNHvpb+ZJJpIoyqW68LMDwQzdVGOeOtY7CMyYQsEP97k/pXe/CTwHqHjPU2+wWAmSCRP9IuJRHbRHP8f8T9PurSvyy5hVbOm4vqe9/ATwKt3o58W+LbdoJLoBoPMmaMNGD8oK9NoxxxzWX481m0Guamsul6LbaU27yGuB88svTAGcIT/er3/WxHbeHtuoQwiOODZIyPsjRgO3oM9D2r4o+Jmtape+LZIrmw06w8gYU7vNdEyTuMp657100Kj5Oeb1f9d0eXXoJyVOOnXzOysvG7eFHtdNs7+yv9VaLcU4FpbnqGmkP3ivtWufEkv26wutZ1+W9gZWlNzHa+UrZHzsJG/gPRcckV4hLdumpRahfSWN4SwkYCME7R0yvT/PNdlb+MJde1XR7jVppNQWNhb2WmW9uN6jI3ORjb9OvTtWnPq3fT+vX+uhlOg1FW+ZseN7rTvHmkXd1qlzqI1SBvJ0Rlg2W5QYCwIh+d2Y9XPt2rxfWNLvdG1GfT9VtpLW9hIEsL43ISMgH8DXrviLXZ9R8W210lpqrOiGO0ghGHmI4L9PlUc/MOOKxPEGn6N4itvJ0uG5XW4C8t3eTz740QDCxMRne7N0IPeorUubbf5/5fcdOFxLp6S+H8v66/5nl9FPkR43ZJFZHU4ZWGCD6EUyuE9e4UUd6KBhRRRQIO1FBooAKllZjEoIXGByOtRUpqovRiavYbRRRUla9BsnQVHUkn3fxqOmAUUUUAFFFFABRRRQAUUUUASQ/e/Cpqhi+8fpUxpAFKpwQcA+xpBRQmI9r/Zh8UvonibUdMjklSfUYs2+E3xeYoP3x2H+12rrf2gfhnYtoc3ibR9LWz1iIiXUIbLLQz7sZdR0UDqSOuea+dtF1S70XVLbUdNmMN3bOJEYdDjsfUHuK++vhp4wXxt4O07UnNlbyyREXVsgDlTjpt7A+h7VorSWvT1/zOOpFxndO1z8+euCDx6ikweTX2L8R/gN4V8QFr3w/cHQ79+NsFuzW7nOcsg5H4cV88eJ/hfrXhvXobC/eNbW4mEFtfGN0jmc9gDgj8ahKXZmvt4Ld2OAxXp3ww1Pw+vgDx54e1/W49Hm1n7B9mmktpZlPkyu75EanHGBzjr9a27P9n7Wb+O6bTte0a7a2/1iRMWYH0wuT1rznxb4L8ReEJkj8R6Tc2Ic4SV1zG/0Ycfh1pJNu1n9xUa0JbPc9j8B+NfAfg3QrPwtPqV5qNjfyXQ1e7t7do4WWXMS7kdN7BY1VgFBwWP0rwG+jihvZ4rWdbiBJGWOZVKiRQSAwB5GRzg81HLG8YUyKVDDKknrTabTRSd0KcNtAVU4wTnr705pS0CxFYgFJO4IAx+rd6ZjNSW8XnzrEJYoy2fmlfao47mi4OxYguFtI4JbK6eK5KsswKfKBnoD3BHaqzMQWOSGJz8owBn2rQ8NQWd5rttbalHqE8Mh2+Tpyq07t2ChuK9q0/4CXd/rkuoa1FN4d8MOVkjgDrPPsI+6SOFP1556VXNfTr2/4BjKUYPU8e8J+GNR8R6ilnYQXTqzBZGggMpXPQ4HX86+w/hZ8MNP8DWEt9PBeTSyRjzft8y7YCvOVUep/GuQzD8OL2FPD2k60dOtoiqXElwEtQrHLSP/ABFh6Cup1nxT4qvNBW60vQY21S4hzahlMplXghgn3Qe+Sc+1b/V3fX+vwOGWKU3r8l/meb+J/i/rF34ve11TRVh0C0kZ0RkKPPgfKWDH5hnnApPGVhp7+Aj4k1uOxWeV/M+xQ5JlLN8pnYfNEvT5F61p2HwN1XXL5tW8f6ioknYT3E/2gZVf7it/CeOeKk8YaPpGp3Fr4c0Gztb2xjceVYLcnZHGv3pieDn1ZifpWsaik3y/Cvl6Ldf5/kYTio2lJa/j6r+kfOPiC9nv7hLqf7BHFICsUcCLGqKOp8scr9T1osdUuLGVbfR7y5WScgPJBFtYZ6qoHJA9sV3fxVstA8OWR0mxvtPu9UZxMYtOQPDbexlPLtj8BXmdjez2UrT2d08ExBG9V5APoe34VnNtS1ev9eZ30kqlP4bL+vI9Be/e2s7mbUxq5urpfsljbRgoZFAxvY9cf7I70vglF07Zp0Wn3V/Mv+k3UcsohtopAPlZ37BM59yAK4YXU01xDJf3l6JD83nSknaOuVHU5/KmLdgWk6It0yScSO8vDDIIBH4VXNFv+v8ALt/wTH6s7cv9eX9b3N280qDVNJ1DUllCzQzErdyyAC9JIAjSPqD3z3HWuPdSjMrghgcEHtXWaZGt1pYGmaPBD5K759UvZsfgmflHPAwCawr2GN4jOjxB2chUQ8uP723+EfzrKceZcy3OqhJwbg9vy/r+kkZ/egjiiiuc6woo/GigAooooGFJS0lAgooopDGv90VHUj9KjqgCiiigAooooAKKKKACiiigCSH7x+lS1FF94/SpRzSEFLSUtACg17x+zZ43v7LWRoUc0z+eqpBCka8KvzOWc+wwBXg1avhrULrSdWh1HTb9bHULY77aQqSS54wOMDr34q4Stp3Ma1NTj5o/QrXPEFrpulT3suqtEkQZmdoCVQf7QAyPrXxP8X/Hc3jjV4DdXWoPb2uUjWRl2bc/fCL3P51ofEb4q6r4o8Pw6RrZu11O3JR5IJ1WJ1wPvbfv59DxXlP51tNxpx5I79f6smc9KE6svaT0S2/z3aLVtdSWchaxmmhfI2yxuY3H5V9qfAfxHeeM/hjZSavZwa3c20jQSmVkypX7pZWzk4718QitTQ9f1bw/cNcaJqN1YytjcYXIDemR0NYppu0tjedNvWO/9eT/ACPrDxPZfDHTvF0Nl4n8OWVlrM7tIFScPEV/vP0C/TFZa/DH4R3mt3Ub65aXd02ZTBbXq28ca+wXI4+tfOvjP+3bu6g1bxJbTmadFBmnK4lOOOnTiueMnLeWqxAgghCRkHtWs3Tva1lp/X9M5aNKduZS1/rtb8vuPrI/AfwJcae11ZvqUtu5ISaOcuEH94DHzAUaJ8Mvh1vEmo69ZXRtgIylvbfY1b/rqvO8nv0rwrwf8YvG/hOzis9J1dWsohtS3uIEdVHscZ/WqcvxF8V3urSXzapGkzOZmAiRVB9gRg1MVB7t/L+vyCdOsrWs/W/4f8E+x9Mfwp4UeOw8L2VpHczr50SWdsqA8cnecn9amvtTs9aAtLzU7rypR5c9nFFuyRz9/tXhPw38Ya14gmfUTB9v12Zkt2v5J1tobWDuVQ4LMPRQQa9Xh0afUL+5S5k1KWK1TzIguIzdMO4x1FbRhBXcf6/8l/pas5Z1qjfK/u/p3OslttE1TyrObTLy7hhCqTJkhMc5IzUmsa0+nWEMltpsbRuwiiBnMaTE9FRepOB3FcVoGqag+q3SJcJNbxndcGzYkQMOBHID82PUgGuhm8QCIRyX+nWbzKjtHa+ZulmxnHkr2+vBodNx0Svb1/yRUaykr7N+S/4JY8Ra3Y2fhmW51bQkndFDCxVfMfOeFK44PtXlHhG31y/8RXGuazpqQ2d7K6xWxVYfJj7BWHzY6DkDvXcXmpeIbhtOul0rTbZLvZshM4LxD+Is/dgKfqMYs7S6uLC5j1K+jHz2mngSSM3fc54UepNOLUVZP8f15lZGc71JXa28l/lqeOfHG/gsd2nwS6X9oOC9jZaeGQdwJGxkv6EcetfPdzMJpGmLYlY5wExn3PbNe6/E3xDqmmzw3y3unx306MtrZWEazG1T+N2mx8pxwQua8V1G5uLqS4u5vLHnyctFEAuR2BHA/Citrp/X5nTglZN23/rsZ8kjyEGR2cjgFjnA9KTeDjcGZM/d3dabSdq47np2RcuLpriNVkHCcKM/Ko9FHb3Peq7goqk7cuM9cnHvUdGOtW5iULaIkl2YUKPmGdzZ+9+Hao6M4NB/nUPXUaVgooopDCiiigApKWk7UDD6UUUUANk6VHUj/d/Go6YBRRRQAUUUUAFFFFABRRRQBJF978KlqKL734VJSELRSdqWgApfWkFOAyQB3oAToOOlFOcMH+dSrdcFcUzvTtYSHxI8sixxI0kjHCqgySfQCvUdE+EMuoaZDc3fijRdIuXQObS/co6+xI4/rXmEHmLMhiEokBypQEMD7Y5p/nTLISdzsTysmWBPuD1qkov4r/18mY1PaNrkaXqv+CdF4r8O6toPmJfWlgLdpAq3Vo6usnptIY8H6VzBBBINaeu6S+lyRFkOyRFYvtAAYjJXjoRWZ16A1VVtvUVD4L3uIe1WLJc3kR8yFRGwfdIMpwc8+1NVPLjEkkcbq4IUb+VPrjrS2lw9vMZF5OMMNucjv9KiKV9TSTbT5T608CX48RJp+pzQFjZwB4rqHTFhQqOpiDjBrrLLV49YnkS8M0Ph4Dd/pKOlwz+quo8tFJ7ZFfNXgDxHpkUXlax4i8QWbEERRIhkEag52xMDwT3+XFdrI/2lvs3hxtRv7a7jAu7eN3C3C+s27hfqortjFTX+S6fczwqjlRlZ7efX8Ud6njfSdJ1y9u5fDzRwafm3j1J77lcc7DjLNnIxjINH226utXt76bRp4odQHmJGoWF5UzkmQE7gvq2K858YfD3X/D9k95b2sP2K3i8yzfOx7YYyck/eA7HOa4v4d+MrpPElxPqdhP4n1S8j8iKa9uCTCuclgx5HvzjFKTjDVLR+v5u233+hUacqkHd6x9Px3/rufWatbwRRTJp2lS2zfNtSTzBuH8KD+9/Oq0Gp6LqGzTdVv7K+1KcGQadYxlHVTkhGVDkEDrk814/qHi2RrO309bXRbRLqEeZepf8AyRx5/vfxNx90U7RPEGl6NDczeZpscUxSVZbaJ2huF5VWuS3MbDtinOCSVnr6/wD23+X5IUar/l0/rpb/ADIvi7bXOn6b5+mf2Va2Ec23yLO3LJ1+7NL0PTlRye9eC+JNUudSuwtzctIsI2KvliNEwTwsagBRz3Ga9g8X+K/7XvQbDUhepaAl5DbF4oIyP9SAODu/vNzXi2ru815cTOuxHYmNVjIAGeAM9h680VpJqyf9fedGBj712v6+4zs0hpSMHkUlcLPYQUfWiikMB1oo70UAFAoooEHajvRRQAUUUlAwooopFISTpUVTdaMD0FMkhoqbA9BRgegpgQ0VNgegowM9BQBDRU20Y7ZowPQUAQ0VNgegpcD0FADIvvfhUlIAB0ApaQgoo7UUAKKD3waBRQB2X9pN4zvdLstY1Axyoq2sLNAo2D13KAW/4FW7D8K5bLVZrLxHeXFmzELZyLZyNDcseg3gcHpxg1xPhvVbyyuVtbdnaG4YI0KQRys5J/hDqQD716DZ+J9a8G3N3a+L4/EpgmUfZtOnvJYwyknLE5wO3SuqLjNXkeZVjUpNxpOy6L+l/mReINF1eytIraP7XfyWTbEu7SKSOaLH3uMYcY4ySK87gvEi1tbnUrY6hGsu6WC4coZR6MRyD9K6nVvG73cs8lneeIdORovLSCPUWkj+hyQcVyNlFBdXe25uEt02s7PIThiBnGQCcmiq4t2j/X4F4WE4RftF/X9djutDnj1jWFn8LeHrO3gj/wCPmxutRDJKpP3fnAI/A5qHx7oca21tqC6Fb+Gy7MjxfaGkSUjumc/kDXT+CvDng+8sxqHiOCxsoyA8flao5eIdMyKiNtGa3/GdtZ3tpYaLYan4TsNE3h5LqC5aSYr6fMgI/KtkuZWl/X5HHKryTUoaa/1rdpnicFhcagyWunvbXDKnmEhfKYAdfvYJFWD4a1+GBJZLG8FpNwZ4oy4ZfXjkivonRNE8K3WmRW2kWWjzG3j2G8nD7pcdW8wbc/TFdlZzS3Gl2CWurW0KQLtkjKiGMY4AUkc1Ps76t/194/rkr2ilb+v62PljwFqt74R8YCS1u2s5SpXzHtWL47AAgkE/gPU16T4w8bXWqasNNvbbXnuEmEsSiRIl3D+ISRbifoAa4r41mP8A4TCa6ivZpCTs2gMUAxztfvn0rnfDl6895aafPLfizaXzI7e3YjaepKk8jp1XmiypScbfgv8Aglyi68FW/wA+nXoekS+PV1PQLm2TSdd1G5tIXa4imvWmhVc4LSKQCw6cHFcrpng2fUoIbuLTLq8WRTIy2k6xWtsG7tIclCO6EfjXonw88S2NrDqlvBp0slqFJhhkzFHuyTh5seYzH3H41i2vhfVNf1VPEHiKK30G1u52wQyx3EjKuVAV2AYe+cmrknL4v6/D/gHPCpyN8un3/wBfcUNGstBs9Hvgy6RqjGIFbfT5cTRSrwH3sWBHvgD2pqatp2ll9QuW0bXtWaJVj063VjbwvnAkmHCynnnsDzisTw5YXEnia5j0/wANaZqlzIWTyL2cuEOeoGR83fgmvQdH+E66ZqUupeJptOtbVV8wRRyGZ1zyQqEArj+8Qam7XuL7tf8ANfd9+g5cq95u/wB39fMybKTxFa6X5MfiLTdPmuwzroWk26vMH6gy/KcJj+J2KjNeXeKVu1v2F/qK3MygErGxdUyB8oYfKPw49K9Oh1bw5fX00OhObaRy0Z8l8XLnori5IwqHuuKyPFlvo1vpU1taSxahrohxLBpkLfZbbb1eWRyS8nXleM9qbWji3/X3/wBeZpRk41L8uvpb9Njyn+dIacc465GevY02uBntoSlo9aSkMWiij8KACgdKKKBB2oooNABRRSUDCiiikNC0fyoopiEopaKACigUlAC0CiigQUGiigBaBSfWigApaTr0paAClpKKALWmzJb3sc0vnlU5PkSbHH0Parms6oL2YNbSahs24b7Xc+cx/HAwKqhLL7Gu57kXW75vkUxAduc5z+FVGxuODkdq15nGNjHkjOXM+hJui8gL5T+cG5fzPlI9NuP1zUY68cZpKWs27mqVjrvh7q2pWOpGy02DTrlLjCyW90yRCYZ+7vJGT6DNdn4r1q/uF+z28Xh/S7qBi00aoJpzjoMgMMe1eTQzwx25X7KjzFgfNdicD0CjH55q3p+rLa3Jnn06zvmK7St15m0fTYyn8ya6adVQja5wVsI6lTnS/wCD+Nj2LRfG2vaPoa3sWp2t1CWxstoFctjqGUfc/Kqmt+KL/wAV6JPqWlLJp8pk2u/9qyAqwP8ADFjH5V51oeqmTUbiSe/j063IaQW4Mogc/wB3ah3fmaorbWN0LiW81eO3dWJSH7PK+/8A3Tg4/E1r7XRNf1+JzLC2k1L12b+Wha8QXN2OLu/u7y6B+fzyzKnuuRj9axEuZkcSRu4lU58wEhh+NLLOVjaC2muPsp5MbtgE+6g4quOvtXNUnd6HpUqSjGzO48D6le29082nW0MhK/M+ozFLWFx0csSBu9jWr4lvLo6lNceIrWy1G7kAed7u8AhlGOPICkbSPYnPpXDaVa31wM2dje3S5BkWEMVK57kdPrWxLpN3JJPbw2aeQCZFYy7oYfYscfN+X0rem9Dhq04xqXv/AJ/mdF4I8fXXh9dQe1tNFtI55fNh1Ce0M0kD9Aq9cj8M+9ReKfiHr3iFGL32yN/vN9xplB+fEmd5Un+Adu1cXb3DadqMVzNFY3UsYz5cw3RtxjnBGTUN9qU10Yy8NvEFQJtij2BsHOTz1+mKXPy3XX+vM1WHTkmtvw/rzNDS9RlhkaGLUrbToogyh/IYhgT04UsT9fzrPv76WUmMXtzcRg5zJ8oJ9cZ5z71RZmZtzHLHqcUhx6k/WsXUdrI6o0IqXN/X5D5ZGlbLsSe3GAB9O1Rmlz8uKbWbd9TVKwUUtJUlBS0d6KACijvRQIO1JS9qKAA0lLSUDCiiigaClpKWgQUlFFAC0UUd6ACgUUUCFFJR3oNABRRRQAUUtFABUkAjZysjhCRwWzgH8AauaFYJqGowxT3dpaQlwHluWOwA+y/Mfwr2DxJp1p4V0Ayi4F/aMSggSyUR84x+9lzLj/dJI9K3o0uZ3Zx4nFKk1BK7Z4jkqcBjgHtSHvznNS3jK9y7R/cz8vJIA9s81DWUtHY6o6q4UUUVJQUUUUAGfz+tSGeUxCIuTGOg9KjpKabWwrJhQaKKQy5Z391ZITZ3t1Cz8OkUjICPqDzTJLm5mjEUs8rRZL7WYsCfXHeqwP1pPrVqVkRyK9yzBcfZmVkhiZh18xdwP4Hio5JXfG6Tdxj6e1RjjnAP1oJzjP6UcztYair3DOetFJ2oqShaSiikMWkoooAKWiigA70UlLQAdqKO1BoEFJRS0DEooooAX8aKBRQAUUlLQAd+KKKO9ABRS0lAgoNApTQAlL9aPxooASrNjZz30/lWqq8gUthnVOPqxFV6VGKOrqRuUgjjPP8AWmrdRO7Wm56h4R1m88F6bd2upRWltcBVlthcWq3EL5JzvKg4Poc1X+IXjHStYs0XTYpI9QYDzpoJGWBuOR5bEj6EYrIsfiLrkNpd2l8tjqVncqVeC6tlCj3GzaR7DoO1clcPHJIXjjEQY5Ma52r7DJJx9a6nWUY2gzzqeDbqc9Va76PT8rkWT6mg0UVyM9JCUtFIKAFpDUjxsmN6MuRkbuM0gjcqWCMVHU44p8rvYSaGUUd6KQwoooFABSUtJQAUUUUAFFFFAxaSiigAooooABRRS0AFFFGKAEpTRQaACkpaSgAooooGnYXvRRRQIP5UUUUAFFLRQAUlLRQIBRQKKAsHeiiigYUUUUCCilpKACiiigApKKKAHBsLjC/lTe/Sig0XCw8yZQAKg9wOTTKKKbbYJWCiiikAlFLRQAlFFFABRRRQMKKWkoAKKWkoAWiig0AJRS0UAHakpe1FABRSUtACUUveigaCiigYoEFFArqPCeq+FrC1nj8S+GLjWJnbMcsWotbbF9NoU5+tNK7Jk7dLnMUd677+3Ph03XwTq6em3W8/zjp41b4Zt9/wr4ij/wBzVkb+cdUqbfVfeiPav+Vnn1LXoq33woc/Poni+P8A3byFv5r9Kekvwid1L2/jmNf4gr2zf4UOnJf8Ov8AMXtv7r+482or0Wdfhppdv9pt21nXXuy/l2kh+ztYpk4MjAYeTpwuV60PD8J5DuF942hLZOwWtuwX2BL5IHvR7NrqCrXduV/ced0V6ILH4VN01rxin+9p8B/k9OXS/hW2M+JvFEf+9pcZ/k9Hs33X3or2nk/uPOaK9LGh/Cp848ba9H/vaRn+TU8eG/hYx4+ImpIMZy2huefwNDptdvvQvars/uPMaDXpv/CKfDFhx8T7hP8Ae0Cc/wAjTrfwH4J1KaK10X4n2Mt7JJjF9pslnEE7sZJCBkDt1PSp5WHtV2f3M8wor0258KfDeWVo4PiFLp0luxgmW502S6EzqcGWN4vlEbdgST71APBvgMjj4p2f46JdD+lNwadrDjUi1c85FJXZeKPDXhjTNHN1ovjqz1q8DhRZpp88DMO5DMMce+KpeC/D+ka7NcprHimw0ARgGM3UMknnE5zjaMDHue9Jxasu4+dWbOaor0sfDvw0+fL+J3hs/wC/DOv81qf/AIQjwLo4WTxJ8QLe9imwIk0GEzuvqZN33R6d6r2U+qI9tDZO55b+FGK9Qb4UQXyGXw5438KaiZiDZ2RvCl5NuPyoYscSe3rTbz4S/ZJjp914v8NWGu23F/ZaldC2WAsMoEkORKcdcAAe9LkfQFWhpr+Z5hR+FejD4UXbEiPxd4GkI/ua7FUi/B3W3/1OteE5v+uetQn+tNU5divaRX/DM81pK9QHwP8AGLKDANGmz/zz1SE/+zUh+BXxBOPL0a3lz08u/tzn/wAfo9nLsT7en3PMKWvQNQ+Dfj/T/s/2nw3Pmd/LjEU0UpJxnkKxwMDqeKmm+C/jckvpmlpq1n/DeWE6PDJjrtLFScHIPHUGjkl2BV6d7cy+884oNd+/wd+IKglvCt/x6FD/ACaq8nwo8eR53eE9V/CHP8qXJLsP29P+ZfecQKK66T4beNo/veE9c/Czc/yFV5PAHjFPveE/EH4adKf/AGWjlfYarU3tJfeczRXQnwR4sHXwtrw+unTf/E1WvPC/iCyiSW80LVreN3EavLZyIGcnAUEjkk9BRyvsP2kO6Miiur134d+LdCnih1DQrzzZIhMFgTz8Kf72zO0+xrIPhzWx10XUx/26Sf4UrNakqtTe0kZfegVYvbG7sZFS+tbi2dhuVZo2QkeoBHIqvSNE01dBSUtJQMWiikoAKKKKBoUUUUGgQUopO9LQAZooooAWikHajtQAtFJ2ooAWik7UtABRmkoNAC0Hn3+tHXNH9aQAPaiiimAfjSUUHigBcUnrR2opAJgHsKUgY6UUlMQYHoKMD0H5UUUDDaPQUmAewpaO1AjQ0PW9U0C6kudE1C60+4kjaF5LaUxsyHqpI7cA/gKoBmB4ZgfY0lHamm1sMnivbqLHlXVwhH92Vh/Wrcev6zF/q9X1FP8AdupB/WsylNPnl3E0nubaeLvEiD5PEOsqM54vpf8A4qpR438VqML4o14D21Gb/wCKrnqKOeXcXJHsdKPHvjAdPFniAf8AcSm/+KqxZ/EfxlaTpMPEuqXDJnat3O1yikjGQsmRn0OMjtXJUUKclqmJ0oNWaRvab4w8S6WLgab4g1a0FxIZphDduvmSHq7YPLH161eHxG8aqAB4r1vHveOf61ylFUq1RbSf3g6cHuka2v8AiPWvEUsMmu6peag8K7Yzcyl9g9s1kUveiolKUneTuOMVFWSsFJS9hSUihaKKSgBaKSihFRP/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transesophageal echocardiography showing spontaneous echo contrast (or \"smoke\") in an enlarged left atrium (LA). This finding is a marker for stasis and is associated with a higher risk of thrombus formation and thromboembolism.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Warren Manning, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_50_18223=[""].join("\n");
var outline_f17_50_18223=null;
